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a b s t r a c t
Tissue culture and murine experimental models were employed to study 
the mechanism by which Coxsackie B virus might cause severe focal necrosis 
of human cardiac tissue.
Human studies included the comparison of the incidence of recent 
Coxsackie B virus infection in patients suffering acute myocardial 
infarction with sex and age matched controls and, the immunofluorescent and 
electron microscopic examination of heart biopsy material.
The severity of cardiac lesions in mice was shown to be directly 
associated with the integrity of the T-lymphocyte response following 
Coxsackie B4 virus inoculation. The cytolytic action of serum was not 
demonstrated in infected mice but the cytotoxicity of activated T- 
lymphocytes against chronically infected "carrier" cells was shown.
Hyperimmune serum from adult male CBA/ca strain mice exhibited a 
cytotoxic in vitro reaction against homologous heart endothelial tissue 
chronically infected with Coxsackie B4 virus. This specific serum 
cytotoxicity was removed after heat inactivation of serum complement 
proteins at 56°C and reinstated f o l l owing addition of Guinea-Pig 
complement. The degree of observable cytotoxicity decreased when serum 
from donor mice of a heterologous strain was used.
Serum levels of creatine kinase where shown to increase following 
viral inoculation of mice but marked increase in specific isoenzyme MB 
levels occured only following T-cell mediated damage.
Comparison of serum antibody response between patients with acute 
myocardial infarction, and age and sex matched controls revealed no 
significant differences in the incidence of serologically diagnosed recent 
Coxsackie B virus infection. High concomitant serum antibody titres were 
however associated with acute myocardial infarction more frequently than
any other cardiac disease. Human cardiac damage was also shown to be 
associated with the presence of Coxsackie B viral antigen.
However, whilst human studies have revealed no conclusive evidence to 
suggest a relationship between Coxsackie B virus infection and acute 
myocardial infarction, experimental studies have demonstrated a mechanism 
by which viruses of the Coxsackie B group could cause severe focal cardiac 
damage.
"This is not the end. It is not even 
the beginning of the end. But it is, 
perhaps, the end of the beginning".
Winston Churchill, 1942.
ACKNOWLEDGEMENTS
I am indebted to Professor Gordon Cumming for awarding me a three year 
studentship at the Midhurst Medical Research Institute, and for his 
continued interest and advice especially during the preparation of this 
thesis.
It is with gratitude that I acknowledge the guidance, encouragement 
and critical assessment afforded me by Dr. Michael Butler and I wish to 
thank Dr. Michael Thomas for help in the collection of clinical data and 
for providing invaluable advice during the developmental stages of the 
study.
To Professor Anthony Davies (Chester Beatty Institute for Cancer 
Research), Dr. Robert Gamble (Epsom Public Health Laboratory), Dr. Timothy 
Coleman, Professor Rodney Cartwright and Dr. John Smith (Guildford Area 
Public Health Laboratory, I offer my warmest appreciation for the provision 
of certain facilities and materials, as well as advice, without which the 
work could not have been done.
I wish to extend my grateful thanks to Mrs. Mairi Hawkins and Mrs. 
Diane Cumming for expert technical advice and to Miss Karen Wadey for 
typing the final manuscript.
Lastly, but by no means least, I wish to acknowledge, with heartfelt 
thanks, the perpetual encouragement and support given by my parents 
throughout the years which has made the final completion of this thesis 
possible.
It is to the memory of my father, David Slocum, that I would like to 
dedicate this thesis.
LIST OF CONTENTS
Page No.
General Introduction . . . . .  .....................................  1
PART 1 
ANIMAL STUDIES
INTRODUCTION .......................................................... 2
The Immune Response and Disease ....................................  2
Mechanisms by which Pathological Change may be Induced .............. 3
Evidence to Suggest an Immunopathology for Human Heart Disease . . 15
METHODS AND M A T E R I A L S ........... .. . .  ........................  19
Preparation of Thymectomised Mice .................................  19
Post-Irradiation Bone Marrow Reconstitution....................  . 20
Adaptation of Virus to Heart Tissue . . . .  ...........................  21
Isolation and Characterisation of Virus from Tissues, Faeces and
S e r u m ................................................................  21
Preparation of Cardiac Endothelial Cells from Normal Mice . . . .  22
Preparation of "Carrier" Cells ...................................... 23
Preparation and Extraction of Immune Spleen Cells ................ 24
Preparation and Extraction of Immune Sera ........................  25
Preparation of Murine Cardiac Tissue for Histological Examination 26
Haematoxylin and Eosin Staining........................................  27
Grading of Myocardial Lesions ........................................  28
Immunofluorescent Examination of Heart Tissue in Normal and
Thymectomised M i c e ...................................................  28
Estimation of Serum Creatine Kinase Levels ............................  32
RESULTS 34
Responses to Viral Infection in an Experimental Mouse Model . . .  34
Timing of Onset of Disease ..........................................  41
Cytolytic Effect of Immune Serum . .................................. 41
Cytolytic Effect of Immune Spleen Cells ...........................  46
Virus Induced Cardiac Damage in a Murine Model .................  49
Cytolytic Effect of Immune Serum in v i v o ...........................  53
Cytolytic Effect of Immune Spleen Cells iri vivo ..................  56
Reduction of Cardiac Lesions after T-Lymphocyte Depletion . . . .  58
Cardiac Specific Enzyme Release after Viral Infection ...........  58
DISCUSSION......................................................... . . 63
Development of Overt Disease after Initial Infection .............. 63
Cytolytic Effect Mediated by the Humoral Response ................  64
Mechanism of Cellular Damage ........................................  65
Complement Requirement   . . .  67
Class of Antibody Responsible for C y t o l y s i s ..................... . 70
Cytolytic Effect of Immune Serum in v i v o ............................ 71
Cytolytic Effect Mediated by the Cellular Immune Response . . . .  72
Genetic Predisposition for Disease . ...............    74
Cardiac Enzyme Release after Coxsackie B Virus Infection . . . . .  77
PART II 
HUMAN STUDIES 
(A)
INTRODUCTION............................   80
The Coxsackie B V i r u s e s ............................................  80
Epidemiological Aspects of Coxsackie B Virus Infections ..........  81
Pathogenesis of Infection ..........................................  84
Spectrum of Clinical Disease Associated with Coxsackie B Virus
I n f e c t i o n .............................................    85
Cardiac D i s e a s e ...................................     88
Virus Infection of the H e a r t ..........................................  90
Antibody Production in Relation to Coxsackie B Virus
Myocardiopathy . . . . . .  ..................... .   96
METHODS AND MATERIALS .................................................  99
Selection of P a t i e n t s .......................................   99
Midhurst Study Group ...............................................  99
Worthing Study Group .........    100
Clinical S a m p l e s ............................ ........................  100
Serum Collection and the Neutralisation T e s t ......................  100
Faeces Collection and Characterisation of Viral Isolates ..........  102
Cell Culture............................................................ 103
Stock Virus Preparation and Titration ............................... 107
RESULTS................................................................  109
Midhurst Study Group ...............................................  109
Worthing Study Group ...................................   116
D I S C U S S I O N ........................................................ 121
Incidence of Recent Infection as Evidence of Etiological
Relationship.........................................     121
Delayed Antibody Response and Predominance of Infection in Males 127
PART II 
HUMAN STUDIES 
(B)
INTRODUCTION .......................................................... 130
Case History I ....................................................... 131
Case History I I .....................................................  132
Case History III  ...........................................  135
Case History I V .....................................................  140
DISCUSSION AND CONCLUSIONS ..........................................  144
GENERAL DISCUSSION ...........    148
CONCLUSIONS AND PROPOSALS FOR FURTHER STUDY  ....................  153
REFERENCES .  .......................................................   156
APPENDIX I ............................................................ 193
STATISTICAL METHODS . . .  ..........................................  193
APPENDIX I I .............    194
LIST OF S U P P L I E R S ...................................................  194
0
g e n e r a l  i n t r o d u c t i o n
The Coxsackie B viruses have been shown to play an etiological role in 
some acute and chronic diseases of both the adult and infant human heart 
but no attempt has been made to differentiate between the cardiac syndromes 
of viral etiology resulting in the term "myocarditis" being used to 
describe both the acute and chronic cardiomyopathies caused by Coxsackie B 
virus infection. The mechanism of pathogenesis in both acute and chronic 
cases is unclear but recent evidence suggests that an interaction, between 
infecting virus and the host immune system, occurs within the target tissue 
resulting in damage of variable severity.
The hypothesis of this project is that infection of the human heart, 
with one or more of the Coxsackie B viruses, might cause focal necrosis so 
severe as to produce symptoms indistinguishable from acute myocardial 
infarction. The experimental approach was therefore designed to examine 
the role of the Coxsackie B virus serotypes in ACUTE heart disease and was 
approached in two ways. Firstly, by identifying a possible mechanism of 
pathogenesis in a susceptible murine model and secondly by retrospective 
human studies.
The precise role these viruses may play in chronic cardiomyopathies of 
the human heart was not actively explored. ,
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P A R T  I 
ANIMAL STUDIES
I N T R O D U C T I O N
THE IMMUNE RESPONSE AND DISEASE
The conventional concept of certain pathological tissue changes being 
the result of infective processes and how the body employs the immune 
systems to counter this antigenic challenge is widely accepted. However, 
it is now evident that in many viral infections, invasion of the cell with 
subsequent viral replication, is not solely responsible for pathological 
changes; rather that an interaction of the host immune systems with the 
infecting virus may cause the tissue damage and subsequent clinical 
symptoms characteristic of a variety of viral infections (Notkins and 
Koprowski, 1973).
An Austrian pediatrician, Clemens von Pirquet, more than 70 years ago 
was the first to suggest that a manifestation of the immune response might 
sometimes be responsible for producing pathological damage. He suggested 
that the clinical manifestations of "serum sickness", (Rash, joint pain, 
shortness of breath, death in severe cases), a disease that can follow the 
injection of foreign serum proteins, was caused by toxic substances 
produced as a result of specific antibody combination with the blood 
proteins (antigens). He further suggested that the skin eruptions, 
characteristic of such viral infections as measles and smallpox, might 
result from an interaction between the virus particles and specific 
neutralising antibodies produced to combat the disease.
Later, studies by Rowe (1954) on the pathogenesis of, and immunity to, 
lymphocytic choriomeningitis (LCM) virus infection in mice demonstrated 
that in the initial stages of infection experimental animals showed no 
clinical manifestations of disease although the virus multiplied rapidly in 
many organs. However, these animals developed characteristic symptoms and
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died after an immune response had been mounted against the infection.
Further work on the pathological effect of LCM virus in 5-6 week old 
Swiss mice demonstrated that the suppression of the immune response by 
total body X-irradiation increased the survival rate and decreased the 
production of pathological lesions in the brain tissue of animals after 
intra-cerebral and intra-peritoneal inoculation of virus. Virus 
replication in brain tissue was identical for both irradiated and non­
irradiated animals (Rowe, 1956).
These preliminary experiments were later expanded and designed to 
determine which facets of the immune response, humoral or cell-mediated, 
were responsible for reacting with infecting virus and subsequently 
producing disease symptoms. By infecting 10-12 week old BALB/c mice with 
LCM virus and suppressing the immune response with intra-peritoneal 
inoculation of cyclophosphamide, post infection, Gilden et al (1972) 
produced classical LCM disease by transfer of spleen cells from animals 
previously immunised with LCM virus. This effect was not achieved using 
normal spleen cells or immune serum. They concluded that, in LCM disease 
of mice at least, pathological changes were produced by an interaction of 
infecting virus with immune lymphocytes. Furthermore they concluded that 
the production of fatal disease after LCM virus infection may be 
determined, in part, by the distribution of viral antigen within the
t
infected brain tissue.
MECHANISMS BY WHICH PATHOLOGICAL CHANGE MAY BE INDUCED
With the accounts of an interaction between infecting virus and the 
host's immune system comes speculation on how these viral antigens may 
induce, either directly or indirectly, immunopathological changes in 
certain tissues. Possible mechanisms are summarised below:
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(1) A virus may directly infect cells of the immune system causing 
specific immunological derangements. Many of the parameters of immune 
function may thus be effected.
(2) Interaction of host immune system with infecting virus may lead to the 
formation of antibody-virus complexes capable of reaction with serum 
factors initiating cellular damage.
(3) Virus infected cells may be stimulated to produce new surface antigens 
which may react with specific antiviral antibody and complement, 
resulting in cellular destruction.
(4) Sensitised lymphocytes may also react directly with changed cell
surface antigens induced by viral infection thus causing cell lysis.
Furthermore both cell mediated or antibody mediated immune responses
to viral infection may induce the activation of biological mediators,
such as macrophages, resulting in immunopathological changes.
(a.)(5) Viral infection may v 7 cause the release of host cell proteins
(antigens), alter these host cell antigens, or depress the
host genome thus "switching-on" the production of embryonic or other 
antigens. Any of these situations may initiate an auto-immune type 
response.
(6) Genetic differences and subsequent alterations in susceptibility 
between individuals may alter the severity of, or response to, a viral 
infection thereby influencing the degree of interaction.
It has been appreciated for many years that certain virus infections 
may be closely associated with and alter the morphology of lymphoid organs. 
Somerville and MacFarlane (1964) using i m m u n o f l u o r e s c e n t  staining 
techniques detected Coxsackie B group virus antigen, adenoviruses and 
herpes zoster in peripheral blood leukocyte smears from patients with 
aseptic meningitis, Bornholm disease and pyrexia of unknown origin.
Viruses or virus-like-particles have also been demonstrated in macrophages 
by immunofluorescence (Somerville, 1968; Gresser and Lang, 1966; Mims, 
1964). More recently it has been shown using Swiss ICR and Nude (nu/nu) 
adult mice that infectious mononuclear leukocytes may be isolated during a 
Coxsackie B3 viraemia. (Gomez et al, 1980). Virus positive mononuclear 
leukocytes persisted in the blood after virus was no longer demonstrable in 
the plasma. As a result of this versatility of infection a virus may exert 
an effect on the immune response through the humoral or cellular aspects of 
the hosts defence system.
Peterson et al (1963) have demonstrated the effect of Gross' Passage A 
lymphatic leukemia virus on the humoral immune response of chronically 
infected adult C3 Hf/Bi strain mice. Their ability to produce specific 
antibody against T2 bacteriophage was markedly decreased. Similarly, the 
specific immunogloblin G (IgG) and immunoglobulin A (IgA) response to sheep 
red blood cells in Osborne Mendel rats was markedly decreased when these 
animals were injected with Moloney leukemia virus at birth (Cremer et al, 
1966). Further investigations have shown that in chickens infected with 
the agent causing Marek's disease (a herpes virus) (Purchase et al, 1968) 
or avian leukosis virus (Dent et al, 1968) a marked depression of humoral 
immune function occurs in response to certain viral antigens. As a rule 
the immunodepressive action of these leukemia viruses is more effective 
when inoculated prior to the administration of the stimulating antigen 
(Notkins et al, 1970). The degree of immunodepression is largely 
proportional to the dose of infecting virus. Furthermore, there is 
evidence to suggest certain viruses are capable of selectively depressing 
specific classes of immunoglobulin (Cremer, 1967; Cure and Cremer, 1969; 
Soothill et al, 1966). Other investigators have demonstrated that viruses, 
other than the leukemia viruses, are capable of immunodepression. Mims and
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Wainwright (1968) using C57/B1 mice demonstrated that when they were 
injected with lymphocytic choriomeningitis virus immune suppression was 
most marked in adult mice, transient in neonates and totally absent in 
chronically infected animals. Osborn and Medearis (1967) have shown that 
interferon production and the host's humoral immune response to a secondary 
infection with Newcastle disease virus was depressed after a previous 
infection with murine cytomegalovirus. Medzon and Vas (1964) infecting 
cultured rabbit spleen cells with Newcastle disease virus showed a 
depression in the ability of these cells to produce antibody to bovine 
serum albumin in vitro. They concluded that the immunodepressive effect of 
this virus was attributable to direct virus induced damage of the cells 
responsible for the production of immunoglobulin.
Subsequent work has shown that not all the effects viruses impose on 
the humoral immune system are depressive, some have an adjuvant effect. By 
injecting CAf-1 male mice with lactic dehydrogenase virus Notkins et al 
(1966(a)) demonstrated a rise in the maximum antibody titre, an increase in 
the number of mice with a demonstrable humoral antibody response and a 
shortening of the induction period. It has also been shown that Venezuelan 
equine encephalitis virus infection in Hartley strain Guinea pigs results 
in immuno-enhancement when challenged with bovine gamma globulin (Craig et 
al, 1969).
In addition to the enhancement and depression of the humoral immune 
response certain viruses have been shown to depress the influence of the 
cellular aspect of the immune response. Indeed, many of the factors 
involved may be common to both humoral and cellular immunity. Dent et al 
(1965) by grafting skin across a weak (non H-2) histocompatibility barrier 
in C3H mice found that subsequent infection with Gross' Passage A leukemia 
virus prevented the normal graft rejection process when these animals were 
6 weeks old. Allograft rejection and graft-versus-host reaction have both
been inhibited in mice by injection with lactic dehydrogenase virus (Howard 
et al, 1969). Furthermore, this virus has been shown to augment tumour 
growth in female Swiss/Webster mice (Bailey et al, 1965).
The concept that persistent antigen-antibody complexes in the blood 
stream may themselves initate pathological changes in certain tissues has, 
since the original observations (in man) of Clemens von Pirquet, gained 
considerable momentum.
Dixon et al (1961) stress the evidence to "suggest an immunologic 
basis for some kinds of human glomerulonephritis". These workers attempted 
to produce a glomerulonephritis in a rabbit model by repeated injections of 
"various foreign serum proteins". They produced an acute proliferative 
exudative glomerulonephritis in some and a chronic membranous proliferative 
glomerulonephritis in others but both conditions, functionally and 
m o r p h o l o g i c a l l y  r e s e mbled h u m a n  acute, sub-acute and chronic 
glomerulonephritis. They further substantiated the immune basis for this 
nephritic disease by demonstrating that the antigens alone were not 
nephrotoxic. They concluded that glomerular injury was produced as a 
result of recurrent interaction between antigen (foreign serum proteins) 
and antibody, either by antigen-antibody complexes localising in the 
glomerular tissue and producing direct tissue damage in some way, or by 
initiating the release of systemic nephrotoxic materials.
Arising from these studies was the implication that, antigen-antibody 
interacti on  and subsequent glo me rular damage, depended upon the 
quantit at ive rel atio nship  of both antigen and antibody. It has 
subsequently been concluded that the chronic glomerulonephritis, associated 
with repeated administration of foreign serum proteins, is most likely to 
occur in individuals with poor humoral antibody response where soluble 
antigen-antibody complexes will be present in antigen excess (Oldstone and
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Dixon, 1971). This situation of antigen excess occurs, with viruses 
capable of forming immune complexes, in animals exhibiting a persistent 
viraemia which stimulates a continuous low level immune response.
The nature of these "nephrotoxic" antigen-antibody complexes deposited 
along the glomerular capillary wall and mesangia has been shown to be virus 
and host antiviral antibody in association with the C3 component of 
complement, whereas circulation complexes consist of virus and host 
immunoglobulin G, presumably antiviral antibody (Oldstone and Dixon, 1971).
There is now considerable evidence for associating immune complex 
disease, both at the site of pathological change and in the circulation, 
with many chronic murine infections. For example, with lymphocytic 
choriomeningitis virus (Oldstone and Dixon, 1969), lactic dehydrogenase 
virus (Notkins et al, 1966(b)), Moloney leukemogenic virus (Hirsch et al, 
1969), Aleutian virus disease of mink (Porter and Larsen, 1967; Porter et 
al, 1969) and in Coxsackie B4 virus infection (Sun et al, 1967).
A similar situation has been reported in humans. Gocke et al (1970) 
reported a previously unrecognised association between HBs Ag -antibody 
complexes and polyarteritis nodosa. They concluded that the deposition of 
complexes, composed of HBs Ag, homologous immunoglobulin M and complement 
components, in the blood vessel walls resulted in the diffuse vascular 
d a mage characteristic of this disease. Furthermore, by using 
immunofluorescent techniques Gocke et al (1971) demonstrated complexes of 
HBs Ag, homologous immunoglobulin M and complement at the site of injury in 
blood vessel walls of patients with polyarteritis nodosa and chronic HBs 
antigenaemia. Complexes comprising HBs Ag and immunoglobulin were also 
detected in free humoral circulation. As HBs Ag is a viral product this 
may well be the first recognition in man of a systemic vasculitis resulting 
from the immune reaction to a viral infection.
It has been demonstrated in the last decade that target cell surface
antigens may be transformed by infection with oncogenic viruses and 
further, that these "new" cell surface antigens may initiate the immune 
response characteristic of tumour rejection. Non-oncogenic viruses have 
also been shown to induce the transformation of cell surface antigens "but 
the biological significance of these antigens has received relatively 
little attention" (Allison et al, 1972).
Evidence has now been produced that morbidity associated with certain 
viral infections may result from an interaction between specific antiviral 
immunoglobulin, and these "new" cell surface antigens in the presence of 
complement components.
In vivo evidence in support of this hypothesis has been produced in 
SWR/J "carrier" mice infected chronically with lymphocytic choriomeningitis 
(LCM) virus (Oldstone and Dixon, 1970). Transfer of anti-LCM virus 
antibody to these animals produced an "acute necrotising inflammatory 
lesion in regions of viral persistence followed by chronic mononuclear 
infiltrates". They concluded that an interaction of anti LCM virus 
immunoglobulin with persisting viral antigen at the tissue site may, at 
least in part, be responsible for the pathogenesis of tissue injury 
associated with chronic lymphocytic choriomeningitis virus infection in 
mice.
Strong in vitro evidence suggesting that antiviral immunoglobulin in 
association with complement may damage virus infected cells, has been 
produced by Fernandes et al (1964). By infecting a rabbit endothelium cell 
line with a fixed rabies virus strain they induced a "carrier" state that 
persisted over several passages but cell growth and morphology was not 
impaired. They found that when these cells were challenged with fresh 
anti-rabies serum the cells were lysed completely. This effect was negated 
upon heat inactivation of immune serum but was restored with fresh hamster
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complement. A more sophisticated approach was adopted by Wiktor et al 
(1968) which confirmed these previous findings by using human diploid 
fibroblasts and other cells of hamster origin infected with a tissue 
culture adapted rabies virus strain. Cytolysis was monitored by release of 
chromium 51.
Although there is much evidence substantiating the role played by the 
cell-mediated immune response in recovery from virus induced lesions 
(Blanden, 1971; Glasgow, 1970; Allison, 1972) there are circumstances where 
the reaction of immune cells with viral antigens, either free or on the 
infected cell surface may induce tissue damage. The cell-mediated 
immunopathology model that has received most attention is that of 
lymphocytic choriomeningitis virus infection in mice. By producing chronic 
disease states, carrier animals injected with virus shortly after birth, 
(Volkert and Larsen, 1964) or transplacentally in utero, Oldstone and Dixon 
(1970) induced substantial tissue injury by direct transfer of immune cells 
to these animals. They also intensified existing tissue damage by 
parabiosis between hyperimmune donors and isologous animals with chronic 
lymphocytic choriomeningitis. Speel et al (1968) by inducing a non- 
cytocidal infection of Enders strain mumps virus in cultures of Chang's 
permanent line of human conjunctiva epithelial cells inhibited the growth 
of, and in some cases destroyed, these virus carrying cells by inoculating 
cultures with splenocytes removed from mice 4-5 days after immunisation 
with mumps virus. They concluded that tissue damage resulted from the 
interaction of immune leukocytes with viral antigen in association with the 
target cell plasma membranes.
The term "auto-immunity" is a general description used when the immune 
response, either antibody or cell-mediated, is directed against the normal 
body constituents. In older individuals the presence of auto-antibodies 
against host antigens such as thyroglobulin, mitochondria, microsomes and
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DNA, in the absence of pathological tissue changes, is relatively common. 
However, a more serious situation arises when auto-antibodies are directed 
against the surface components of cells such as erythrocytes. In certain 
severe auto-immune conditions such as a progressive and chronic thyroiditis 
known as Hashimoto's disease the pathological manifestations are thought to 
result largely from a cell-mediated immune response directed against the 
target cell antigens.
It has been appreciated for many years that influenza viruses are 
capable of incorporating cellular antigens from the cultures in which they 
are grown (Cohen, 1944; Knight, 1946). The most widely studied of these 
host cell antigens is a sulphated mucopolysaccharide found in chicken 
liver, bile and the allantoic cells. Influenza viruses cultured in chick 
allantoic cavity become closely associated with this host antigen. 
Chickens immunised with influenza virus containing antigens derived from 
the chorioallantoic cells in which they were cultured produce an auto­
antibody against that same antigen present in the liver and bile fluids 
(Harboe and Haukenes, 1966). It was therefore proposed that antigens 
present on a host tumour cell may be immunogenically weak and that if these 
antigens were incorporated into the lipid or protein coat of an infecting 
virus they may be transformed into more potent immunogens. Lindenmann and 
Klein (1967) immunising A2G mice by a single intra-peritoneal injection of 
lyophilised homogenate of Ehrlick's ascites tumour cells, previously 
infected with an oncolytic strain of influenza A virus, successfully 
prevented development of tumours in these animals when challenged with 
uninfected tumour cells. Similar homogenates of non-infected tumour cells 
were not protective. They concluded that the immunogenic potency of 
certain host cell components was greatly enhanced by incorporation into the 
envelope of an infecting virus.
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Varying susceptibility to certain virus infections, associated with 
genetic variability, has been documented and it may be that undefined 
genetic factors linked with the major histocompatibility loci of the mouse 
determine the severity of the clinical manifestations associated with 
certain viral infections in these animals (Wld. Hlth. Org. Techn. Rep. 
Ser., 1968). The resistance of mice to Group B Arbovirus infections is 
determined by a single gene.
A minimum of 31 distinct histocompatibility genes (or more correctly 
gene complexes) comprise the histocompatibility systems of the laboratory 
mouse. These are present throughout the entire genome including the sex 
chromasomes. Of these so called H-genes the strongest histocompatibility 
barrier is presented by antigens coded for by the H-2 system. 
Recombination studies have revealed two distinct gene complexes, within the 
H-2 system, responsible for controlling cell surface antigens. These gene 
complexes are referred to as H-2D and H-2K (Plate 1). These loci are 
seperated by at least two other gene complexes; Ss-Slp (controlling 
variations in serum proteins) and Ir-1 (regulating the magnitude of the 
immune response) (Amos et al., 1972).
Gorer (cited by Amos et al, 1972) made the initial observation 
suggesting that the H-2 locus was a major factor in determining the 
susceptibility of mice to the induction of primary viral neoplasm. He used 
mouse strains C57 BL/6 and C57 BL/10 and B10.BR and B6.AK which differ 
principally from one another at the H-2 locus. The former two strains are 
highly resistant to gross virus leukaemogenesis while the later two are 
very susceptible to the same virus dose. Furthermore, it was suggested at 
the time that the H-2K region, or a very closely linked gene locus, was 
responsible for viral susceptibility by determining the degree of immune 
response. The H-2D histocompatibility locus appears to be irrelevant in 
this respect. In the inbred mouse at least, it is now possible to predict
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the degree of immune response to a given antigen from a knowledge of the 
histocompatibility type of the animal.
The major histocompatibility system in man is known as HL-A and the 
possible association betwen the presence of certain HL-A antigens and the 
susceptibility to certain diseases has been investigated for many diseases. 
It is only within the last 10 years though that convincing associations 
have been shown. Stokes et al (1972) studying patients with adult coeliac 
disease showed that the HL-A1 specificity occured in 78%, and HL-A8 in 88%, 
of patients with active disease. This was significantly greater than the 
33.2% and 29.5% for each antigen respectively demonstrated in a control 
population of 268 individuals. Also, the frequency of the combination of 
HL-A1 and HL-A8 was significantly greater in patients with disease than in 
controls. Mackay and Morris (1972) have shown a high frequency of HL-A1 
and HL-A8 antigens in patients with chronic active hepatitis. Blumberg et 
al (1969) produced evidence suggesting that genetically governed variations 
in the immune response may be a factor determining susceptibility to 
hepatitis virus infection.
A similar high incidence of HL-A antigen W27 was noted for patients 
suffering from ankylosing spondylitis. Schlosstein et al (1973) have shown 
that 88% of patients with ankylosing spondylitis exhibited the HL-A 
specificity W27 compared with only 8% of normal controls. Brewerton et al 
(1973) have also shown that 72 out of 75 patients with ankylosing 
spondylitis had the HL-A antigen 27, compared with 3 out of 75 in control 
patients. Also of significance was the fact that 52% of first degree 
relatives also showed this association.
The cause of these diseases is unknown but the high incidence of 
certain HL-A antigens in certain disease states suggests these 
specificities may be related to the etiology of the disease. Perhaps there
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is a very close linkage of a gene governing immunological responsiveness to 
the disease with the gene or genes responsible for determining HL-A 
specificity or a strong biochemical cross-reaction between the possible 
etiological agent for the disease and the given HL-A antigen.
EVIDENCE TO SUGGEST AN IMMUNOPATHOLOGY FOR HUMAN HEART DISEASE
Since the appreciation that some viruses only produce clinically 
distinct disease when the host launches a strong immunological reaction 
against the infecting virus, cardiologists are increasingly aware of the 
possibility that such a reaction takes place in viral infections of the 
pericardium. Such a situation, in oppostion to the straightforward 
"infection concept", is usually supported by a relatively high white blood 
cell count and s o m e t i m e s  dramatic response to steroid therapy. 
Confusingly, latent periods between infection and onset of acute symptoms 
may vary between a few days to several weeks. This possibility is not 
confined only to pericarditis. It is clear that rheumatic fever, post- 
cardiotomy syndrome and post-myocardial infarction syndrome "are acute or 
inflammatory disease manifestations associated with polyserositis and 
pleural pericardial pain. It is quite possible that hypersensitivity is a 
contributory or even basic mechanism in each instance". (J.A.M.A., 1962). 
If these pathological changes were induced by an immune reaction, then it 
would be reasonable to suggest that the immune response would be directed 
against streptococcal antigens, surgically induced trauma or necrotic 
lesions respectively.
In a number of studies on human chronic and acute cardiac disease 
states circulating anti-heart antibodies have been detected suggesting an 
auto-immune pathology. Zabriske et al (1970) noted the close association 
between the clinical course of rheumatic fever and high titres of humoral
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anti-heart antibody. When the disease was inactive these high titres 
decreased significantly over a 2-3 year period following acute rheumatic 
fever, or even disappeared, and reappeared on exacerbation of the disease. 
It is not clear whether this exacerbation of disease followed the rise in 
heart reactive antibody titre or whether antibody increase followed an 
increase in streptococcal antigen. Similarly the relationship between 
immunological phenomena and post myocardial infarction syndrome has been 
described (Kuch and Chorzelski, 1971). An increase in serum titres of 
auto-antibodies towards the heart invariably coincided with the overt 
clinical manifestations of the disease.
In African patients, with and without known heart disease, Shaper et 
al (1967) noticed a high incidence of heart auto-antibodies. They drew 
attention to the suggestion that in patients with endomyocardial fibrosis 
the frequency of heart auto-antibodies may be higher and the presence of 
such a u t o-antibodies is associated with the presence of malarial 
antibodies. This led to speculation whether anti-malarial antibodies may 
cross-react with the tissues of the heart. Further studies of the heart in 
endomyocardial fibrosis suggest that a hypersensitivity reaction may be the 
underlying immunopathological mechanism responsible for producing heart 
damage (van der Geld et al, 1966). In the immigrant and indigenous peoples 
of Uganda, Shaper et al (1968) noted a syndrome where high titres of 
malarial antibody were associated with elevated levels of IgM and 
circulating auto-antibodies to heart tissue, thyroid and gastric parietal 
cells. This was particularly noticeable in those people who had come from 
areas of low malarial incidence to live in areas of high malarial 
concentration. They concluded that the presence of heart tissue auto­
antibodies associated with an unusual host immune response to malarial 
infection may play a critical role in the pathogenesis of endomyocardial
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fibrosis.
Davies et al (1964) showed that cardiac auto-antibodies are produced 
in experimental animals after immunisation with heterologous and homologous 
cardiac tissue but were unable to correlate the titre of humoral heart 
antibodies with the extent of the myocardial lesions. This lack of 
correlation between the titre of circulating antiheart antibodies and the 
presence of histologically demonstrable myocardial lesions was apparent to 
Laufer et al (1970) when injecting heterologous heart extracts into 
experimental rabbits, guinea-pigs and rats.
Passive immunisation with either homologous or heterologous anti-heart 
sera did not produce myocarditic lesions due, it would appear, to the 
specificity of the anti-heart antisera for intra-cellular components only. 
These antibodies only become cytotoxic after disruption of the cell-wall 
barrier with isoprotenerol (Laufer and Davies, 1969).
In vivo studies have shown that lymphocytes from Lewis rats immunised 
with rabbit heart antigen inoculated into normal recipient rats were 
associated with the development of myocarditis, of variable severity, with 
lymphocytic infiltration suggesting a cellular immunopathology in some 
cases (Friedman et al, 1971).
Evidence suggesting a causative immunopathological mechanism in 
Coxsackie B virus associated heart disease has been produced by Woodruff 
and Woodruff (1974). Using adult female CDI and BALB/c mice they 
demonstrated that the virus replicated to a high titre in the hearts of 
these animals but was not detectable six to eight days after the initial 
intra-peritoneal injection. Using i m m u n o d e p r e s s e d  a n i m a l s  they 
demonstrated the necessity for an intact T-lymphocyte response in the 
pathogenesis of inflammatory necrotic changes in the myocardium following 
Coxsackie B virus infection. Additionally it was shown that the antibody 
response to viral infection, at least in the first eight days post
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infection, is not T-cell dependent. Furthermore, the deprivation of T- 
lymphocytes did not impair the recovery mechanism which would imply that in 
normal animals the extensive infiltration of the cardiac muscle is not 
essential for inhibition of viral growth.
In vitro studies have been used to demonstrate an immunopathogenesis 
for Coxsackie B viral heart disease (Wong et al 1977(a)). Measuring 
cytolytic activity in Coxsackie B virus infected neonatal fibroblasts of 
BALB/c mice by release of ~^Cr they demonstrated cytotoxic spleen cells in 
adult males of the same strain, three days after inoculation with Coxsackie 
B3 virus. By selectively eliminating certain cell populations from the 
cytotoxic pool they confirmed the primary role of T-lymphocytes in the 
pathogenesis of Coxsackie B heart lesions and concluded that B-cells and 
macrophages played a relatively insignificant role. Using an In vitro 
assay Wong et al (1977(b)) showed that neonatal mouse myocardial cells, 
infected with Coxsackie B^ viruses, were susceptible to damage caused by 
spleen cells, previously sensitised to the same virus strain. They 
concluded that their evidence suggested that, following Coxsackie B^ 
infection, mice were able to mount a cell-mediated immune response with the 
subsequent production of cytotoxic T-cells with an ability to damage other 
tissues infected with the same virus.
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M E T H O D S  A N D  M A T E R I A L S
PREPARATION OF THYMECTOMISED MICE
Animals to be thymectomised were anaesthetised with anaesthetic ether 
(May and Baker Ltd.)^^ in a "box type" chamber (Jencon's (Scientific) 
Ltd.) The animal was then stretched out on its dorsal surface with
flexors (small "bull-dog" clips attached to elastic bands) attached to each 
of all four limbs and secured by dissection pins (Baird and Tatlock)^. A 
tooth clip attached to the upper incisors was secured by a pin and a cotton 
wool bolster was placed under the shoulders to raise the thorax to the 
operating position. The ventral surface of the thorax and neck region was 
swabbed with cetrimide (Imperial Chemical Industries Ltd.)^. A mid-line 
longitudinal incision was made about 20 mm long through the skin above the 
anterior end of the sternum using previously sterilised blunt ended 
scissors and fine forceps (Thackray Ltd.)^\ It was then often necessary 
to adjust the flexors holding the front paws to stretch the skin back. The 
salivary glands were then carefully separated (profuse bleeding may occur 
if they are not handled gently) and deflected either side of the incision. 
One point of a blunt ended pair of scissors was inserted under the right 
clavicle, and a cut made at an oblique angle to the anterior end of the 
sternum. The same was done for the left side. Care was taken at this 
stage to prevent damage to the brachial circulation complex. The anterior 
end of the sternum was deflected upwards and any tissue covering the thymus 
was parted. A finger was placed under the diaphragm and pressed upwards in 
such a way that the contents of the thorax forced the thymus into an easily 
visible position. This procedure also helped prevent pneumothorax. Both 
lobes of the thymus were then removed consecutively by suction using a 
pasteur pipette attached to a water p u m p ^ K  The forelimb flexors were
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removed, the anterior end of the sternum relocated and the skin over the 
thorax clipped together with stainless steel wound clips (Clay Adams)^. 
The animal was released and placed in a recovery cage.
Recovery from the anaesthetic should be quick and no special post 
operative care was practised. Post operative mortality in excess of 10% is 
indicative of careless technique.
POST-IRRADIATION BONE MARROW RECONSTITUTION
Normal, 12 week old donor mice were killed by cervical dislocation and 
pinned out, ventral surface uppermost on a six inch square cork board. By 
cutting through the axilla of the hind limbs to the pelvic girdle and 
dislocating the ball and socket joint between the pelvis and femur, the 
femur was deflected upwards, dislocating the knee joint and removed. 
Femurs were paired and placed in a sterile petri dish (Sterilin Ltd.)^^ 
containing sterile filter paper (Whatman Ltd.)^^ moistened by single 
strength sterile medium 199 containing antibiotics, streptomycin (100 
mg/ml) and penicillin (100 IU/ml) (Wellcome Laboratories Ltd.)^^. The 
epiphyses of each bone were removed with scissors and a 23 gauge, 1" needle 
(Sherwood Medical Industries Ltd.)^^ was inserted into the central cavity 
of the femur for about 2-3 mm. Bone marrow was then flushed out with 2 ml 
of single strength sterile medium 199^^ from a sterile polypropylene 
syringe^^ attached to the needle. This procedure was performed on both 
ends of the femur. Using the same needle the bone marrow cell suspension 
was aspirated several times to break up cell clumps.
A viable cell count was performed, as subsequently described, with
£
approximately 25 x 10 stem cells being produced from each donor. Each 
lethally irradiated recipient mouse was injected, via the tail vein with 5
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x 10^ cells in 0.4 ml of single strength sterile medium 1 9 9 ^ \  using a 
sterile gauge 5/8" needle^^. This procedure is carried out within 4 h of 
lethal irradiation (850 rads in 15 min).
ADAPTATION OF VIRUS TO HEART TISSUE
A strain of Coxsackie B4 virus was heart adapted by serial passage 
through four groups of three week old male CBA/Ca strain mice. Stock virus 
was titrated in tissue culture and inoculated in 0.2 ml at a 100 TCID^q 
dilution. Hearts were harvested, weighed, homogenised in Griffiths 
tubes^^ and resuspended at 10% (w/v) in normal saline containing
penicillin (1000 IU/ml) and streptomycin (1000 mg/ml). The resultant virus 
suspension was used to reinoculate mice as above and the procedure 
repeated. Finally, hearts were harvested and processed as above. The 
virus was titrated in tissue culture as subsequently described and stored 
in 1 ml plastic vials^^ in gas phase liquid nitrogen (Liquidaire
Ltd.)( U ) .
ISOLATION AND CHARACTERISATION OF VIRUS FROM TISSUES, FAECES AND SERUM
Pieces of tissue were suspended at 10% (w/v) in cell maintenance 
medium and homogenised in sterile Griffiths t u b e s ^ \  Faecal material 
(0.1 g) was emulsified in 0.9 ml of test diluent and viral infectivity 
titrations were performed by the method subsequently described for stock 
virus suspension. Furthermore, type specificity of infective virus was 
confirmed by the method described later for Coxsackie B virus serotypes. 
Virus in serum was titrated directly.
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PREPARATION OF CARDIAC ENDOTHELIAL CELLS FROM NORMAL MICE
The cell lines used for lymphocyte and immune serum cytotoxicity 
assays were derived from a primary culture of cardiac endothelial tissue 
from 24h old neonatal mice.
A suitable quantity (18-20) of 24 h old mice were killed by 
decapitation and pinned out on a cork board ventral surface uppermost. All 
procedures described hereafter were performed using aseptic technique under 
a laminar flow cabinet (Hepaire Ltd.)^^. Neonates were swabbed with 70% 
alcohol. The chest was opened by a median line incision just below the 
xiphisternum and extended up the left side of the chest close to the 
sternum to the base of the neck. A transverse cut across the top and base 
of the sternum to the right axilla and flank respectively enabled 
deflection of the sternum and right chest wall to expose the still beating 
heart. Iris scissors were inserted beneath the heart and the great vessels 
were cut close to the atria. Excised hearts were washed three times in 
separate tissue culture dishes (Corning L t d . i n  Hank's balanced salt 
solution without calcium and magnesium, (Flow Laboratories L t d . ) ^ ^  
previously cooled at +4°C for 1 h. Washing dishes were stored in an ice 
bath. During the first wash unwanted tissue was trimmed from the heart and 
blood clots removed from the heart chambers by gentle palpation with 
forceps. Washed hearts were then cut into 1 mm  pieces and transferred into 
a 100 ml capacity Erlenmeyer flask with 10 ml of trypsin solution^ 
diluted in Hank's balanced salt solution without calcium and magnesium to
0.125% (v/v). This tissue trypsin mixture was incubated at 37°C for 10 min 
and gently agitated using a magnetic "flea" with a stirrer^^ set at 60 
rpm. The supernatant containing connective tissue and red blood cells was 
decanted carefully, discarded and the tissue was recharged with 10 ml of 
trypsin solution. This enzymic treatment was repeated every 10 min for the
following hour. As trypsin and cell suspension were withdrawn 2 ml of cell
growth media was added to the trypsin cell suspension to neutralise enzymic
activity. Trypsinised cells were washed twice in pre-cooled maintenance
medium, suspended in 2 ml of maintenance media, and stored in an ice bath.
On completion, cell suspensions were pooled and a viable cell count
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performed. Cells were subsequently seeded into 25 cm plastic disposable 
growth flasks^^ at a concentration of 5 x 10“* cells/ml, in 6 ml of growth 
medium.
This final suspension of cells comprised two distinct populations, 
myocardial beating elements and endothelial cells at an approximate ratio 
of 3:2. These cell types were separated using an adaptation of the "flip- 
flop" differential attachment technique described by Kasten (1973). This 
technique is based on the differential rate of attachment of endothelial 
cells and myocardial beating filaments. The following procedure was 
adopted to enable the production of a "pure" culture of murine cardiac 
endothelial cells.
After seeding, growth flasks were incubated at 37°C for 2 h and then 
sharply tapped on the side of a bench to dislodge any myocardial cells 
prematurely attaching to the growing surface. Endothelial cells attach 
within 2 h. Culture media, with the myocardial cell suspension, was 
withdrawn, discarded and growth flasks were recharged with 6 ml of fresh 
growth media.
PREPARATION OF "CARRIER" CELLS
Primary cultures of murine cardiac endothelial cells were established 
and grown to confluency in 25 cm^ disposable plastic culture f l a s k s ^ ^  
using the method previously described. After 2 days incubation at 37°C
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primary cultures were inoculated with 0.5 ml of 100 TCID^q Coxsackie B4 
virus suspension and incubated a further 2 h before washing and re-seeding 
with 6 ml of fresh growth media. Cultures could be maintained through 15 
consecutive passages before cell degeneration was apparent. Cells used for 
cytotoxicity testing were used between passes 2 and 10. Cells were 
harvested by the method described for Vero cells and seeded at 1 x 10"* 
cells/ml concentration into tissue culture treated microtitre plates^^. 
Further incubation of plates overnight produced confluent monolayers of 
endothelial cells supporting replicating virus without cytopathic effect.
PREPARATION AND EXTRACTION OF IMMUNE SPLEEN CELLS
Adult (10-12 weeks) mice were used as spleen cell donors. Donor mice 
were given an intraperitoneal inoculation of 0.2 ml of 100 TCID^q Coxsackie 
B4 virus suspension and killed by cervical dislocation five days later. 
Spleens were removed aseptically through a mid-line incision of the ventral 
abdominal wall, previously swabbed with 70% alcohol, and placed separately 
in sterile culture d i s hes^^ containing 5 ml of sterile phosphate buffered 
saline without calcium and magnesium but with foetal bovine serum at 5% and 
precooled to +4°C. Spleens were cut in 2 mm fragments with iris scissors 
and finely teased with a pair of sterile 21 gauge 38 mm hypodermic 
n e e d l e s ^ ^ *  This procedure was observed using the low power objective 
(X10) of a CK-Olympus inverted microscope (Gallenkamp Ltd.)^"*\ The 
resultant spleen cell suspension was then repeatedly aspirated into a 
sterile 5 ml polypropylene syringe^^ through a 21 gauge 38 mm hypodermic 
needle to disrupt the cell suspension further.
The associated erythrocytes were lysed by the addition of 0.4 ml of 
Zaponin (Coulter Electronics Ltd.)(^. Cells were agitated briskly for 5
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sec and washed twice in fresh 5 ml aliquots of phosphate buffered saline 
(+4°C). Enumeration of viable cells was performed by the method described 
later and cells were stored in an ice bath until use.
Specific depletion of T-lymphocytes from i m m u n e  spleen cell 
preparations was effected by the use of F7D5 anti-Thi-1.2 antigen 
monoclonal antibody (OLAC Ltd.)(^. Immune spleen cell populations, at a 
concentration of 1 x 10"* cells/ml in 5 ml of phosphate buffered saline 
without calcium and magnesium were agitated gently for 2 h at +4°C with 
F7D5 antibody at a dilution of 1 in 900. Remaining immune spleen cells 
were washed twice in 5 ml of fresh phosphate buffered saline before use in 
the in vitro and in vivo systems.
PREPARATION AND EXTRACTION OF IMMUNE SERA
Adult male (10-12 weeks) mice were used for the preparation of high 
titre immune sera. Batches of 10 animals were inoculated via the intra- 
peritoneal route with 0.2 ml of 100 TCID^q Coxsackie B4 virus. These 
groups were similarly re-inoculated on day 3, 7 and 12 and exsanguinated by 
retro-orbital bleeding, under anaesthetic, on day 15. Blood was allowed to 
clot (1.5 h at +4°C) and centrifuged at 1000 G for 15 min. A small sample 
of serum was retained for antibody titration with the remainder being 
stored in gas phase liquid nitrogen^"^ in sterile plastic vials^^.
Sera for studies in serial antibody levels was obtained from animals 
using the following techniques. The mouse was immobilised by downward 
pressure on the back with the 2nd, 3rd, and 4th fingers and grasped firmly 
by the scruff of the neck between thumb and forefinger. The animal was 
positioned right eye uppermost and slight pressure beneath the socket 
caused the eye to protrude. A bleeding pipette was inserted gently into
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the medial canthus of the right eye, directed below the eyeball and towards 
the optic foramen. Rotation of the pipette about its longitudinal axis 
ruptured the retro-orbital plexus and withdrawal of the pipette about 1 mm 
resulted in free blood flow into the bore. When sufficient blood had been 
obtained simultaneous withdrawal of the pipette and release of the mouse 
resulted in minimum after-bleeding. Blood was discharged, from the pipette 
with a rubber teat, into 2 ml capacity polypropylene micro-centrifuge tubes 
(Alpha Laboratories Ltd.)^^. The pipette was at all times held very 
lightly with constant attention being paid to the condition of the mouse.
Blood was also obtained by tail bleeding from mice placed in a wooden 
ventilated retaining box with a 1 mm slit cut in one side through which the 
tail was held. One to 2 mm  of tail was amputated with sterile sharp 
scissors and the tail gently massaged along its length. Talcum powder was 
used to reduce friction between the "stroking" fingers and tail to prevent 
serious bruising as this hindered further efficient bleeding. As blood 
drops formed at the tail tip, they were collected into 2 ml polypropylene 
micro centrifuge t u b e s ^ ® \  Blood was allowed to clot (1.5 h at +4°C)> 
centrifuged at 1000G for 15 min and the resultant serum supernatant was 
stored in 4 ml capacity sterile glass b i j oux^^ and stored at -20°C.
PREPARATION OF MURINE CARDIAC TISSUE FOR HISTOLOGICAL EXAMINATION
Buffered formalin was prepared by making a 10% aqueous solution of 
formaldehyde (BDH Chemicals L t d . ) ^ ^  and adding sodium dihydrogen 
phosphate (NA P0^ . 2H20)^^^ at 4.5 gm/1 and disodium hydrogen
phosphate (Na£ HPO^ . at 6.5 gm/1. Murine hearts were removed
immediately after death and divided into two. Tissue comprising the left 
heart was placed in 10 ml of buffered formalin and fixed in this solution
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for 24 h prior to dehydration and clearing. Dehydration was carried out
using a histokinette (Hendrey Relays and Electrical E q u i p m e n t ) ^ ^  and
involved successive passage of the fixed tissue through 50%, 70%, 90%, 95%
and absolute ethanol^*^ for a period covering 22 h. Clearance of absolute
(19}ethanol from tissues was achieved by immersion in tissue chloroform^ 
After clearance the tissue was impregnated with polywax (paraffin wax and a 
plastic polymer) with a melting point of 57°C (Difco Laboratories)^^. 
Total impregnation required three, one hour immersions of tissues in 
polywax in a vacuum embedding bath^.
Following complete impregnation tissues were embedded in 10 mm square 
polywax blocks which in turn were mounted on 30 x 30 x 20 mm wooden 
"chucks". Sections (4 p) were cut from these mounted, trimmed blocks on a 
Leitz sledge microtome (Leitz)^^ and were floated onto water held at 22°C 
in a two litre capacity water bath (Grant Instruments (Cambridge) Ltd)^^. 
Three sections were selected and floated onto glass microscope slides, 
previously coated with albumin to aid section adherence, and finally 
incubated at 37°C to dry.
Polywax present in the sections was removed by xylene immersion and 
clearance of xylene was affected by successive rinsings of the slide 
through absolute ethanol, 95%, 90%, and 70% ethanol and finally distilled 
water.
HAEMAT0XYLIN AND E0SIN STAINING
EhrlictTs haematoxylin was prepared by dissolving 6 gm of haematoxylin 
in 300 ml of absolute alcohol. To this mixture 300 ml of distilled water 
were added. An excess of potassium alum ( A ^  (SO^)^, 2 4 E^O) is
added, and the resulting mixture is left in sunlight for 5-6 months to
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mature.
Slide mounted tissue sections were flooded with haematoxylin for 10 
min and then rinsed in distilled water. Sections were "blued" in tap water 
for 10 min and differentiated with 1% hydrochloric acid in 70% ethanol to 
remove excess stain from cellular cytoplasm. Further "blueing" in tap 
water for 10 min was followed by flooding the slide with 1% aqueous 
solution of eosin for 3 min. Sections were washed for 3 min in distilled 
water, and finally dehydrated by successive passages through 70%, 90%, 100% 
ethanol, with ethanol being cleared with xylene. Sections were mounted in 
a neutral mountant (XAM mountant - G. T. Gurr)^^.
Tissues stained in this way exhibit blue stained nuclei against a 
background of pink cytoplasm.
GRADING OF MYOCARDIAL LESIONS
Myocardial lesions were graded for mononuclear cell infiltration and 
necrosis on a scale of 0-4. Grade 0 indicated normal heart tissue with no 
observable microscopic damage. Grades 1 and 2 indicated small or large 
discrete areas of mononuclear cell infiltration respectively, but with no 
areas of necrosis. Grades 3 and 4 indicated areas of mononuclear cell 
infiltration associated with small and large necrotic foci respectively 
(Plate 2).
IMMUN0FLU0RESCENT EXAMINATION OF HEART TISSUE IN NORMAL AND THYMECTOMISED 
MICE
Tissue for immunofluorescent study was snap-frozen in gas phase liquid 
n i t r o g e n ^ a n d  8 pm sections were cut on a Bright cryostat fitted with a
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Photomicrograph of a section of mouse heart 
(x640) stained with haematoxylin and eosin 
s h o w i n g  m o n o n u c l e a r  cell infiltration (M) 
associated with small discrete necrotic foci
(N.F.)•
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Jung rotary microtome and variable speed automatic cutter (Bright 
Instrument Company Ltd.)^^). Tissue blocks were transferred from storage, 
without thawing, and sealed to the microtome "chuck" with Bright, CRYO-M- 
BED, embedding compound^"^. "Chucks” and embedding compound were 
previously cooled in solid carbon dioxide and ethanol. The automatic 
cutter was set at very low speed and sections were transferred from the 
knife direct to clean glass slides (six sections per slide) previously 
stored at room temperature. Tissue sections were finally dried in air for 
24 h to ensure complete section adhesion.
The following indirect method of staining was used for tissue 
sections. Slides were flooded with specific anti-Coxsackie B4 human 
a n t i b o d y ^ ^  and incubated at 37°C for 30 mins in a humidity chamber. 
Specific serum was rinsed off with three changes of phosphate buffered 
saline ( P B S ) ^ ^  over 12 min. Excess PBS was removed by gently blotting 
slides with fine tissue paper. Tissue sections were then flooded with 
fluorecein isothiocyanate conjugated anti-human horse g l o b u l i n ^ ^  and 
incubated for a further 30 min at 37°C in a humidity chamber. Slides were 
rinsed with three changes of PBS and mounted under coverslips in 
g l y c e r o l ^ ^  and examined for flourescence using a Carl Zeiss Photo 
microscope III fitted with high pressure mercury vapour illumination (Carl 
Zeiss)^^.
Fluoroscein isothiocyanate conjugated anti-human horse globulin^^ 
and anti-Coxsackie B virus a n t i s e r u m ^ ^  were titrated, in chessboard 
fashion, to determine the optimum dilution of each reagent that produced 
maximum specific fluorescence and minimum non-specific fluorescence in 
infected murine heart tissue. This tissue was obtained 6 days after intra- 
peritoneal inoculation of an adult male CBA/Ca strain mouse with 0.2 ml 100 
TCID cjq Coxsackie B4 virus suspension. Type specific virus was isolated 
from this heart tissue in Vero cell culture. Control heart tissue from an
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adult male CBA/Ca strain mouse inoculated with saline showed no specific 
fluorescence and no virus was isolated from this tissue. The optimum 
dilution for Coxsackie B4 antiserum was 1/40 and for fluorescent 
antiglobulin, 1/10.
The following controls were set up for each experimental group 
examined:
Positive Controls
1. Infected mouse heart tissue plus conjugate.
2. Infected mouse heart tissue plus unconjugated anti-human 
horse globulin.
Negative Controls
1. Unifected mouse heart tissue plus conjugate.
Both conjugated and unconjugated horse anti-human globulin and human 
anti-Coxsackie B virus globulin were adsorbed with homogenised heart tissue 
from CBA/Ca strain adult male mice prior to staining to reduce 
autofluorescent factors and non-specific binding of anti-Coxsackie B 
globulin.
The same staining procedure was adopted when screening the human 
biopsy material for the presence of specific Coxsackie B viral antigen. 
The optimum dilution of human anti-Coxsackie B antibody varied for each 
specific serotype but remained 1/10 for the fluorescein conjugated 
antibody.
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ESTIMATION OF SERUM CREATINE KINASE LEVELS
Total serum CK estimations were made using the commercially produced 
CK-NAC activated test (Boehringer Ltd.)^®\
The substrate, reconstituted in an imidazole buffer, 0.1g/l; pH 6.7; 
contained enzymes, coenzyme and activator in the following concentrations, 
adenosine diphosphate 2.0 M/1; NADP:2.0 M/1; creatine phosphate: 30 M/1; 
hexokinase: 2.5 U/ml; glucose-6-phosphate dehydrogenase: 1.5 U/ml and N- 
acetylocysteine: 20 M/1. In addition the imidazole buffer contained 
g l u c o s e  at 20 M / 1 ;  m a g n e s i u m  a c e t a t e  at 10 M / 1  a n d
ethylenediaminotetraactic acid at 2 M/1.
Complete reagent solution (2.5 ml; substrate + buffer) was mixed 
thoroughly with 0.1 ml of test serum in a sterile plastic bijou^^ and 
incubated for 3 min at 25°C. This mixture was then placed in a 1 cm light 
path cuvette^^ and an initial absorbance reading obtained on an SP1700 
Ultra Violet Spectrophotometer (Pye U n i c a m ) ^ ^  at 340 nm wavelength. 
Additional readings were obtained after 1, 2, and 3 min. The mean
absorbance change per minute ( A  /min) was used to determine the final 
concentration of serum CPK in units/litre using the following equation:
U/l at 25°C = 4127 x A  /min; at 340 nm wavelength
Serum CK isoenzyme levels were estimated using the commercially 
produced isoenzyme CK-MB t e s t ^ ® \  This involves the adsorbtion of the 
creatine kinase isoenzymes onto sephadex A-50 and their subsequent stepwise 
elution.
Sephadex A-50 at a concentration of 20 mg/ml was suspended in 
imidazole buffer, 0.1 M/1 at pH 6.7. Buffers A and B both imidazole 
buffers, 0.1 M/1 but at pH 6.7 and 6.8 respectively. Buffer B had
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additional magnesium chloride at 150 M/1 concentration.
Columns of sephadex A-50 were prepared by pipetting 2.0 ml of gel 
suspension into the plastic "mini" columns provided. When the buffer had 
drained off, the gel column was approximately 3/4" long and 0.5 ml of test 
serum was carefully placed on the gel surface and allowed to drain through 
completely. Two 5 ml aliquots of buffer A were run on the column and the 
CPK-MM fraction eluate discarded. Finally, three 1 ml aliquots of buffer B 
were placed on the column and the eluate, containing the CPK-MB and CPK-BB 
isoenzyme fractions, was collected and pooled forming the test sample. 
CPK-MB level determinations were performed on this test sample by adding 
1 ml to 2.5 ml of the reagent solution and the same test procedure 
undertaken as described for total serum CPK estimations.
CPK-MB isoenzyme levels were calculated using the following equation:
U/l at 25° = 3333 x A  /min; at 340 nm wavelength
Temperature was controlled by fluid circulation using a SP871 constant
(I*)')temperature cell housingv .
33
R E S U L T S
RESPONSES TO VIRAL INFECTION IN AN EXPERIMENTAL MOUSE MODEL
The titre of infective Coxsackie B4 virus present in the faeces of 
MFl/Olac male mice increased rapidly and reached peak levels six days after 
initial viral inoculation via the peritoneum (Fig. 1). Shedding of 
infective virus particles from the replication sites of the alimentary 
canal decreased to undetectable levels by day 19.
Secondary challenge with the same virus dose (Fig. 2) resulted in an 
antibody response of greater magnitude than after primary inoculation but 
titres fell slowly. Neither after primary nor secondary infection was 
there persistence of antibody of the order shown for human titres 
(Table 9).
Results from repeated stimulation of the immune system in the mouse 
demonstrated the persistence of high neutralising antibody titres (Fig. 3) 
similar to the situation in some human patients (Table 9) but when 
antigenic boosting was stopped antibody titres declined rapidly.
Heterotypic antibody responses occurred between the different 
serotypes of the Coxsackie B virus but not between encephalomyocarditis 
virus (EMC) and the Coxsackie B group (Fig. 4). Heterotypic responses 
between the Coxsackie B virus serotypes were of greater magnitude than 
homotypic responses but only occured against those serotypes to which there 
had been previous exposure. Subsequent inoculation with EMC virus produced 
a normal homotypic neutralising antibody response to this virus (not shown) 
but no heterotypic responses to any of the Coxsackie B group serotypes.
Sera from control animals exhibited variable neutralising ability to 
all the Coxackie B serotypes tested but this reaction did not increase to 
significant levels over the experimental period and persisted after heat
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Fie. 1.
VIRAL SHEDDING FROM THE ALIMENTARY CANAL OF MICE
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DAYS
Levels of Coxsackie B4 virus in the faeces of MFl/Olac male 
mice after primary intra-peritoneal inoculation with 0.2 ml of 
100 TCID^q virus suspension.
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Fig. 2.
ANTIBODY RESPONSE TO SECONDARY CHALLENGE * *
TIME (DAYS)
Geometric mean titres of antibody in MFl/Olac strain male mice 
after primary Coxsackie B4 infection and challenge 20 days 
later with 0.2 ml of 100 TCID^q Coxsackie B4 virus inoculated 
via the intra-peritoneal route. The standard deviation of the 
geometric mean titres are plotted for each experimental and 
control group. Asterisks mark those experimental and control 
group mean titres that are statistically significantly 
different (p < 0.05) from one another.
Key to Fig. 2
^  O— @ I n f e c t e d  animals (n=10) 
-O— O-— O — O ” Control animals (n=5)
Fig. 3.
ANTIBODY RESPONSE FOLLOWING REPEATED CHALLENGE
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TIME (DAYS)
Geometric mean titres of antibody for MFl/Olac strain male mice 
after intra-peritoneal inoculation of 0.2 ml 100 TCID^ q 
Coxsackie B4 virus suspension. Animals were repeatedly 
challenged with 0.1 ml 100 TCID^q virus suspension on days 15, 
30 and 45. The standard deviation of the geometric mean titres 
are plotted for each experimental and control group. Asterisks 
m a r k  those e x p e r i m e n t a l  group m e a n  titres that are 
statistically significantly different (p < 0.05) from their 
corresponding control group mean titres.
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Key to Fig. 3
Infected animals ( 
Control animals (n
n=10)
=5)
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Fig. 4.
HETEROTYPIC ANTIBODY RESPONSES
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Fig. 4 is a continuation of Fig. 3 showing the increase in 
geometric mean titre of heterotypic neutralising antibody in 
MFl/Olac strain male mice (n=10). Animals were previously 
inoculated with 0.2 ml 100 T C l D ^  Coxsackie B4 virus and 
subsequently with 0.2 ml 100 TCID^q Coxsackie B1 and B6 virus 
on days 90 and 120 respectively. To avoid conjestion the 
standard deviations for each group geometric mean titre are not 
plotted but follow the trend exhibited in Fig. 2 and Fig. 3. 
All geometric mean titres for the infected groups were 
significantly different (p < 0.05) from the corresponding mean
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titres of control groups with the exception of those mean 
titres shown by sera taken on the day of primary inoculation. 
These are marked by an asterisk. All heterotypic antibody 
responses were significantly greater (p < 0.05) than the 
corresponding homotypic response except during the declining 
phase of both homotypic and heterotypic response.
Key to Fig. 4 
0B4 (n=10)
0B1 (n=10) ) Infected Groups
0B6 (n=10)
0B4 (n=5)
0B1 (n=5) \ Control Groups
0B6 (n=5)
— © ----
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treatment at 56°C for 30 min.
TIMING OF ONSET OF DISEASE
After infection, in both female and male adult CBA/Ca strain mice, the 
manifestation of overt cardiac lesions occurs first on days 5 and 6 
respectively. Maximal necrosis occurs on days 7 and 8 respectively when 
humoral neutralising antibody response to Coxsackie B virus infection has 
reached peak levels. Antibody rise to peak levels for T-lymphocyte deprive 
mice shows a delay over immune intact animals (Fig. 5). Subsequent 
clearance of infective virus titres from heart tissue of immune deprived 
and immune intact animals is shown to be similar (Fig. 6) and infective 
virus particles could not be recovered from heart tissue after day 11 
following primary infection.
Test and control animals were inoculated with 0.2 ml of 100 TCID^q 
virus suspension and 0.2 ml of virus suspension medium respectively via the 
peritoneum. All animals were killed by exsanguination under anaesthetic 
via the retro-orbital plexus and heart tissue was collected and prepared 
for histological and immunofluorescent examination.
Control groups showed no increase in specific antiviral antibody 
in response to virus suspension medium and showed no histological evidence 
of necrotic cardiac lesions.
CYTOLYTIC EFFECT OF IMMUNE SERUM
Results demonstrate that immune serum produced in CBA/Ca strain male 
mice against Coxsackie B^ virus has a significantly greater (p < 0.05) 
cytolic effect on Coxsackie B^ infected "carrier" cells originating from 
the same mouse strain, than non-immune serum from the same mouse strain and
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ANTIBODY RESPONSE IN NORMAL AND IMMUNE - COMPROMISED MICE
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VIRUS TITRES IN HEART TISSUE
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sex (Fig 7(a)).
This significant variation (p < 0.05) was also shown for heterologous 
immune serum from an outbred mouse strain MFl/Olac males (Fig. 7(b)) and 
for immune serum from human males (Fig. 7(c) when compared with non-immune 
serum from the same source. However, immune serum from male MFl/Olac 
strain mice, heterologous sera, showed a significantly (p < 0.05) reduced 
cytolytic effect when compared with homologous immune serum. Similarly, 
non-species specific immune serum (human male) showed a significantly (p < 
0.05) decreased cytolytic action compared with heterologous immune mouse 
serum.
Heat inactiviation of the complement protein system resulted in 
significant reductions (p < 0.05) in the mean number of wells showing 
cytolysis for both homologous and heterologous immune male mouse serum and 
immune human male serum, compared with intact immune serum. Reconstitution 
of serum complement in each group resulted in a return of cytolytic 
activity to levels marginally higher, but not significantly so, than intact 
raw immune serum (p > 0.05). This cytolytic effect was, in each group, 
significantly greater (p < 0.05) than cytolysis achieved with heat 
inactivated serum.
Exposure of infected "carrier" cells to complement alone failed to 
produce a significantly (p > 0.05) greater cytolytic effect than the degree 
of cytolysis generated in the infected "carrier" cell control (Fig. 7(d)). 
Similarly, exposure of uninfected "carrier" cells to immune homologous 
serum did not produce a significantly greater (p > 0.05) cytolytic effect 
than that "spontaneous" cytolysis occurring in uninfected "carrier" cell 
controls (Fig. 7(d)). There was a significant increase (p < 0.05) in the 
number of wells showing "spontaneous" cytolysis between the uninfected and 
infected "carrier" cell controls (Fig. 7(d)).
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TH E CYTOLYTIC EFFECT OF IMMUNE SERUM 
Fig. 7 (a).
V)
t/i
OH>-o
Fig. 7 (b).
SD4 1
m
Fig. 7 (c).
SDi 0*80 
0 0 0 0 0 0j 
J O O O O O
Fig. 7 (d).
SD+1*12 SD±1*16
t~”' ~'l l
Cytolytic activity of serum against Coxsackie B4 virus infected 
"carrier" cells originating from CBA/Ca strain neonatal mice. 
Comparison of the mean percentage cytolysis caused by male 
CBA/Ca strain mouse serum (Fig. 7(a)), male MFl/Olac mouse 
serum (Fig. 7(b)) and male human serum (Fig. 7(c)).
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Key to Fig. 7 (a), (b) and (c)
Non Immune Serum 
Immune Serum
Heat Inactivated Serum (56°C for 30 mins) 
Complement Reconstituted Serum
A
B
C
D
Key to Fig. 7 (d)
Complement control 
Infected "carrier" cell control 
Uninfected "carrier" cell control 
Uninfected "carrier" cells exposed to 
immune homologous serum
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The degree of cytolysis produced in infected "carrier" cells by immune 
homologous serum differs significantly (p < 0.05) between males and 
females. (Table 1).
Table 1
SERUM DONORS
MALES FEMALES
MEAN NUMBER 
OF WELLS SHOWING 
CYTOLYSIS
24.8 18.2
STANDARD
DEVIATION + 1.58 + 1.76
CYTOLYTIC EFFECT OF IMMUNE SPLEEN CELLS
Immune spleen cells from male CBA/Ca strain donors exhibited a 
cytolytic effect against Coxsackie B^ infected homologous "carrier" cells 
(Fig. 8(a)). Reduction in T-lymphocyte population from the immune spleen 
cells resulted in a significant (p < 0.05) decrease in cytolytic effect 
(Fig. 8(a)). This significant decrease in cytolsis following T-cell 
depletion was also shown for female homologous donors (Fig. 9(a)) and both 
male (Fig. 8(b)) and female (Fig. 9(b)) heterologous donors. The degree of 
cytolysis produced by immune spleen cells from males and females was 
significantly different (p < 0.05) for both homologous donors (Fig. 8(a) 
and Fig. 9(a)) and heterologous donors (Fig. 8(b) and Fig. 9(b)). 
Furthermore, a significant variation (p < 0.05) in cytotoxicity occured 
between immune spleen cells from male homologous donors (Fig. 8(a)) and 
male heterologous donors (Fig. 8(b)). This same significant variation (p < 
0.05) occured b e t w e e n  female derived homologous (Fig. 9(a)) and 
heterologous (Fig. 9(b)) immune spleen cells. There was a significant
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Fig. 8 and Fig. 9 - Legend 
Cytotoxicity of spleen cells from CBA/Ca strain (Fig. 8(a)) and 
MFl/Olac strain (Fig. 8(b)) male mice and CBA/Ca strain 
(Fig. 9(a)) and MFl/Olac strain (Fig. 9(b)) female mice for 
CBA/Ca strain derived "carrier" cells. Spleen cell donors were 
immunised with Coxsackie B4 virus.
Key to Fig. 8 and Fig. 9
Intact Immune Spleen Cells/Infected "Carrier" 
Cells
"T"-Lymphocyte Deprived Immune Spleen Cells/ 
Infected "Carrier" Cells
Infected "Carrier" Cell Control
Non-infected "Carrier" Cell Control
Non-immune Intact Spleen Cells/Infected 
"Carrier" Cells
Intact Immune Spleen Cells/Non-infected 
"Carrier" Cells
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difference (p < 0.05) between the degree of cytolysis occuring in infected 
and non-infected "carrier" cell controls (Fig. 8 and Fig. 9) but there was 
no significant difference (p > 0.05) in the decree of cytolysis occuring in 
non-infected carrier cell controls and the same cells exposed to homologous 
immune spleen cells (Fig. 8 and Fig. 9).
Similar results were obtained when the infected "carrier" cells were 
derived from MFl/Olac strain neonatal mouse cardiac endothelium. For both 
MFl/Olac and CBA/Ca strain male spleen cells there was a significant 
difference (p < 0.05) in the degree of cytolysis produced by immune spleen 
cells, compared with non-immune spleen cells, when both were exposed to 
infected, MFl/Olac derived, "carrier" cells (Fig. 10). There was a 
significant difference (p < 0.05) between the degree of cytolysis shown by 
homologous (MFl/Olac) spleen cells (Fig. 10(a)) and heterologous (CBA/Ca) 
spleen cells (Fig. 10(b)). There was no significant difference (p > 0.05) 
in the degree of cytolysis between non-infected "carrier" cells and the 
same cells exposed to homologous immune spleen cells. There was however, a 
significant difference (p < 0.05) between the infected and non-infected 
"carrier" cell controls.
VIRUS INDUCED CARDIAC DAMAGE IN A MURINE MODEL
Adult male and female CBA/Ca strain mice showed severe cardiac lesions 
following Coxsackie B virus infection. The degree of severity of these 
lesions was closely associated with the presence of T-lymphocytes 
(Table 2).
Comparison of groups B and E for males (Table 2(a)) and females 
(Table 2(b)) showed a significant difference in the incidence of cardiac 
lesions (Grades 0-4). Males - p < 0.005; Females - 0.01 > p > 0.005.
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Fig. 10 (a).
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Cytotoxicity of spleen cells from MFl/Olac strain (Fig. 10(a)) 
and CBA/Ca strain (Fig. 10(b)) male mice for "carrier" cells; 
derived from MFl/Olac strain neonatal cardiac endothelium and 
supporting a sub-lethal infection of Coxsackie B4 virus.
Key to Fig. 10 
A: Intact Immune Spleen Cells/Infected "Carrier" Cells 
B: Intact Immune Spleen Cells/Uninfected "Carrier" Cells 
C: Non-immune Intact Spleen Cells/Infected "Carrier" Cells 
D: Infected "Carrier" Cell Control 
E: Non-infected "Carrier" Cell Control
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TABLE 2
Table 2 - Legend
The incidence of focal cardiac lesions (Grades 0 to 4) as 
a percentage of the total in each group of male (Table 2(a)) 
and female (Table 2(b)) CBA/Ca strain mice following intra- 
peritoneal inoculation with Coxsackie B4 virus.
Key to Experimental groups
Group A = Normal control mice (inoculated with virus
suspension medium only)
Group B = Normal experimental mice
Group C = Thymectomised mice
Group D = Irradiated, bone-marrow reconstituted mice
Group E = T h y m e c t o m i s e d ,  irradiated and b o n e - m a r r o w
reconstituted
TABLE 2(a)
VIRUS INDUCED DAMAGE IN MALE MICE
GRADES OF GROUP GROUP GROUP GROUP GROUP
CARDIAC A B C D E
LESION (n=15) (n=15) (n=15) (n=15) (n=15)
0 100.0% - 40.0% 40.0% 46.7%
1 - 13.3% 33.3% 53.3% 46.7%
2 - 6.7% 6.7%
3 - 46.7% 20.0% 6.7% 6.7%
4 - 33.3%
TABLE 2(b)
VIRUS INDUCED DAMAGE IN FEMALE MICE
GRADES OF 
CARDIAC 
LESION
GROUP
A
(n=15)
GROUP
B
(n=15)
GROUP
C
(n=15)
GROUP
D
(n=15)
GROUP
E
(n=15)
93.3%
6.7% 13.3%
13.3%
53.3%
20.0%
13.3%
46.7%
13.3%
26.7%
26.7%
53.3%
6.7%
13.3%
20.0%
60.0%
20.0%
52
Although the male control group showed no cardiac damage (Group A; Table 
2(a)) a degree of "spontaneous" focal mononuclear cell infiltration occured 
in a small proportion of female controls (Group A; Table 2(b)). In the 
males (Table 2(a)) there was a significant decrease (0.01 > p > 0.005) in 
serious cardiac lesions between groups B and C. This significant decrease 
(p < 0.005) also occured between groups B and D. In the females however 
(Table 2(b)) a significant decrease in severe cardiac lesions occured 
between groups B and D (0.01 > p > 0.005) but not between groups B and C 
(0.25 > p > 0.1).
All experimental groups were inoculated with 0.2 ml of 100 TCID^q , 
heart adapted, Coxsackie B4 virus on day 0. Animals were killed on day 8 
by exsanguination, under anaesthetic, via the retro-orbital complex. 
Hearts were removed immediately and prepared for histological examination. 
Control groups (A) were inoculated with 0.2 ml of virus suspension medium 
only and housed in separate cubicles.
CYTOLYTIC EFFECT OF IMMUNE SERUM IN VIVO
Intact homologous immune serum inoculated into T-cell deprived, male 
mice, infected with heart adapted Coxsackie B4 virus, (Table 3(a)) did not 
significantly increase the incidence of cardiac lesions when compared with 
a control group (0.9 > p > 0.75). Furthermore, there was no significant 
difference in the incidence of cardiac lesions in animals inoculated via 
the intraperitoneal and intravenous routes (Table 3(a)) (0.99 > p > 0.975). 
There was no significant increase (0.95 > p > 0.9) in severe cardiac 
lesions in infected male mice (with intact immune system) inoculated with 
immune serum compared with controls inoculated with virus suspension medium 
only (Table 3(b)).
Adult T - l y m p h o c y t e  deprived (Table 3(a)) and i m m u n e  intact
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TABLE
Table 3 - Legend
The incidence of focal cardiac lesions (Grades 0 to 4), in 
T-lymphocyte deprived mice as a percentage of the total for 
each experimental and control group.
Key to Table 3(a)
Group 1 = Inoculated intra-peritoneally with intact homologous 
anti-Coxsackie B4 serum.
Group 2 = Inoculated intravenously with intact homologous anti- 
Coxsackie B4 serum.
Group 3 = Inoculated intra-peritoneally with virus suspension 
medium only.
Key to Table 3(b)
r
Group 1 = Inoculated with intact homologous immune serum.
Group 2 = Inoculated with virus suspension medium only.
CYTOLYTIC EFFECT OF IMMUNE SERUM IN VIVO
TABLE 3(a)
GRADES OF
CARDIAC
LESION
GROUP
1
(n=15)
GROUP
2
(n=15)
GROUP
3
(n=15)
33.3%
53.3%
13.3%
26.7%
53.3%
13.3%
6.7%
26.7%
60.0%
6.7%
6.7%
TABLE 3(b)
GRADES OF 
CARDIAC 
LESIONS
GROUP
1
(n=15)
GROUP
2
(n=15)
20.0%
13.3%
40.0%
26.7%
13.3%
6.7%
46.7%
33.3%
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(Table 3(b)), male mice were inoculated, intraperitoneally with 0.2 ml of 
100 TCID,-q , heart adapted, Coxsackie B4 virus on day 0. Pooled homologous 
immune serum (0.4 ml) was inoculated, intraperitoneally or intravenously, 
on day 5 into all experimental groups. Virus suspension medium was 
inoculated into control groups. All animals were killed on day 8 by 
exsanguination under anaesthetic via the retro-orbital plexus. Heart 
tissue was removed immediately and prepared for histological examination.
CYTOLYTIC EFFECT OF IMMUNE SPLEEN CELLS IN VIVO
Adult, CBA/Ca strain male mice, T-lymphocyte deprived and infected 
with heart adapted Coxsackie B4 virus, showed no significant difference 
(0.25 > p > 0.1) in the severity of necrotic cardiac lesions when 
inoculated with homologous immune spleen cells (CBA/Ca strain male donors) 
or heterologous immune spleen cells (MFl/Olac male donors) (Table 4). 
Both experimental groups 1 and 2 (Table 4) show a significantly greater 
number of necrotic lesions than their uninfected control groups 3 
(p < 0.005) and 4 (0.05 > p > 0.025) respectively. Although there was a 
marked level of mononuclear cell infiltration in uninfected control groups 
3 and 4 the incidence of necrotic lesions was marginally greater in the 
virus infected control group 5 although there was no significant variation 
between group 1 and group 5 (0.25 > p > 0.1) or group 2 and group 5 (0.5 > 
p  > 0.25).
Adult male CBA/Ca strain T-lymphocyte deprived mice, groups 1, 2 and 
5, were inoculated with 0.2 ml of 100 TCID^^ heart adapted Coxsackie B4 
virus suspension. Immune spleen cells from male donors were inoculated
5
intra-peritoneally on day 3 (1 x 10 cells in 0.5 ml of cell maintenance 
medium). Cell maintenance medium (0.5 ml) was inoculated into 5 control
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TABLE 4
CYTOTOXICITY OF HOMOLOGOUS AND HETROLOGOUS IMMUNE SPLEEN CELLS IN VIVO
GRADES OF 
CARDIAC 
LESION
GROUP
1
(n=15)
6.7%
40.0%
26.7%
26.7%
GROUP
2
(n=15)
13.3%
53.3%
13.3%
20.0%
GROUP
3
(n=15)
60.0%
26.7%
13.3%
GROUP
4
(n-15)
66.7%
26.7%
6.7%
GROUP
5
(n-15)
26.7%
60.0%
13.3%
Group 1
Group 2
Group 3
Group 4
Group 5
Key to Table 4
Virus infected mice inoculated with homologous immune spleen 
cells.
Virus infected mice inoculated with heterologous immune 
spleen cells.
Uninfected mice inoculated with homologous immune spleen 
cells.
Uninfected mice inoculated with heterologous immune spleen 
cells.
Virus infected mice inoculated with virus suspension medium 
only.
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animals on the same day via the same route.
REDUCTION OF CARDIAC LESIONS AFTER T-LYMPHOCYTE DEPLETION
Reduction of the T-lymphocyte component of homologous immune spleen 
cells reduced the ability of spleen cells to initiate necrotic cardiac 
lesions ill vivo (Table 5(a)). This reduction occured for both sexes of 
CBA/Ca strain adult mice but in neither case was this statistically 
significant (Males: 0.1 > p > 0.05; Females: 0.5 > p > 0.25). Whilst for 
both males and females there was a reduction in the severity of cardiac 
lesions in control animals inoculated only with cell suspension medium 
compared with animals inoculated with homologous spleen cells, this 
difference was significant in the males (0.05 > p > 0.025) but not in the 
females (0.25 > p > 0.1). T-lymphocyte deprived CBA/Ca strain male (Table 
5(a)) and female (Table 5(b)) mice were inoculated with 0.2 ml 100 TCID^q > 
heart adapted, Coxsackie B4 virus on day 0. Intact and T-cell deprived, 
immune spleen cells (1 x 10^ cells in 0.5 ml cell maintenance medium) from 
homologous CBA/Ca strain male donors were inoculated intraperitoneally on 
day 5. Cell suspension medium was inoculated into controls on the same 
day. All animals were killed on day 8 by exsanguination under anaesthetic 
from the retro-orbital plexus. Heart tissue was removed immediately and 
prepared for histological examination.
CARDIAC SPECIFIC ENZYME RELEASE AFTER VIRAL INFECTION
Results show an increase in serum titres of total creatine 
phosphokinase (CPK) following virus infection in male CBA/Ca strain, immune 
intact, mice. This rise in total CPK was coincidental with the day on 
which maximal cardiac necrosis occured. There was also an increase in
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REDUCTION IN CARDIAC LESIONS FOLLOWING T-LYMPHOCYTE DEPLETION
Table 5(a) - Males
GRADES OF GROUP GROUP GROUP
CARDIAC 1 2 3
LESION (n=15) (n=15) (n=15)
0 - 13.3% 26.7%
1 46.7% 66.7% 60.0%
2 6.7% 13.3% 13.3%
3 20.0% 6.7%
4 26.7%
Table 5(b) - Females
GRADES OF 
CARDIAC 
LESION
GROUP
1
(n=15)
60.0%
20.0%
20.0%
GROUP
2
(n=15)
13.3%
53.3%
6.7%
20.0%
6.7%
GROUP
3
(n=15)
20.0%
60.0%
6.7%
13.3%
The Incidence of focal cardiac lesions (Grades 0 to 4) in male and 
female mice as a percentage of the total for each group.
Key to Table 5
Group 1 = Inoculated with homologous immune spleen cells
Group 2 = Inoculated with T-cell deprived homologous immune spleen cells
Group 3 = Inoculated with cell suspension medium only
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cardiac specific isoenzyme (CPK-MB) expressed as a percentage of the total 
(Table 6). This reached peak levels after the day on which maximal 
necrosis occurred. Virus infection of T-lymphocyte deprived animals 
resulted in a slight increase in total CPK levels but little increase in 
CPK-MB levels. However, immunoflourescent examination showed Coxsackie B4 
virus to be present in the heart tissues of both groups throughout the 
experimental period. Immune intact and T-lymphocyte deprived control 
animals showed no coincidental increase in total CPK or CPK-MB levels.
Adult CBA/Ca strain, normal and T-lymphocyte deprived, male mice were 
inoculated intraperitoneally with 0.2 ml of 100 TCID^q , heart adapted, 
Coxsackie B4 virus on day 0. Control animals were inoculated at the same 
time, via the same route, with 0.2 ml virus suspension medium only and 
housed in separate cubicles. Three animals from each group were killed 
daily by exsanguination via the retro-orbital plexus and the serum pooled. 
Heart tissue was removed immediately from every animal and prepared from 
histological and immunofluorescent examination.
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TABLE
Table 6 - Legend 
Total creatine (CK) and heart specific isoenzyme (CK-MB) 
levels for groups 1, 2, 3 and 4.
Key to Table 6 
Group 1 = Normal mice
Group 2 = T-lymphocyte deprived mice
Group 3 = Normal control mice
Group 4 = T-lymphocyte deprived control mice
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DEVELOPMENT OF OVERT DISEASE AFTER INITIAL INFECTION
Maximum mononuclear cell infiltration and cardiac myofibre necrosis 
(Grade 3 and 4 lesions) occured in female and male mice seven and eight 
days respectively, after primary infection with mouse heart adapted 
Coxsackie B4 virus. Infective virus titres were no longer present 12 days 
after infection in both normal and T-lymphocyte deprived, male and female 
mice suggesting that an intact T-lymphocyte response is not necessary for 
normal clearance of virus from infected cardiac tissue. However, Coxsackie 
B4 viral antigen was detectable by indirect immunofluorescent techniques a 
further 10 days after infective virus was no longer isolated.
This data is in accord with previously published work (Woodruff and 
Woodruff, 1974) involving Coxsackie B3 infection in adult female CDI and 
BALB/c strain mice. Six days after infection of CDI strain mice, heart 
tissue was infiltrated with mononuclear inflammatory cells with associated 
necrotic foci and infectious virus was not detectable in tissues six to 
eight days after infection. This faster mononuclear cell response and 
clearance of infective virus from cardiac tissues may represent mouse 
strain differences in the time taken between initial stimulation and 
maturation of the cellular constituents of the humoral and cellular immune 
systems. The inability to isolate infective virus after 12 days probably 
reflects the increase in titres of extravascular Immunoglobulin A (IgA) 
effectively neutralising virus particles released by budding from infected 
cell surfaces. Furthermore, if most of the antibody binding sites on the 
virus coat were masked by IgA it is probable that the viral antigen, 
detectable by immunofluorescence after day 12, comprises intracellular 
viral antigen not bound by extracellular IgA.
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CYTOLYTIC EFFECT MEDIATED BY THE HUMORAL RESPONSE
In vitro evidence has been produced showing that Coxsackie B4 
antiserum has, in the absence of cellular immune components, a cytolytic 
effect on cultured cardiac cells chronically infected with the same virus 
type. This suggests that immune serum might be responsible for producing 
focal cardiac lesions iii vivo where heart tissue supports replicating 
virus. The significant reduction in cytotoxicity following complement heat 
inactivation shows this serum component to be very important in in vitro 
antibody mediated damage. The possibility that In vivo lesions may result 
from antibody - complement interaction is supported by evidence showing the 
earliest production of cardiac lesions, in both male and female CBA/Ca 
strain mice infected with heart adapted Coxsackie B4 virus, occurs 
coincidentally with the production of high titres of humoral neutralising 
antibody. However, data obtained from T-lymphocyte deprived mice shows 
antibody responses to Coxsackie B4 virus occured over a similar time period 
and were of the same order of magnitude but there was a much lower 
incidence of mononuclear cell infiltration and necrotic cardiac lesions. 
This conflicting data suggests that high humoral antibody titres, in the 
presence of complement, play little or no significant role in the genesis 
of necrotic cardiac lesions during the acute phase of infection in vivo, 
but that damage is closely associated with intact immune function. The 
possibility remains that humoral antibody - complement mediated damage may 
occur during the chronic phase of infection or that extra-cellular antibody 
may react with intra-cellular or extra-cellular virus particles.
The occurence of high antibody titres at a time when maximal cardiac 
damage occurs may simply reflect the time course for small lymphocyte 
proliferation, following primary antigenic challenge, and subsequent 
maturation to functional T and B-lymphocyte populations.
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The delay in antibody response, and subsequent rise to high levels, in 
T-lymphocyte deprived animals compared with normal mice is probably due to 
the removal of T-cell helper function during the maturation of cells to 
full antibody production capability.
MECHANISM OF CELLULAR DAMAGE
The exact mechanism by which specific antiviral immunoglobulin and 
complement cause a cytotoxic effect on cultured cells, infected chronically 
with homologous virus strain, is unclear. Perhaps the most obvious 
possibility is a direct interaction between antibody and virus particles 
budding from the infected cell membrane. Subsequent cell lysis might occur 
as an unfortunate but unavoidable sequel.
Such a hypothesis is not compatible with studies on the cytolytic 
activity of antirabies serum and complement for cultured cells infected 
chronically with vaccine strain rabies virus (Wiktor et al, 1968). In HEP 
Flury virus infected tissue culture cells the proportion of virus particles 
released from the infected cell by budding is small compared to the amount 
of particles retained by the structurally intact cell (Hummeler et al, 
1967). Furthermore, it was 72 hours after initial infection that virus 
particles were detectable budding at the cell surface, whereas cytolytic 
activity of immune serum in Nil-2 cells (hamster origin), infected with 
either HEP Flury or PM rabies virus strain, was detectable 16 to 18 hours 
after initial infection (Wiktor et al, 1968). Similarly, Duc-Nguyen et al, 
(1966) showed that ferritin-conjugated anti-influenza virus antibody bound 
to the infected cell surface before influenza virus particles began budding 
on the cell surface.
Evidence from indirect immunofluorescent studies on the membranes of
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intact "carrier" cells infected chronically with Coxsackie B4 virus, shows 
that the earliest virus was detectable, in any of the infected cultures, 
was four days after initial infection. Moreover, anti-Coxsackie B4 serum 
that produced little marked cytolytic effect in "carrier" cells two days 
after infection showed a greatly increased cytolytic effect in cultures of 
"carrier" cells four days after initial infection and older. This would 
suggest that cytolytic damage, in Coxsackie B4 infected "carrier" cells, 
arose as a result of immune antibody reacting with budding virus particles 
on the cell surface.
Conclusions from studies on the intracellular development of 
myxoviruses and paramyxoviruses (Rose and Morgan, 1960; Marcus, 1962) 
proposed that immunological alterations of the cell membrane occured, as a 
result of virus infection, with subsequent failure of the immune system to 
recognise "self". No lytic antibody was described for these systems but 
new cell membrane constituents were recognised by haemadsorbtion tests 
(Marcus, 1962). Evidence substantiating such a possibility arises from 
studies on the reaction between herpes virus infected cells and antiherpes 
virus serum (Roizman and Roane, 1961). Although injury to herpes-infected 
cells was not determined by the number of viable cells surviving exposure 
to antiherpes serum, but by the inability of herpes-infected cells to 
support virus replication, it was shown that antiherpes serum exerted an 
anticellular effect on herpes-infected cells. Since this phenomenon occurs 
at a time when no virus release occurs from the cell (Roizman and Spring, 
1967) lysis cannot be explained by direct interaction between budding virus 
and antibody. Furthermore, Nii et al (1968) indicate that herpes virus is 
not released from the infected cell by budding.
Another possible mechanism by which antiviral serum may induce 
cytolysis in cells infected by homologous virus is when viral coat proteins 
share antigenic determinants with the host cell. Herpes virus has been
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shown to contain host cell specific antigens (Watson and Wildy, 1963). 
Although rabbit anti "carrier" cell serum neutralised Coxsackie B4 virus 
infectivity for monkey kidney cells it is doubtful whether antibody to host 
cell components plays any significant role in cytolysis as anti-Coxsackie 
B4 immune serum exhibits little cytotoxic effect on uninfected "carrier" 
cells.
These results are not in accord with previous data (Wong et al, 
1977(a)) which failed to show any cytolytic activity for immune mouse and 
rabbit serum, against Coxsackie B3 virus infected neonatal fibroblasts in 
the presence of complement proteins.
One factor, however, common to these reports is the necessary 
requirement for complement proteins for the full expression of cytolytic 
activity in immune serum.
COMPLEMENT REQUIREMENT
Following the activation of the primary complement component (Cl) by 
the complex of antibody bound to antigen an amplified "cascade" effect is 
produced. This results in the activation of terminal components (C8 and 
C9) which possess the ability to lyse cells to which they are fixed, 
presumably by enzymic disruption of the phospholipid structure. The 
possibility that complement acted as an esterase, digesting some components 
of the cell membrane has been previously recognised.
It would seem likely that in those cases where cell lysis occurs in 
the presence of immune serum and complement and before virus particles can 
be detected budding from the infected cell membrane (Wiktor et al, 1968; 
Roizman and Spring, 1967) that antibody binds to antigens on the infected 
cell surface. These antigens could be either of viral origin or dictated
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by the viral genome. Thus activated complement would be brought into close 
association with the cell membrane effecting cell rupture. Certainly, in 
the case of "carrier" cells infected with Coxsackie B4 virus exposure to 
complement alone produces markedly less cytolysis than complement and 
immune serum combined. This suggests that antibody is necessary to provide 
a vehicle by which complement is brought into close contact with the cell 
membrane to achieve maximal cytolysis. The marginal increase in the 
incidence of cytolysis for complement controls over infected "carrier" cell 
controls may reflect a degree of spontaneous complement activation in the 
absence of immune serum. It is possible that Coxsackie B4 immune antibody 
binding to "new" antigens on the cell membrane, specified by the viral 
genome, or to antigenic determinants shared by virus and host cell, may 
penetrate the cell after complement mediated perforation of the membrane. 
Good evidence in support of this hypothesis comes from studies on the 
localisation of specific antibodies raised against whole ascites tumour 
cells or fractions of them. Using air-dried smears of tumour cells and 
either anti-gammaglobulin conjugated with fluorescein isothiocyanate 
(Dumonde et al, 1961) or ferritin coupled anti-gammaglobulin (Easton et al. 
1962) these workers have shown that in the absence of complement, 
antibodies reacted only with surface antigens and failed to penetrate 
intact cells. The appearance of membrane bound ferritin conjugated 
antibody within the cytoplasm of some intact cells was considered to result 
from pinocytosis (Easton et al, 1962). When these ascites cells were 
exposed to conjugated antibody in the presence of complement proteins 
however, antibody was able to enter the partially disrupted cells. 
Antibody continued to react with cell surface antigens but fluorescence 
studies showed generalised cytoplasmic staining (Dumonde et al, 1961). 
Further electron microscopic studies indicated ferritin conjugated antibody 
bound to smooth membranes derived from "elements of the endoplasmic
reticulum and segments of the cell surface membrane" (Easton et al, 1962). 
Whether antibody was bound to the mitochondria, nuclear membrane or rough 
endoplasmic reticulum was not clear. Of possible significance is the fact 
that the morphological response of these tumour cells varied according to 
whether antibody was presented as whole serum or the gammaglobulin fraction 
(Bitensky, 1963). It would appear that, for ascites tumour cells at least, 
intracellular antigens are present which bind specific antibody but only 
when the cell membrane has been so modified by complement to allow the 
penetration of antibody.
Whether antibody binding to intracytoplasmic virus particles would 
cause the morphological disruption observed is questionable. Certainly, 
the fixation of specific antibody to the surface of tumour cells causes 
localised morphological disturbances and disrupts the binding of the 
membrane phospholipid, but extensive cellular damage may result from damage 
to intracytoplasmic lysosomes with subsequent leakage of hydrolytic 
enzymes, de Duve (1959) considers leakage of acid hyrolytic enzymes might 
easily cause cell death. Further damage may result from extracellular 
diffusion of these enzymes. Moreover, the effects of antibody might be 
augmented by other stimuli rendering lysosomes more fragile. For example, 
Bitensky and Gahan (1962) have shown that lysosomes in rat liver cells are 
affected by wide ranging influences such as diet, anaesthetics and surgical 
trauma. It has also been shown (Bitensky, 1963) that the fragility of 
these organelles in the glandular epithelium of normal human endometrium 
varies with the phase of the menstrual cycle indicating that possibly 
l y s o s o m a l  suseptibility to antibody may be related to h o r m o n a l  
concentration.
Such an action may be responsible for the cytotoxicity exhibited by 
specific antibody against Coxsackie B4 virus infected "carrier" cells. It
69
is probable in this case that the antigens responsible for antibody 
attachment to the cell surface are viral in origin as cell lysis occurs 
coincidentally with the earliest detection of Coxsackie B4 virus "budding" 
on the infected cell membrane.
CLASS OF ANTIBODY RESPONSIBLE FOR CYTOLYSIS
The activation of the primary complement component (Cl) is initiated 
by binding through the subfraction Clq to CH2 sites present on the Fc 
portion of the immunoglobulins (Ig) forming a complex with homologous 
antigen.
The cytolytic activity of anti-rabies serum against rabies infected 
cells has been shown to be present in the 7S IgG fraction of immune serum 
(Wiktor et al, 1968). The appearance of this lytic antibody parallels the 
presence of neutralising, complement fixing and haemagglutination- 
inhibiting antibody. The ability to bind to cells is common to all 
immunoglobulins however (Roitt, 1980), but only IgG and IgM have been shown 
to fix complement consistently although there have been reports of a 
synergism between IgA, lysozyme and complement in the killing of certain 
coliform organisms. Furthermore, it has been shown to have the ability to 
bind polymorphs and to activate the alternative, rather than the classical 
complement pathway (Roitt, 1980). This complement fixing ability varies 
between the IgM and IgG classes and even with the subclasses of IgG, IgG^ 
fixing complement well, and IgG^ fixing complement poorly, if at all. 
Because of the polyvalent nature of the IgM molecule and the presence of 
several Fc regions within the single antibody molecule binding Cl 
c o m p l e m e n t  is very efficient. It was not k n o w n  which class of 
immunoglobulin predominated in immune serum cytolytic for Coxsackie B4 
virus infected "carrier" cells. However, all immune mouse sera were
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collected during the acute phase of infection, this would suggest IgM 
antibody would predominate, although primary inoculation of mice with 
bovine serum albumin show the timing of IgG-^ and IgM antibody to be very 
close suggesting significant levels of both were present in immune serum 
(Torrigiani, 1980). Pooled human immune sera show a lower incidence of 
cytotoxicity which may result from the lack of IgM present as sera were 
obtained from convalescent patients. However, heterologous mouse immune 
sera also showed a decrease in incidence in spite of being acute phase 
sera. This raises the possibility of an immunological alteration of the 
cell membrane, subsequent upon virus particles budding from the cell 
membrane, that only homologous immune sera can fully exploit.
In terms of the focal cardiac lesions that may result from antibody- 
complement reactions in vivo IgG, because of the relative ease with which 
this molecule passes into extravascular spaces, is more likely to account 
for the majority of damage that might be caused by this mechanism.
CYTOLYTIC EFFECT OF IMMUNE SERUM IN VIVO
The inability to reproduce, in vivo, the cytotoxic effect of immune 
serum combined with complement suggests that this mechanism, so clearly 
demonstrable in vitro, does not play a significant role in the production 
of cardiac lesions in the virus infected intact animal. This may result 
from an excessive dilution factor arising from in vivo inoculation or 
activation of the complex system of inhibitors present in the intact system 
to enable regulation of the complement "cascade" (Roitt, 1980).
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CYTOLYTIC EFFECT MEDIATED BY THE CELLULAR IMMUNE RESPONSE
It has been shown in this work that the development of necrotic 
cardiac lesions, following Coxsackie B4 virus infection in adult male and 
female mice, is closely associated with the T-lymphocyte maturation 
response. The relatively high incidence of mononuclear cell infiltration, 
associated with small patches of myofibre necrosis (grade 3 lesion), in 
group C males compared with groups D and E males is almost certainly due to 
the persistence of peripheral T-lymphocytes, remaining after bilateral 
thymectomy. These cells may subsequently mature to produce a sub­
population of killer cells cytolytic for Coxsackie B4 infected cardiac 
tissue. In groups D and E where the entire T-lymphocyte population has 
been destroyed by radiation the incidence of grade 3 lesions is very low. 
However, the presence of small necrotic lesions associated with mononuclear 
cell infiltration suggests that a small proportion of damage is associated 
with cells of the immune system other than T-cells. This may be 
particularly applicable to female mice where the incidence of grade 3 
lesions is markedly higher in groups totally deprived of T-lymphocytes than 
for the same groups in the male mice. This may reflect a greater 
incorporation of mononuclear phagocytic cells, such as monocytes and 
macrophages, in the cell mediated response against Coxsackie B viruses in 
female mice.
Although Wong et al (1977c) point out that differences in male and 
female mouse T-cell cytotoxicity are not widely reported there is evidence 
that the cytotoxic reactivity is more vigorous in male mice (Gorczynski,
1976). Although cytotoxic T-cells arising in Coxsackie B virus infected 
female mice are undoubtedly involved in cardiac tissue injury (Wong et al, 
1977(c)). The more vigorous cytotoxic T-cell response of male mice 
certainly correlates with the increased susceptibility of male mice to
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Coxsackie B viral disease (Berkovich and Ressel, 1967) and for human males 
(Sainani et al, 1968). This disparity in T-cell cytotoxicity may well be 
influenced by hormonal levels as castration of both male and female mice 
decreased and increased susceptibility respectively. Castration of female 
mice was by ovariectomy (Berkovich and Ressel, 1967). Corroborative 
in vitro evidence shows that immune spleen cells, previously sensitised by 
exposure to Coxsackie B4 virus, show a greater mean percentage cytolysis 
than immune spleen cells from female mouse donors. Furthermore, following 
T-lymphocyte depletion of immune spleen cell populations, the reduction in 
mean percentage cytolysis is less for female mouse donors than male mice. 
This is consistent with the belief that the genesis of cardiac lesions in 
female mice is less T-lymphocyte dependent but perhaps more orientated 
towards mononuclear phagocytic activity (Wong et al, 1977c).
Uninfected female mice showed a very high incidence of spontaneous 
mononuclear cell infiltration and this was possibly caused by unintentional 
infection with an undefined cardiotropic agent or associated with small 
patches of necrosis arising from focal ischaemia caused by thrombotic or 
embolic occlusion of the minor coronary vasculature.
Additional in vivo reconstitution experiments have shown that an 
increase in severe cardiac lesions, in T-lymphocyte deprived mice, can be 
achieved by intra-peritoneal inoculation of immune spleen cells sensitised 
in a donor of the same strain. Characteristically this incidence in 
marginally less for female mice. T-lymphocyte depletion of the immune 
spleen cell populations with specific anti-Thy-1.2 antibody resulted in a 
marked reduction in grade 3 and 4 lesions for male mice but 
characteristically less for female mice.
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GENETIC PREDISPOSITION FOR DISEASE
Perhaps, significantly, the incidence of cytotoxic reactivity of 
immune serum and immune spleen cells, both in vivo and in vitro, is 
markedly reduced when the donor mouse strain differs from the target 
strain.
In vitro experiments using "carrier" cells derived from the cardiac 
endothelium of CBA/Ca strain neonates and sustaining a non-cytolytic 
infection of Coxsackie B4 virus, clearly demonstrate the reduction in 
cytolytic activity of heterologous, MFl/Olac mouse strain and immune human 
serum compared with homologous (CBA/Ca strain) immune serum. This suggests 
that the interaction between infected target cell and antibody combined 
with complement, resulting in cell lysis and death, may not result solely 
from an interaction with virus particles budding from the infected cell 
surface. It is likely that a recognition process occurs resulting in 
homologous immune serum binding preferentially to infected "carrier" cells.
Reciprocal in vitro experiments using "carrier" cells derived from 
both MFl/Olac strain and CBA/Ca strain neonatal cardiac endothelium also 
shows that a greater cytolytic effect occured between syngeneic immune 
spleen cells and target "carrier" cells when compared with allogenic donors 
and hosts. A similar disparity in cytolytic effect is shown by females of 
both mouse strains but reflects the characteristic overall reduction in 
cytotoxicity as noted by Wong et al, (1977(c)).
This evidence further suggests that the cytotoxic response, of both 
immune serum and immune spleen cells against infected target cells, is 
closely linked with cell surface phenomena only fully recognised and 
exploited when both donor and target host share the same genetic "make-up".
There is strong evidence to suggest that the genetic "make-up" of the 
host, while not a direct mechanism for producing immunopathological damage,
74
certainly influences the nature and severity of lesions incurred during 
viral infections. Studies on mice with internally recombinant H-2 alleles 
has suggested that the H-2K region, or a very closely linked locus, is 
responsible for the susceptibility to virus infections by determining the 
degree of both humoral and cellular immune response (Amos et al, 1972).
It is significant that the Ir-1 gene complex is closely positioned to 
the H-2K region thus supporting the hypothesis that H-2 influence on viral 
infection, particularly during leukemogenesis, is reflected by immune 
response as determined by Ir-1 type (Amos et al, 1972).
These histocompatibility linked specific immune response genes appear 
to control the recognition ability of antigenic determinants by the thymus 
derived immunocompetent cell population (T-Lymphocytes). Thus, these loci 
may exert control over delayed hypersensitivity and graft rejection and 
additionally influence the production of humoral and cell surface antibody 
because of the T-cell helper function in potentiating the immunoglobulin 
production of B-Lymphocytes.
Doherty and Zinkernagel (1976) showed that cytotoxic thymus derived 
lymphocytes (T-cells) taken from mice infected acutely with lymphocytic 
choriomeningitis virus interact only with H-2 compatible virus infected 
target cells. Moreover, cytotoxic T-cells have been shown to be produced 
in mice after infection with lymphocytic choriomenigitis (Zinkernagel and 
Doherty, 1974), ectromelia virus (Gardner et al, 1974), and vaccinia virus 
(Kasnowski and Ertl, 1975). Furthermore, maximal cell lysis occurs when 
the target and effector cells hosts share the K or D end of the H-2 gene 
complex. It appears that cytotoxic cells recognise both viral and H-2 
antigenic determinants present in virus infected target cells and it has 
been suggested that this reactivity is directed mainly against H-2 antigens 
that have been modified by the infecting virus. This is certainly
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consistent with the hypothesis of some authors "that immunologic 
alterations specified by the viral gene take place at the surface of the 
infected cell" (Rose and Morgan, 1960; Marcus, 1962). Suggestions on the 
nature of the interaction between virus and H-2 genes or the molecular 
characteristics of such altered self antigens remains a matter for 
conjecture.
Although this mechanism, with respect to Coxsackie B virus infections 
in mice has not been directly explored, Wong et al (1977(b)) found that 
Coxsackie virus specific cytotoxic T-cells were found to be H-2 restricted 
in that they exhibited little or no reactivity against allogeneic target 
cells.
It is tempting to propose that variation in the susceptibility of 
certain mouse strains, to T-lymphocyte mediated cardiac lesions, reflects a 
c o m p r o m i s e d  ability of host T-cells to recognise viral antigenic 
determinants thus mounting a decreased response, both humoral and cell- 
mediated.
Abnormal frequencies of histocompatibility antigens have been reported 
in a number of human diseases, such as adult coeliac disease (Stokes et al, 
1972), Hodgkin's disease (Zervas et al, 1970; Morris et al, 1971), 
disseminated lupus erythmatosus (Grumet et al, 1971), acute lymphoblastic 
leukemia (Walford et al, 1970), chronic glomerulonephritis and ankylosing 
spondylitis (Brewerton et al, 1973; Schlosstein et al, 1973). In other 
diseases however, which show an increased family incidence suggesting 
involvement of genetic factors, no abnormality in the pattern of HL-A 
antigens exists when compared with controls. Diseases such as regional 
enteritis (Thorsby and Lie, 1971).
The absence of HL-A W27 antigen, a high frequency of which is closely 
associated with ankylosing spondylitis, in African Negroes (Dausset, 1972) 
and the presence in American Negroes at the low frequency of 4% suggests
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that W27 may have come from Caucasians in America. Further evidence 
suggesting close association between W27 and a susceptibility to ankylosing 
spondylitis comes from 8 out of 10 American Negroes with the disorder had 
W27.
In another racial population this trend was not supported. Among 
Japanese the incidence of ankylosing spondylitis has been estimated at 4 in 
10,000 (Tsujimoto, 1970), a similar incidence to that found in Caucasians. 
Nowever, in normal Japanese W27 is present in only 1% of the normal 
population (Mittal et al, 1972) against 8% of the Caucasian population 
(Schlosstein, 1973).
This close association between certain HL-A antigens and disease 
states suggests such antigens influence the susceptibility of an individual 
to the disease. This possible mechanism of influence is unknown but 
evidence from animal studies poses at least three possibilities.
Firstly, a given cell-surface antigen may have a molecular composition 
favouring selective binding to a virus. Cells having such a surface 
antigen would preferentially bind virus increasing susceptibility to the 
virus.
Secondly, a particular virus may share antigenic determinants with an 
HL-A antigen preventing subsequent recognition of the virus as foreign.
Lastly the possibility exists that the genes responsible for governing 
the immune responses are influenced in some way by the HL-A gene complex or 
antigens.
CARDIAC ENZYME RELEASE AFTER COXSACKIE B VIRUS INFECTION
Following focal heart damage, where cell death occurs, the serum 
levels of a number of enzymes increases. Such enzymes as lactate
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dehydrogenase (LDH) and creatine kinase (CK) increase in activity 2-6 hours 
after damage occurs reaching a maximum after 2-3 days. A significant 
improvement in enzymic diagnosis of focal heart damage occured with the 
ability to detect the isoenzymes of LDH and especially CK. Three 
isoenzyme forms of CK are found in the cytoplasm, MM in the skeletal 
muscle, BB in the brain and gastrointestinal tract and MB in the 
myocardium. Accurate assessment of focal myocardial damage in man has been 
helped greatly by the demonstration that the MB isoenzyme of CK is 
localised virtually exclusively in the myocardium as opposed to other 
tissues (Wagner et al, 1973). Blomberg et al (1975) consider the rise in 
serum CK-MB the most sensitive and specific enzyme indicator of the 
presence or absence of acute myocardial infarction.
It is to be expected that high serum titres of total CK would evolve 
following a systemic infection with a myotropic virus such as Coxsackie B4. 
The recovery of infective viral titres from liver and the adductor muscles 
of the thigh confirm the widespread infective potential of this virus 
strain, in spite of heart adaptation by serial passage.
In the experimental mouse model the increase in cardiac specific 
isoenzyme (CK-MB) is confined to the normal animals. Reduction in overall 
necrotic lesions (grade 3 and 4) following T-lymphocyte depletion, results 
in a marked decrease in CK-MB cardiac isoenzyme release. The increase in 
total CK levels shown by thymectomised animals probably occurs because of 
enzyme release, from heart and peripheral skeletal muscle, as a result of 
intracellular virus replication. To obtain high levels however, complete 
cellular disruption would certainly need to occur. Whether or not severe 
damage to skeletal muscle and liver parenchyma occurs as a result of a 
cellular immune interaction is not known, but the number of lesions in the 
adductor muscles of the thigh (although not common in immune intact 
animals) are reduced in T-lymphocyte deprived animals. Certainly, an
increase in overall CK levels, largely comprising the CPK-MM isoenzyme 
fraction common to muscle, would occur as a result of damage incurred 
whilst bleeding animals from the retro-orbital plexus.
It is significant that- those samples for group 2 showing relatively 
high percentage levels of CK-MB isoenzyme, came from animals with 
histological evidence of grade 3 or 4 cardiac lesion. An independent 
series (n=45) showed a mean percentage level of 7.4 for CK-MB isoenzyme in 
normal untreated male CBA/Ca strain mice.
The cause for percentage levels higher than this, as seen in group 3 
and 4, may be due to the independent series sample not being large enough 
to clearly demonstrate the full range of CK-MB background levels present in 
this mouse model. It is possible that an infective agent may be is present 
in outwardly healthy animals, causing a mild myocarditis resulting in a 
sustained release of CK-MB isoenzyme into the blood stream. Possibly the 
same cause of "spontaneous" mononuclear cell infiltration noted earlier. 
More likely, the incidence of focal cardiac lesions in apparently healthy 
mice, as a result of myocardial ischaemia and subsequent infarction, is 
higher than previously expected. The cause of such ischaemia is probably 
"spontaneous" embolic or thrombotic occlusion of coronary vessels as 
microscopic examination of uninfected animals yields no evidence of 
atheromatous-like plaques being present in the coronary arteries.
The delay in rise of total CK and CK-MB isoenzyme levels reflects the 
picture in human patients where CK may take 36 hours to reach maximum serum 
titres (Gerlach, 1974).
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P A R T  II 
HUMAN STUDIES 
(A)
I N T R O D U C T I O N
THE COXSACKIE B VIRUSES
Following a number of suggestions Cooper et al (1978) recommend that 
the family of small RNA containing viruses, the Picornaviridae, be divided 
into four genera of equal status. They are the rhinoviruses, apthoviruses, 
cardioviruses and enteroviruses. Included in the later genus are the human 
polioviruses, human Coxsackie viruses and the human ECHOviruses. Detailed 
structural and chemical investigations on poliovirus and ME virus, a 
"cardiovirus", (Rueckert, 1971) and foot-and-mouth disease virus (Talbot 
and Brown, 1972) reveal a non-enveloped, icosahedral capsid, 25-40 nm in 
diameter. The RNA genome is infectious and may act as a template for 
additional RNA synthesis or may be encapsulated to form progeny virions 
(Young, 1979). These family characteristics of the Picornaviridae are 
shared by all the genera.
The Coxsackie viruses derived their name from the town in New York 
State, from which the first isolate from two boys was characterised in 
August 1947 (Dalldorf and Sickles, 1948). These early isolates were 
further classified into Coxsackie virus groups A and B on the basis of 
their pathogenicity in neonatal mice.
The group A Coxsackie viruses, of which there are 24 distinct 
serotypes (Green, 1978), may be cultivated in neonatal mice up to 72 hours 
of age but older mice become increasingly less susceptible (Lerner et al, 
1962; Grodums and Dempster, 1959). The primary pathological effect is that 
of a patchy but widespread hyaline degeneration of the skeletal muscle 
fibres with an increased inflammatory response leading to flaccid paralysis 
(Wilson and Miles, 1975).
The six group B Coxsackie viruses, first cultivated in neonatal mice
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up to 24 hours old produce, in addition to a widespread myositis, marked 
reactions in sub-cutaneous brown fat, the meninges, cerebral cortex, the 
pancreas, liver and cardiac muscles (Swain and Dodds, 1967). The 
incubation period for group B viruses is prolonged in neonatal mice and 
delay in the development of clinical symptoms (spastic paralysis) may be 10 
days or more after the initial inoculation. Further studies demonstrated 
that some serotypes of the ECHO virus sub-group were capable of replication 
in neonatal mice. This has led Rosen et al (1970) to recommend that all 
further enterovirus discoveries be identified by sequential numbering 
irrespective of sub-groups. Since then four new enterovirus serotypes (68- 
71) have been recognised sharing the group characteristics (Young, 1979).
EPIDEMIOLOGICAL ASPECTS OF COXSACKIE B VIRUS INFECTIONS
"The intestine of man provides them with a habitat but they 
do not colonise it with the frequency or the persistence of 
intestinal bacteria". -Christie, 1980.
For a greater part of the year Coxsackie viruses cannot be isolated 
from faecal specimens but it would appear, that in temperate climates, the 
highest incidence of infection is during the warmer part of the year. For 
example the highest incidence of infection, for Coxsackie B group viruses 
in tropical Madagascar occurs between January and March (Sureau and 
Kauffman, 1965). However, in areas such as the Southern States of America, 
where there is a higher mean annual temperature with less severe 
temperature fluctuations between winter and summer, enteroviruses in 
general may be isolated throughout the year but with a less pronounced 
upsurge of incidence during the summer months (McLean, 1966). A study of 
180 patients with recent Coxsackie B virus infections showed 97% occuring
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during the months of May and November with 40% occuring during August 
(Artenstein et al, 1965). Furthermore, these workers demonstrated the 
predominance of a single serotype during a given year. Although the 
majority of these patients were from the United States, some were also 
included from Europe, Bermuda, Panama, Japan and Hawaii. All age groups 
were affected but the clinical presentation varied from aseptic meningitis, 
being the most common manifestation, to pleurodynia, cardiac involvement, 
exanthema, enanthema, orchitis and non-specific febrile illnesses. McLean
(1966) quotes similar figures for many enteroviral serotypes in many 
geographically distinct areas. Coxsackie virus serotypes have also been 
isolated during early winter from North Alaskan Eskimos (Banker and 
Melnick, 1951), indeed enteroviruses as a whole are clearly capable of 
causing disease at any time of the year in widely separated geographical 
areas. (Shingu et al, 1970; Morgante et al, 1972; Seddon and Duff, 1971).
Although Coxsackie B viruses may cause disease at any age the highest 
incidence is in children, in which the agent is frequently epidemic 
(Hoskins et al, 1979; Schiff, 1979; Green 1978). These epidemics are 
invariably restricted to populations where close confinement results in 
rapid virus dissemination between infected and non-infected members of the 
community. Brightman et al (1966) describe a Coxsackie B5 virus infection 
occuring among newborn infants in a maternity hospital in Philadelphia. 
The outbreak occured when an epidemic in the local community was at peak 
incidence. Characteristically, these infants showed a spectrum of clinical 
manifestations from sub-clinical infection to aseptic meningitis. 
Furthermore, the outbreak occured during the summer months of August and 
September.
Studies over the period 1958 to 1970 have shown that Coxsackie viruses 
B2, B3, B4 and B5 occur in a cyclical pattern every three to six years 
(Brit. Med. J. 1971). Coxsackie B1 however, although isolated less
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frequently usually fails to show this characteristic periodicity and rarely 
reported Coxsackie B6 infections also fail to show any periodic increase in 
infections (Brit. Med. J. 1971). Evidence however, from two small 
outbreaks in England and Wales, one in 1970 and another in 1976, of 
Coxsackie B1 virus showed that each lasted two years, the distribution of 
cases was biphasic and peak incidence occured during the summer months 
(Communicable Disease Reports; Public Health Laboratory Service, 1964-
1977).
Occasionally, Coxsackie B virus epidemics occur over a widespread 
geographical area, such as the 1965 outbreak of Coxsackie B5 in Europe 
(Grist and Bell, 1969) during which a wide variety of clinical symptoms 
were encountered.
It is thought that man is the only host naturally susceptible to the 
Coxsackie virus in whom infection may often be inapparent. In Metropolitan 
New York families 49% of Coxsackie virus infections have been estimated to 
be sub-clinical (Kogon et al, 1969; Melnick, 1957) highlights the increased 
incidence of infection in children and communities with a low standard of 
hygiene and emphasises the importance of the faecal-oral transmission route 
for this virus, although in a much smaller number of cases the virus is 
disseminated from focal lesions in the oropharynx by droplet transmission 
(Green, 1978). A hazard now well recognised in maternity units is the 
intra-uterine infection of foetuses with Coxsackie viruses (Cohen, 1969). 
Brightman et al (1966) describing Coxsackie B5 infections in newborn 
infants, showed that only 8.6% of full-term infants had laboratory 
diagnosed infections but 66.7% of premature infants had proven infection. 
Furthermore, virus was present in the placenta from a small proportion of 
these premature deliveries suggesting that in utero infection of the foetus 
occurs after virus crosses the placental barrier during the viraemic phase
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of the infected mother.
PATHOGENESIS OF INFECTION
Coxsackie virus pathogenesis has not been directly studied in man but 
the pathogenesis of poliovirus has been examined in some detail. This in 
combination with fragmentary evidence on the Coxsackie group viruses, 
suggests very strongly that similarities in pathogenesis occur within the 
enterovirus family, except for the principal target organs involved 
following primary replication.
Virus particles implant and replicate in susceptible tissues of the 
distal gut and pharynx. Subsequent replication occurs in the lymphoid 
tissues of the alimentary tract. This is especially marked in the tonsils 
and Peyer's patches of the ileum. The amount of virus recoverable from the 
faeces of infected individuals exceeds that recovered from tonsillar tissue 
with suggests that gut replication exceeds that of the pharynx. The 
maximal duration of viral excretion from the pharynx and faeces is 3 to 4 
weeks and 5 to 6 weeks respectively. Up to 70 days has been recorded for 
faecal shedding of Coxsackie B virus (Lerner et al, 1975). Following 
replication in the alimentary lymphatic tissues virions pass to the deep 
lymph nodes resulting in a viraemia. The virus may then pass 
haematogenously to extra-neural tissue such as the liver, spleen, and bone 
marrow. In subclinical infections, which are the most common, host defence 
mechanisms contain the infection at this point. However, in a small number 
of infected persons further replication occurs in reticulo-endothelial 
sites causing a heavy and sustained release of virus into the blood stream 
and probably coincides with the "minor illness" of poliomyelitis infections 
and the non-specific febrile illness associated with other enteroviral 
infections. Dissemination to major target organs via the blood stream
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occurs at this point. Inflammatory necrotic lesions may then be observed 
in the meninges, heart and skin whilst histopathological lesions are not 
associated with earlier replicative events (Sabin, 1956, 1957, 1958; 
Bodian, 1955, 1956).
SPECTRUM OF CLINICAL DISEASE ASSOCIATED WITH COXSACKIE B VIRUS INFECTION
When one or more serotypes of Coxsackie B group viruses are present in 
a community either in an epidemic or sporadic mode a wide spectrum of 
clinical manifestations may follow. Diseases which occur include aseptic 
meningitis, maculopapular or vesicular exanthemata, respiratory tract 
infections, pleurodynia, myocarditis and pericarditis. Less common 
manifestations of Coxsackie B disease include flaccid paralysis of the 
skeletal muscles, pancreatitis and orchitis. Although many enteroviruses 
may be capable of producing such disease symptoms they will be discussed 
only with reference to the Coxsackie B virus group. Furthermore, although 
there is equal prevalence of Coxsackie B virus infections among males and 
females of the same population, there is a higher incidence of clinically 
distinct diseases associated with such infections in males (Sainani et al, 
1968). The high incidence in males may be associated with increased 
physical activity. Certainly, exhausting exercise during the incubation 
period of certain viral infections has been considered to enhance the 
incidence and severity of the subsequent disease in both experimental 
animals (Tilles et al, 1964; Levinson et al, 1945) and man (Sutton et al, 
1967).
Mild pharyngitis may occur early in the onset of aseptic meningitis 
with fever and headache preceeding the clinical symptoms of acute meningeal 
irritation. Lower motor neurone paralysis or encephalitis may occur, often
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indistinguishable from that caused by poliomyelitis infection, but recovery 
is usually complete (Cohen, 1969).
All Coxsackie B virus serotypes, except B6, have been associated with 
outbreaks of aseptic meningitis (McLean, 1966).
However, symptoms associated with the infections described by Dalldorf 
and Sickles (1948) were usually muscular. One patient had preliminary 
symptoms of violent headache but neither patient exhibited nuchal rigidity. 
The muscles of the thigh and trunk were predominantly affected with 
complete recovery taking many months. Isolation of the virus in suckling 
mice showed the muscles of the limbs, spinal groups, intercostal, masseter 
and scalp to be among those affected. Smooth muscle and the myocardium 
were not infected and no lesions were found in the large peripheral nerves 
or central nervous system.
Coxsackie viruses groups A and B have both been associated with 
localised outbreaks of exanthemata. The Coxsackie A viruses associated 
with these symptoms tend to be commoner in children aged two or more years, 
with exanthemata being frequently vesicular and occasionally urticarial. 
The Coxsackie B virus eruptions are usually maculopapular and more frequent 
in infants aged under two years (Lerner et al, 1962).
Although ECHO viruses and Coxsackie A virus serotypes are more 
commonly associated with upper respiratory tract symptoms, Coxsackie B5 
virus has been isolated from a patient presenting with an acute cyanotic 
attack. All lung lobes were found to be partially congested at necropsy 
(Butler et al, 1962). However, the symptoms associated with these viral 
infections are clinically indistinguishable from those caused by 
rhinoviruses, adenoviruses and parainfluenza viruses. The Coxsackie B 
group viruses have been isolated from children and infants with lower 
respiratory tract disease in association with a wide spectrum of illness 
(Dery et al, 1974). Eckert et al (1967) report twelve cases of lower
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respiratory tract disease associated with Coxsackie B virus infections in 
patients ranging in age from one to 19 months. However, Young (1979) 
considers the Coxsackie A and B group viruses to be only rare causes of 
non-bacterial pneumonia more commonly caused by Mycoplasma pneumoniae, 
influenza A viruses and certain adenoviruses.
Both groups A and B Coxsackie viruses have been implicated in disease 
resembling paralytic poliomyelitis (Steigman, 1958; Kibrick, 1959). Kalter 
et al (1958) in a study of 152 patients with a preliminary clinical 
diagnosis of paralytic poliomyelitis, showed an 11% recovery rate of non­
polio enteroviruses. During the years 1955 to 1957 Magoffin et al (1961) 
noted the presence of a transient flaccid weakness of the skeletal muscles 
in Californian patients following Coxsackie B virus infection.
Gamble et al (1969) provided evidence which suggested that high 
Coxsackie B4 virus titres were, on occasion, associated with diabetes 
mellitus. Gamble and Taylor (1969) demonstrated a seasonal incidence in 
the onset of diabetes mellitus in patients under 30 years of age which 
showed a significant correlation with the seasonal incidence of Coxsackie 
B4 virus. Further work showed that intra-peritoneal inoculation of 
Coxsackie B4 virus in CDI mice produced a rise in blood sugar levels to 
diabetic values 12 days after virus administration whilst serum insulin 
remained inappropriately low (Coleman et al, 1973). They further showed a 
viral specificity for the Islets of Langerhans with little histological 
damage of the acinar tissue.
Although evidence reviewed by McLean (1966) suggested that the 
enteroviruses may be associated with epidemics of infantile gastroenteritis 
in the northern hemisphere there is scant evidence to incriminate the 
Coxsackie B group viruses directly with an etiological role in this 
syndrome.
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Bornholm disease (epidemic pleurodynia) was recognised as early as 
1856 in Iceland but the role of the Coxsackie B viruses in its etiology was 
not confirmed until 1949 (Curnen et al, 1949; Weller et al, 1950; Findlay 
and Howard, 1950).
Pleurodynia probably results from direct viral invasion of the muscles 
following a viraemia, but group B Coxsackie viruses have not however been 
demonstrated by histological or isolation techniques from the skeletal or 
intercostal muscles of patients suffering from myalgia or pleurodynia. 
Lepine et al (1952) claim to have isolated a Coxsackie virus from a muscle 
biopsy of a patient suffering from suspected pleurodynia. However, the 
usual clinical characteristics of pleurodynia were not present and the 
virus isolate was not serologically identified. Despite the recognition 
that patients with this disease may relapse, recovery is usually complete, 
although some debility may continue for many months during convalescence 
(Sylvest, 1934; Warin et al, 1953).
Warin et al (1953) showed that 3 to 6 per cent of cases during an 
epidemic of pleurodynia developed as aseptic meningitis. Orchitis, in post 
pubertal males, was a rare complication (Gordon et al, 1959). Cardiac 
manifestations and pneumonia are further complications of Bornholm disease 
(Bain et al, 1961) although Sylvest (1934) failed to detect any. However, 
Hanson (1930) observed "not infrequently a blowing murmur over the 
precordium" and considered he had observed signs of myocardial impairment.
CARDIAC DISEASE
Approximately 450,000 people die a sudden cardiac death annually in 
the United States. This amounts to 65% of the deaths attributable to 
coronary disease every year. While many causes of this phenomenon have 
been identified they relate primarily to myocardial ischaemia, the single
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most important consequence of coronary atherosclerosis (Lown, 1980). The 
two major etiological processes of sudden cardiac death are hypertension 
and atherosclerosis. Hypertension has been shown to persist for long 
periods without producing overt symptoms and atherosclerosis may develop in 
focal areas of blood vessels beginning in the first and second decades of
life. This may continue undetected for two to six decades until two thirds
of the vessel lumen is occluded and/or embolic occlusion occurs. Symptoms 
will then appear suddenly in the form of angina, claudication, stroke, 
"heart attack" or sudden death.
M u c h  e p i d e m i o l o g i c a l  evidence regarding the role of personal 
characteristics or risk factors in coronary artery disease has been 
obtained from several long term studies of fairly large population samples 
(Dawber, 1973) and a detailed list of these risk factors has been compiled. 
Major risk factors constitute age, male sex, hypertension, cigarette 
smoking, blood glucose and the presence of the low and high density 
lipoprotein fractions of plasma cholesterol. Lesser factors are quoted as 
overweight, a sedentary way of life, hardness of water, family history of
heart disease before age 65, personality type and stress (Levy, 1979).
Myocardial infarction may occur in the absence of complete occlusion 
when the diameter of the coronary vessels is reduced by atheromatous 
plaques and a sustained state of ischaemia is imposed on a specific area of 
myocardium. The time course of ischaemia before a frank infarct is 
precipitated will vary according to the demands imposed on the myocardium. 
Alternatively, occlusion may occur without subsequent infarction providing 
collateral blood flow is sufficient to supply the nutritional demands of 
the surrounding myocardium.
The reported incidence between thrombotic occlusion of atheromatous 
coronary vessels and acute myocardial infarction has varied between 21% and
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91% (Davis, 1970).
Evidence from a study of the records of a London Hospital (Morris, 
1951) shows that during the post second world war years the incidence of 
acute myocardial infarction was increasing, although during this time there 
was very little increase in pathologically demonstrable atherosclerosis. 
More recent work suggests that the "occluding" thrombus invariably succeeds 
rather than precedes the acute episode (Roberts, 1972). This lends weight 
to the suggestion that an infective process, undetectable by gross 
pathology, may play an etiological role in some cases of acute myocardial 
infarction, particularly in those cases of sudden death without supporting 
pathological evidence of atheromatous disease.
VIRUS INFECTION OF THE HEART
In man, as in the experimentally infected mouse, the newborn are very 
susceptible to viral myocardial disease although there are many reports 
indicating a significant role for Coxsackie viruses in juvenile and adult 
heart disease (Verlinde et al, 1956; Abelman, 1971; Overall, 1972). These 
frequent reports of Coxsackie B group infections associated with cardiac 
dysfunction have led Waterson (1980) to state, "In the United Kingdom 
Coxsackie viruses are the most commonly associated with acute viral 
infections of the heart".
Inflammatory lesions and structural abnormalities of the heart arising 
prenatally are collectively termed "congenital heart diseases". In the 
United States infants born with congenital defects of the heart and 
associated great vessels have been estimated at 250,000 per annum (Overall, 
1972). A number of viruses have been incriminated in prenatal infections 
and the Coxsackie B group viruses may occasionally play an etiological role 
in any subsequent congenital heart defects. Transplacental passage of the
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Coxsackie B viruses has been shown to occur in mice (Soike, 1967) and in 
humans (Kibrick and Benirschke, 1958; Richardson, 1977). Brown and Evans
(1967) examining expectant mothers during the first trimester of pregnancy, 
found an increased incidence of Coxsackie B3 and B4 virus infections in 
mothers of infants with congenital heart defects when compared with mothers 
of normal infants bora at the same time. Four-fold or greater, change in 
specific serum antibody titres was considered diagnostic of recent 
infection.
Since Gore and Saphir, (1947) showed that in a series of 1402 cases of 
clinically diagnosed myocarditis, rheumatic and diptheritic carditis 
contributed only 10% each of the total, increasing attention has been paid 
to the possibility that viruses may play a causative role in inflammatory 
myocardial disease (Kawai et al, 1978).
As electrical potentials have never been demonstrated in the 
pericardium those electrocardiographic abnormalities associated with acute 
pericarditis are thought to result from inflammation of the underlying 
myocardium (Wolff and Grunfield, 1963). Furthermore, the manifestations of 
pericarditis and myocarditis may predominate in different age groups. 
Waterson (1980) believes that the clinical signs of p ericarditis  
predominate in the adult but in neonates a severe myocarditis dominates. 
However, he stresses that although one or other clinical manifestations may 
predominate, infection of the pericardium rarely occurs without involving 
the underlying myocardial tissue and vice versa. Thus, the term 
"myopericarditis" has been adopted (Smith, 1966).
Cardiac involvement by the Coxsackie B viruses in neonatal myocarditis 
was first documented in Rhodesia (Montgomery et al, 1955) and South Africa 
(Javett et al, 1956), later in Holland (van Creveld and de Jager, 1956; 
Verlinde et al, 1956) and in the United States (Kibrick and Benirschke,
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1956). Fletcher and Brennan (1957, 1958) were among those to record the 
first cases of cardiac complications associated with Coxsackie B virus 
infection in adults. The true incidence of Coxsackie B myopericarditis is 
difficult to asses because the "positive" cases are those recorded and 
there is usually little accompanying evidence from the background 
population regarding the number of clinically apparent cases of carditis 
without significant virology, or those cases with positive virological 
findings but no clinically apparent myopericarditis (Grist and Bell, 1969).
Lerner and Wilson (1973) have proposed a system of "Orders of 
Association" for suggesting the criteria of diagnosis to establish an 
etiological role for a particular virus in acute myocardial disease. These 
"Orders of Association" may be summarised as follows:
High-Order association -
(A) Virus isolated from heart or pericardial fluid OR
(B) Type specific virus localised in heart in areas of pathological change 
by immunofluorescence or antibody labelled with peroxidase or 
ferritin.
Moderate-Order association -
Virus isolated from THROAT or FAECES AND either:
(A) Fourfold antibody rise demonstrated between acute and convalescent 
sera OR
(B) Concomitant titre of 1/32 or more of type specific IgM antibody
92
demonstrated.
Low-order association -
(A) Virus isolated from THROAT or FAECES OR
(B) Fourfold rise in antibody demonstrated between acute and convalescent 
sera OR
(C) Single serum showing titre of 1/32 or more of type specific IgM 
antibody.
They further suggested that low-order and moderate-order association 
became moderate and high respectively if appropriate controls did not show 
the same virological findings or if the virus isolated produced similar 
heart disease in experimentally inoculated mice.
Although all age groups have been affected, viral myocardial disease 
appears to be more common during the second and third decades of life in 
males rather than females possibly due to increased activity in men.
Neonatal myocarditis often occurring in epidemic form, is invariably 
fatal and presents as a fulminating illness with fever. Respiratory 
distress, cyanosis, extreme tachycardia or arrhythmia, cardiac dilation, 
congestive heart failure and circulatory collapse are also common symptoms. 
In adults acute myopericarditis characteristically presents as a benign 
illness. However, Coxsackie B virus associated myopericarditis is being 
reported with increasing frequency. Fever, arrhythmias, severe congestive 
heart failure and pericardial effusion are common symptoms. The pain and 
electrocardiographic abnormalities mimic acute myocardial infarction which
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may lead to a misdiagnosis. Although complete recovery usually occurs 
residual electrocardiographic abnormalities, cardiac enlargement and 
c o n s t r i c t i v e  p e r i c a r d i t i s  h a v e  been reported (Smith, 1970). 
Electrocardiographic defects are variable in patients with Coxsackie B 
virus induced m y o p e r i c a r d i t i s  (Sainani et al, 1968), making the 
differential diagnosis from myocardial infarction difficult. These changes 
are occasionally preceded by an upper respiratory tract infection.
The condition of idiopathic congestive cardiomyopathy involves 
progressive cardiac dysfunction with failure of the myocardium without 
obvious cause and with fully patent coronary arteries. There is now 
evidence to suggest that the Coxsackie B viruses may play a causative role. 
Recent studies have shown that high neutralisation titres to Coxsackie B 
viruses were more common in patients with congestive cardiomyopathy than in 
age and sex matched controls (Cambridge et al, 1979). Additionally these 
high titres were more common in those patients with a short clinical 
history of congestive cardiomyopathy, that is, a year or less. The 
evidence that some patients with congestive cardiomyopathy had recently 
suffered a febrile illness lends support to the suggestion that congestive 
cardiomyopathy and Coxsackie B virus infections are associated in some way 
(Waterson, 1978).
It has been suggested that certain chronic valvular diseases, 
considered to be of unknown etiology, may be produced by a variety of 
cardiotropic viruses (Burch and De Pasquale, 1964). In heart tissue 
obtained from 55 autopsies, mainly from young patients varying in age from 
still births to 30 years, Burch et al (1967) demonstrated Coxsackie B virus 
antigens in both the myocardium and mitral valves in 5% of their study 
group. De Pasquale et al (1966) suggested the causal role of Coxsackie B4 
virus in acute valvulitis by recovery of virus from the heart and 
immunofluorescent visualisation in the valves of experimentally inoculated
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Cynomolgous monkeys.
Woods et al, (1973) looked at the relative frequencies of recent 
infection with the Coxsackie B group viruses in patients admitted to their 
coronary care unit with assorted cardiomyopathies. They found nearly 10% 
of their patients suffering from acute myocardial infarction had evidence 
of recent infection with a Coxsackie B virus. Diagnosis of recent 
infection was made if virus was isolated from throat swabs or stools in the 
presence of a rise in homologous antibody; and also if a fourfold or 
greater rise in specific neutralising antibody occured between acute and 
convalescent serum samples in the presence or absence of virus isolation. 
In a later paper Woods et al (1975) described 233 patients with acute 
transmural myocardial infarction of which 8.6% had evidence of active 
Coxsackie B virus infection which occured predominantly in men aged between 
45 and 54. Serological diagnosis was made on the basis of four-fold or 
greater rise in specific serum antibodies between acute and convalescent 
sera.
Nicholls and Thomas (1977) studied a group of 38 patients with acute 
myocardial infarction and found that 26.3% had had a recent infection with 
one of the Coxsackie B viruses. Diagnosis was based on a four-fold or 
greater increase in specific antibody titre between acute and convalescent 
sera. Furthermore, concomitant static titres as low as 1/160 were regarded 
as evidence of recent infection; criteria not usually acceptable 
considering the persistent nature of Coxsackie B virus neutralising 
antibody in man. Virus isolation was not attempted in this study.
It has been shown by Burch et al (1971) that Coxsackie B infection can 
produce arteritis and capillary damage in mice and monkeys as a result of 
hypertrophy of the endothelial cells lining the coronary vasculature and 
they pointed out that these changes can be extensive even producing
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complete occlusion of the coronary vessels supplying the myocardium.
Burch and Shewey (1976) describe two young male patients who had 
suffered acute myocardial infarction in conjunction with clinical 
characteristics associated with viral infection, however, a viral diagnosis 
was not confirmed. Although the relationship is tenuous the possibility 
that coronary artery disease in man may be caused by a virally induced 
arteritis subsequently producing a conventional picture of myocardial 
ischaemia, and resultant infarction, should be considered.
Contrary to this evidence, analysis of samples from two geographically 
distinct populations failed to demonstrate an increased incidence of recent 
infection with a Coxsackie B virus strain over their control groups (Wood 
et al, 1978; Griffiths et al, 1980). In each case however, selection of 
control patients from populations with an increased possibility of 
Coxsackie B infection, may account for the relatively high incidence of 
serologically diagnosed recent infection in these groups.
ANTIBODY PRODUCTION IN RELATION TO COXSACKIE B VIRUS MYOCARDIOPATHY
There are two well established characteristics concerning the 
production of Coxsackie B virus neutralising antibodies in man. They are:
1. Neutralising antibody responses following primary infection are highly 
type specific with little or no cross reaction occuring.
2. Subsequent infections produce heterotypic or anamnestic responses; 
these heterotypic responses may be of greater magnitude than the 
homeotypic responses.
Schmidt et al (1973) have shown that Coxsackie B viral specific
96
Immunoglobulin M (IgM) neutralising antibodies are detectable in the serum 
three days after the onset of a viral myocardiopathy. This is gradually 
replaced after 4-6 weeks by viral specific Immunoglobulin G (IgG). Little 
data exists on the timing of production of specific Immunoglobulin (IgA) 
throughout the infection sequence. Although in subjects immunised with 
oral attenuated poliovirus vaccine the IgA response in serum is detectable 
at 4-6 weeks but is generally of low magnitude and not present in all 
persons (Ogra and Karzon, 1971). Secretory immunity develops about 2 weeks 
after infection in most persons and persits for up to 15 years.
It has been noted that when acute-phase serum specific antibody titres 
are 1/32 or greater the chances of demonstrating a diagnostic rise in titre 
are greatly reduced (Young, 1979). The detection of specific IgM 
antibodies is generally regarded as a reliable indicator of recent 
infection, but little is understood about heterotypic or anamnestic IgM 
responses which may be of a greater magnitude. The possibility that a 
"chronic" infection with Coxsackie B viruses may be responsible for a 
prolonged IgM production beyond the acute phase, should also be considered.
Rager-Zisman and Allison (1973) consider these humoral circulating 
antibodies to be the the most important factor in limiting Coxsackie B 
virus disease as opposed to infection. Certainly, the efficiency of these 
circulating antibodies has been demonstrated for poliovirus infection by 
Bodian and Nathanson (1960) in experimentally infected chimpanzees where 
trace amounts of type-specific neutralising antibodies prevents viraemia 
and subsequent paralysis. It has been shown that before exposure to 
n e u r o virulent polioviruses passive i m m u n i t y  may be conferred by 
administration of immune serum globulin (Muench, 1955; Stevens, 1959). 
However, after the onset of clinical signs of central nervous system 
infection, parenteral administration of serum immune globulin does not
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modify the outcome (Hammon and Roberts, 1948). At this stage of the 
illness patients invariably have developed circulating antibodies. This 
work and that by Bahlke and Perkins (1945) shows that immune globulin can 
play no effective role in the treatment of established disease.
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M E T H O D S  A N D  M A T E R I A L S
SELECTION OF PATIENTS
Midhurst Study Group
The test group for this study consisted of 189 patients admitted to 
the Special Care Unit of King Edward VII Hospital, Midhurst, Sussex 
(Cardiac test group). Subsequently, 19 patients were found to have no 
diagnosable heart disease and omitted from the test group. Of the total 
cardiac test group (n=170) 113 were diagnosed as acute myocardial
infarction (AMI group) and the remaining 57 patients (having cardiac 
diagnoses other than AMI) were classified as the "other cardiac" group. 
Control group patients (n=55) were obtained from other non-cardiac wards of 
King Edward VII Hospital, Midhurst. These patients had predominantly 
pulmonary diagnoses. One patient was later shown to be suffering 
congestive cardiac failure and deleted from the group. These controls were 
not individually age and sex matched but prior to and during the study it 
was ascertained that the ratio of males to females admitted to these wards 
was approximately 2:1. The same as that for the cardiac test group and 
"other cardiac" group.
The control group was also shown to have a similar age span as the 
cardiac patients. This assured that variations in serological results, 
attributable to age and sex, were reduced to a minimum. The distribution 
of sexes within each group were as follows:
AMI group "other cardiac" group Control group
/ \ / \ / \
MALES FEMALES MALES FEMALES MALES FEMALES
I I I  I I  I
78 35 36 21 35 19
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Worthing Study Group
The Worthing study group consisted of 50 patients admitted to the 
Coronary Care Unit of Worthing General Hospital, Worthing. Of these, 31 
were diagnosed as having acute myocardial infarction (AMI group). The 
remaining 19 ("other Cardiac" group) had cardiac diagnoses other than AMI. 
Two patients from this study group showed serological evidence of recent 
Coxsackie B virus infection, both were male and from the AMI group. The 
distribution of sexes between the "other cardiac" and AMI group were as 
follows:
AMI group
/ \
MALES FEMALES
I I
20 11
CLINICAL SAMPLES
SERUM COLLECTION AND THE NEUTRALISATION TEST
Whole blood was collected by venipuncture from patients involved in 
the Midhurst and Worthing studies, the day after admission. Second samples 
from Midhurst study patients were obtained between day 10 and day 15 
following admission. Any further follow-up samples were obtained through 
the General Practitioners responsible for individual patients during the 
following months. Second samples from Worthing study patients were 
obtained after 3 months through their General Practitioners. This was to 
test the hypothesis that specific serum antibody levels to recent Coxsackie 
B virus infection showed a delay in rising to significant levels compared 
with the conventional 14 days. After collection blood was placed
"other cardiac" group
/ \
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immediately into L/107 snap top, plastic tubes to clot^^\ After storage 
at room temperature for 3-5 h samples were agitated and centrifuged at 
1000 G for 15 min to deposit fibrin and red blood cells. Serum was 
collected by glass Pasteur pipette (Scientific Furnishings Ltd.)^^ placed 
in sterile plastic bijou, coded and stored at -20°c» Sera were processed 
in batches of ten so that individual samples were stored no longer than 
four weeks.
A small proportion of sera exhibited toxicity towards the culture 
cells producing a cytopathic effect. The exact nature of this serum 
toxicity was ill understood but considered to result from non-specific 
antibody activity. These non-specific interference factors were removed by 
absorbtion of sera with freshly prepared sedimentable cellular antigens 
prepared from Vero cell cultures. Cells were prepared as for the 
neutralisation test, washed (x3) in phosphate buffered saline without 
calcium and magnesium^^ and resuspended in the serum to be absorbed. The 
serum-cell suspension was agitated (not vigourously) for 2 h at room 
temperature and finally centrifuged at 1000 G for 30 min at +4°C in an MSE 
High Speed 18, refrigerated centrifuge, (MSE Ltd.)^^. All sera 
exhibiting anticellular characteristics were rendered non-toxic by this 
procedure.
The test used throughout this series to determine serum antibody 
titres to the six Coxsackie B virus types was a five-volume , constant 
virus-varying serum, neutralisation test. This was performed in microtitre 
with a Vero cell culture host system. The total test volume comprised two 
volumes of serum dilution, two volumes of virus dilution and one volume of 
cell suspension. Test sera were previously diluted in test diluent (0.3 ml 
of serum in 2.1 ml of diluent). Remaining diluted serum was stored at 
-20°C. The use of 96-well, sterile flat bottomed (8 x 12) microtitre 
plate s ^ ^  enabled six sera to be titrated twice in parallel in each plate
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up to a dilution of 1/512 using a hand held m u l t i d i l u t e r T h e  final 
row of each plate was used for serum and cell control purposes. A virus 
control back titration for each virus serotype used was established on a 
separate plate. Incubation took place at 37°C over three days in a 
humidified atmosphere of air; and plates were read on an Olympus CK 
inverted microscope^"^* Serological diagnosis of recent infection was 
made only by demonstration of a fourfold or greater rise or fall in 
Coxsackie B virus specific neutralising antibody titre between acute and 
convalescent serum samples.
One volume = 25 vi.
FAECES COLLECTION AND CHARACTERISATION OF VIRAL ISOLATES
Faecal samples were collected from all patients in the test and 
control groups of the Midhurst Study as soon after admission as possible. 
Problems of constipation were overcome within 2-4 days by the oral 
administration of a mild laxative. Faeces were placed in sterile 
disposable universal containers'^ and finally emulsions were made of all 
samples in Hank's buffered salt solution^^). These were immediately 
placed at -20°C and virus isolation was attempted at weekly intervals. 
Samples were never in storage longer than seven days prior to isolation 
attempts.
Virus isolation was attempted in Vero cells on all faecal samples from 
patients with paired serum samples by the adsorbtion technique (Grist et
al, 1974). Tube cultures were seeded with 0.5 ml of growth media
5 o
containing 1 x 10 cells/ml and incubated for 72 h at 37 C. Faecal
emulsions were thawed, centrifuged at 1000 G for 15 min and 0.1 ml of
102
supernatant was inoculated, using sterile pipette tips (Buckley Membranes 
L t d . ) ^ ^  into two tube cultures and incubated at 37°C in the sloped 
position for 1.5 h. Growth media was replaced with 1 ml of prewarmed 
(37°C) growth media and the cultures were reincubated at 37°C on a roller 
d r u m ^ .  Cultures were examined daily for cytopathic effect with a medium 
change necessary at intervals (3-5 days) to maintain pH. Culture fluid 
from every tube producing cytopathic effect was passed to two fresh 
cultures and reincubated. The reproduction of similar cytopathic effect 
was taken as evidence of successful isolation of virus. Culture fluid from 
tube cultures suspected of being infected were titrated, as described, to 
establish the TCID^q of the infectious isolate.
Virus group specificity was established by neutralisation of 50 jil of 
100 TCID^q infectious fluid, with equal volumes, of varying dilution, 
polyvalent Coxsackie B virus a n t i s e r a ^ ^ *  Using the same microtitre 
plates used for the serum antibody neutralisation test with Vero cells as 
the host, 50 jil of reconstituted polyvalent a n t i s e r u m ^ ^  was diluted, 
using a hand-held multidiluter^^, across the plate resulting in dilutions 
from 1/10 to 1/5120 in maintenance medium. Equal volumes of 100 TCID^q 
infectious fluid were then added to each serum dilution, incubated for 2 h 
at room temperature, and finally 25 jil of Vero cell suspension (1 x 10^ 
cells per ml) were seeded into each well.
Confirmation of Coxsackie B virus type specificity was obtained by 
neutralisation with monovalent, type specific Coxsackie B antisera^"^.
CELL CULTURE
Unless otherwise stated items were sterilised by moist heat above 
100°C in a non-jacketed autoclave for 20 minutes (15 psi gauge 
pressure)^). Certain items were oven dried at 60°C for 30 min. Labile
103
fluids were sterilised by filtration through a 25 pm exclusion limit 
millipore filter (Millipore (U.K.) Ltd.)^^ previously sterilised by moist 
heat with filter in situ.
Mains water was de-ionised by passage through a B113 free flow 
Elgastat de-ionising still (Elga products Ltd.)^^. De-ionised water was 
further distilled in a two litre capacity D-ionstill^\ Distillate was 
transfered in 90 ml amounts into 500 ml borosilicate glass bottles, 
sterilised and stored at room temperature.
To reduce variation between batches of single strength media, 
sufficient concentrate and media additives to cover the test series, were 
purchased from the same product batch at the outset of the study. All 
additives were dissolved in sterile media diluent.
Commercially produced medium 199 with Earle's s a l t s ^ ^  was purchased 
at tenfold concentration in liquid form without sodium bicarbonate or L- 
glutamine. All stock media concentrate was stored at +4°C and added to 
sterile media diluent at a 10% concentration.
L-glutamine was p u r c h a s e d ^ ^  in sterile liquid form at a 200 mM/1 
concentration, stored in 2 ml amounts at -20°C and added to single strength 
media at a final recommended concentration of 0.1 gm/1.
Antibiotic concentrate of penicillin and streptomycin^^ were stored 
at -20°C and added to single strength media at 100 IU/ml and 100 mg/ml 
respectively.
A molar solution of N-tris (hydroxymethyl) methyl g l y c i n e , w a s  
added to single strength media at a 5% concentration.
Sodium b i c a r b o n a t e ^ ^  dissolved to a 7.5% concentration and 
sterilised by autoclaving, was added as a metabolic supplement at a final 
concentration of 2.2 g/1.
Foetal bovine s e r u m , m y c o p l a s m a  and virus screened prior to
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purchase, was added to growth media at a 10% concentration and maintenance 
media at 1%. Aliquots of 25 ml were stored at -20°C and membrane filtered 
prior to use.
The cells employed for the neutralisation test, stock virus production 
and virus isolation techniques were a continuous line of African green 
monkey kidney cells (Vero c e l l s ) ^ ^ .  These cells are "fibroblast-like" 
and were originally supplied at a pass number of 127 (Lot No. 1 6 8 9 1 ) ^ ^ .  
From this original culture sufficient cells were grown and stored to allow 
all techniques to be carried out on cells between pass 130 and pass 150.
This cell line was virus and mycoplasma screened prior to purchase, 
and further tested every subsequent passage for the presence of mycoplasma 
species by using a commercially produced isolation k i t ^ ^ .  A 1 ml sample 
of cell culture was freeze-thawed (-20°C + 20°C x 3) and 0.1 ml inoculated 
onto a mycoplasma test agar plate and 0.5 ml into 10 ml of mycoplasma test 
broth. Subculture of inoculated broth was carried out onto agar plates 
afer 3 days. Plates were incubated, inverted, in an atmosphere of 95% ^  
5% CO2 (B.O.C. Special Gases)^"^ in a modified McIntosh and Fildes 
anaerobic jar^) at 37°C* Plates were examined daily and discarded as 
negative if no growth occured after 21 days. Sealed tubes were incubated 
at 37°C in air. With all isolation attempts a positive control of 
lyophilised Mycoplasma arginini was reconstituted and isolated by primary 
inoculation into broth followed by agar plate isolation.
Mycoplasma contamination was confirmed by microscopic examination of 
plates with an Olympus CK inverted microscope^"*). Contaminated cultures 
were discarded.
9
Cell cultures were grown as monolayers in 75 cm growth area tissue 
culture treated disposable plastic flasks^^) and harvested using a mixture 
of 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) in a 
buffered salt solution^^). Flasks with confluent monolayers were washed
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twice in 10 ml of prewarmed (37°C) phosphate buffered saline without 
calcium and magnesium salts^^* The cell sheet was then bathed in 5 ml of 
prewarmed typsin-EDTA solution and incubated for 3-7 min at 37°C. Cells 
were then diluted, washed twice and resuspended in 10 ml of prewarmed 
maintenance medium. Cells were dispersed further by aspiration, with care 
being taken to prevent excessive "frothing" of the media. Cells not used 
for the neutralisation test or re-seeding bottles were discarded into 2% 
sodium hypochlorite solution^^* Growth flasks were re-seeded only with 
cells from the same vessels.
Cells were stored in gas phase liquid nitrogen (-160°C) in a union 
carbide refrigerator^^. Cells to be stored were washed, harvested from 
the grow t h  flasks and suspended in growth m e d i u m  wit h  d i m ethyl 
l sulphoxide^^ added at a 10% concentration as the cryo-protective agent.
Cells were adjusted to a concentration of 1 x 10^ cells per ml and placed 
in sterile plastic storage ampoules^^* Initially the cell suspensions 
were placed at +4°C for 30 min before being cooled at -20°C for 2 h. 
Further cooling for 2 h at -70°C preceded storage in vapour phase liquid 
nitrogen.
Cell recovery was achieved by removing ampoules from storage and 
placing at 37°C in a preheated waterbath^» After thawing, ampoules were 
sterilised by immersion in 70% ethanol held at room temperature. Cells 
were removed, washed twice in 5 ml of growth medium to remove all traces of 
dimethyl sulphoxide, divided and resuspended in 25 ml of growth medium in 
two 75 cm^ area tissue culture treated plastic growth f l a s k s ^ ^ .  
Incubation at 37°C took place overnight and the following morning media was 
discarded. Cultures were washed once in 5 ml of growth medium and 
recharged with 25 ml of fresh growth medium and incubated to confluency (3- 
5 days).
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Enumeration of cells was performed by using an improved Neubauer 
counting chamber (haemocytometer)^^.
Cell monolayers were dispersed by enzyme treatment and resuspended in 
phosphate buffered saline without calcium and m a g n e s i u m ^ E s t i m a t i o n  of 
viable cell numbers was achieved by incorporating a vital stain, 0.5% 
trypan blue suspended in 0.85% saline at pH 7 . 2 ^ ^  into the diluting media 
at a 0.1% concentration.
STOCK VIRUS PREPARATION AND TITRATION
Stock virus strains of all the Coxsackie B serotypes were obtained 
from the Coxsackie B virus reference laboratory^**). Subsequent virus 
stock was grown in Vero cells. Cultures were grown to 85% conf luency in 
plastic 75 cm^ growth area disposable growth f l a s k s ^ ^ ,  washed in 
p r e w a r m e d  (37°C) phosphate buffered saline without magnesium and 
calcium^^\ recharged with maintenance medium and seeded with 0.2 ml of 
stock virus solution. After development of severe cytopathic effect, 
cultures were freeze-thawed (-20°C + 20°C x 3) to ensure complete cell 
membrane rupture and release of intra-cellular virions. Finally, virus 
suspensions were clarified by centrifugation at 1000 G and the supernatant 
was stored at +4°C with an equal quantity of 2M magnesium chloride^^ to 
stabilise the virus.
Stock virus was titrated as follows. Serial tenfold dilutions of 
stock virus suspensions were made in cell maintenance media (test diluent) 
from 10"1 to 10~® using a F i n n p i p e t t e ^ ^  with separate sterile tips for 
each volume transfer. Using this sterile pipetting system 50 }il of each 
virus dilution was transferred to four wells of a sterile, tissue culture 
treated, microtitre plate^^. The same pipette was used starting at the 
most dilute virus suspension and 50 y.1 of test diluent was added to make up
107
the volume occupied by the serum dilution in the test proper. Finally
4
25 pi of Vero cell suspension (75 x 10 concentration) was added to each 
well. Plates were incubated at 37°C in an atmosphere of air for 72 hours. 
Scoring of wells was on the presence or absence of cytopathic effect and 
Karber's formula was used to calculate the Tissue Culture Infective Dose^Q 
(TCID^q) or 50% end points for each virus serotype.
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R E S U L T S
MIDHURST STUDY GROUP
Isolation of Coxsackie B virus strains was achieved from five faecal 
samples. Three from male patients diagnosed as having acute myocardial 
infarc tion, on e from a female pa tien t from th e"o th er card iac" group and 
one from a male patient from the control group. All patients with a 
positive isolation showed diagnostic serology to the homologous virus 
serotype. Four other patients with acute myocardial infarction were shown 
to have significant serology.
Serological diagnosis of recent Coxsackie B virus infection was made 
only by demonstration of a four-fold change in specific neutralising 
antibody titre.
Four "other cardiac" patients subsequently shown to have serological 
diagnoses of recent infection with one of the Coxsackie B viruses had 
clinical diagnoses as follows: two suffered ischaemic heart disease with
supra-ventricular fibrillation, one suffered ischaemic heart disease with 
gastritis and one patient presented with myocarditis complicated by 
pericardial effusion. Ischaemic heart disease in these three patients was 
diagnosed by non-invasive methods.
Results showed that the incidence of serologically diagnosed recent 
Coxsackie B virus inf ec tion d id no t d iffer sign if ican tly (0.9 > p > 0.75) 
betweeen the AMI group and the "other cardiac" and control groups of the 
Midhurst study (Fig. 11). Results further indicate that the incidence of 
clinical evidence of recent respiratory tract infection was greater in 
patients from each group with serological evidence of recent infection than 
in those without serological evidence of recent infection (Table 7).
Although there was a notable seasonal increase in the incience of
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Fig. 11.
IN C ID E N C E  O F  COXSA CK IE B VIRUS IN FE C T IO N
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A Chi-Square analysis was used to determine any significant 
differences in the incidence of recent Coxsackie B virus 
infection between the test and control groups. Because the 
expected values for the incidence of infection in the ’’other 
cardiac” and control groups were below 5 those two groups were 
considered one for the calculations.
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TABLE 7
TOTAL NUMBER OF PATIENTS
WITH serological 
evidence of infection
WITHOUT serological 
evidence of infection
AMI Group
Con trol 
Group
0 th er - 
Card iac 
Group
Number of Patients with 
clinical evidence of recent 
respiratory tract infection
----6 27----
---2 11---
 3 14----
-106
50
53
The incidence of clinical evidence of recent respiratory tract 
infection in each study group w i th or w i thou t serological evidence of 
recent infection with one or more of the Coxsackie B group viruses.
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recent Coxsackie B virus infections and acute myocardial infarction, close 
correlation of the two was not shown. The summer and winter increases in 
recent Coxsackie B infections are sudden with an abrupt decrease to 
background levels within a few wedts. Seasonal rises in the incidence of 
acute myocardial infarction however, increase gradually to a summer peak 
over the preceding months. There was an abrupt fall in numbers during 
September but increased again over the winter period (Fig. 12).
The age distribution for male and female patients with clinically 
diagnosed acute myocardial infarction followed conventional patterns. The 
incidence for males covered a broader age range, 35-85+ years (Fig. 13(a)) 
than for females, 50-84 years (Fig. 13(b)). The incidence of serologically 
diagnosed recent Cosxackie B virus infection was not confined to any 
particular age group. The peak incidence of acute myocardial infarction in 
men covered a wider age range, 50-80 years than in females, 70-75 years.
Three male patients showed a marked delay in diagnostic antibody 
change. All were diagnosed as having suffered acute myocardial infarction 
but failed to demonstrate a diagnostic change in specific antibody titre 
between first and second samples. Third and fourth samples were obtained 
fortuitously as these patients were re-admitted with exacerbation of 
cardiac illness within three weeks of discharge. All three patients 
demonstrated a diagnostic rise in specific antibody titres between the 
first and fourth serum samples over a time period of 28, 42 and 50 days 
respectively (Fig. 14). Continued antibody titre measurements in these 
patients was not possible as all three died in the succeeding 6 week 
period. Throughout the period of surveillance antibody titres to the other 
Coxsackie B serotypes was ^ 1/8. For all three patients the first cardiac 
infarction episode occured on day 0, the day of admission to hospital. 
Only patient KC gave an unsolicited history of having a "flu-like" illness
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Fig. 12 (a).
SEASONAL IN C ID E N C E  O F CO X SA CK IE B VIRUS IN F E C T IO N
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Fig. 12 (b).
SEASONAL INCIDENCE OF MYOCARDIAL INFARCTION
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Comparison of the seasonal incidence of recent Coxsackie B 
virus infection (Fig. 12(a)), for the total number of patients 
in the Midhurst Study Group showing serologically demonstrable 
recent Coxsackie B virus infection, with the seasonal incidence 
of acute myocardial infarction (Fig. 12(b)) for both sexes. 
Monthly incidence represents the sum of the same months for 
both years of the sample period. The time scale is depicted by 
letters indicating the months January to December.
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AGE DISTRIBUTION OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 
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Fig. 13 (a). 
(Males)
Fig. 13 (b). 
(Females)
The age d i s t r i b u t i o n  for male (Fig. 13(a)) and f e m a l e  
(Fig. 13(b)) patients w i t h  acute m y o c a r d i a l  infarction. 
Numbers in parentheses indicate the age of the patient(s) 
within that age group with serological evidence of recent 
infection. The asterisks denote those patients from whom virus 
was isolated.
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Increase in specific Coxsackie B viral antibody in three male 
patients following acute myocardial infarction.
in the 5 days prior to admission.
WORTHING STUDY GROUP
This study was prompted by observations during the Midhurst study that 
some patients had exhibited a delay in producing a diagnostic change in 
specific Coxsackie B antibody titres between first and second serum samples 
(Fig. 14). This posed the possibility, in some patients at least, that the 
time period of 14 days between first and second serum samples was not 
sufficient to allow the host^s immune reponse to produce a significant 
change in specific antibody levels.
Serum samples from patients comprising the Worthing study group failed 
to show an increase in the percentage of serologically diagnosed recent 
Coxsackie B virus infections compared with patients comprising the Midhurst 
study group. No member of the "other cardiac" group showed serological 
evidence of recent Coxsackie B infection but two patients from the AMI 
group, both males, had diagnostic rises in specific antibody between acute 
and convalescent sera.
Results show an increase in the percentage of patients with "high" 
titres to one or more of the Coxsackie B virus serotypes in the AMI group 
compared to the "other cardiac" group irrespective of sex (Table 8).
Table 8
TOTAL NUMBER TITRES TO ANY PERCENTAGE
OF PATIENTS SEROTYPE OF OF TOTAL
>, 1/512
AMI group 31 13 41.9
"Other Cardiac" 19 5 26.3
group
Distribution of high titres in the Worthing study group. Titres of ^  1/512 
were scored in both acute an convalescent phase samples.
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Results indicate that in both the Worthing and Midhurst study patiepts 
with myocardial infarction and serologically diagnosed recent Coxsackie B 
virus infection are predominantly male (Fig. 15).
Specific antibody persistence occured in a small number of patients 
from the Midhurst study group. In some cases this was many months 
(Table 9).
Antibody titres were determined for the 104 normal adults comprising 
the Midhurst population sample. Comparison of the number of males with 
titres of } 1/512 to Coxsackie B4 virus, in one or both sera, showed a 
higher incidence in the AMI group of the Midhurst study than in the "other 
cardiac", control group and Midhurst population sample (Fig. 16). The AMI 
and "other cardiac" group of the Worthing study showed similar disparity in 
the males. Such resul ts w ere no t d emons tra ted by femal e members of the 
same groups or by the Coxsackie B serotypes other than B4.
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Fig. 15.
SEX DIFFERENCES IN ACUTE COXSACKIE B VIRUS INFECTION
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Incidence of recent Coxsackie B virus infection in male and 
female patients, with acute myocardial infarction, from the 
Midhurst and Worthing study groups expressed as a percentage of 
the total of both AMI groups.
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rig . 16.
INCIDENCE OF HIGH ANTIBODY TITRES IN MALES FROM EACH TEST GROUP
“ o t h e r  c a r d i a c ”  g r o u p
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C o n t r o l  g r o u pM
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M i d h u r s t  p o p u l a t i o n  s a m p l e
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Worthing Study Group Midhurst Study Group
Comparison of the incidence of neutralising titres (^-1/512) to 
Coxsackie B4 virus between male patients of the Midhurst and 
Worthing study groups.
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TABLE 9
PATIENT
J.S. ( ^ )  CB4
J.D. ( ? )  CB4
H.P. ( ? )  CB1
A.M. (<£) CB3
DATE
28. 3.79
11. 4.79
29. 5.79
12. 6.79
13. 9.79 
25. 9.79
27. 3.79 
5. 4.79 
8. 8.79 
17. 8.79
8. 6.78
30. 6.78
11.12.78
22.12.78
12.12.78
28.12.78 
23. 4.79
3. 5.79 
29. 8.79 
11. 9.79
TITRE
256
256
256
128
256
256
512
512
512
512
256
256
256
256
256
256
256
256
256
128
Persistence of antibody titres in male and female patients from the 
Midhurst study group.
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D I S C U S S I O N
INCIDENCE OF RECENT INFECTION AS EVIDENCE OF ETIOLOGICAL RELATIONSHIP
Acute myocardial infarction is widely considered to result from a 
reduced coronary blood supply caused by atheromatous occlusion of vessels 
supplying the myocardium. Atherosclerotic lesions occur more frequently 
with increasing age. As a result it has been suggested that the increasing 
frequency of fatal cardiac infarction in younger men, demonstrating little 
or no pathological changes in the coronary vessels, may be attributable to 
other, more clearly defined etiological processes; possibly viruses. This 
view is enhanced by the proposed "epidemiological shift" of the Coxsackie 
virus from being an infection predominantly of children to that of young 
adults. Increasing hygienic conditions during childhood, decreasing the 
incidence of previous exposure, is the most probable cause of this shift. 
(Grist and Bell, 1969).
Evidence from the infarct patients of the Midhurst Study does not 
agree with the hypothesis that acute myocardial infarction associated with 
serological evidence of recent Coxsackie B virus infection predominates in 
a particular age group.
The results from the Midhurst Study show only marginal differences in 
the incidence of recent infection between the three test groups; and do not 
support the hypothesis that a recent infection with one of the Coxsackie B 
virus serotypes initiates the pathological changes in the human myocardium 
capable of precipitating the clinical symptoms of acute myocardial 
infarction. This does not exclude the possibility that virus induced 
myocardial damage may occur, at a later time, when recent infection is 
beyond detection by changes in specific serum antibodies. Certainly, 
myocarditis of viral etiology may either occur simultaneously with the
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acute phase of infection or as a sequel (Woodward and McCrumb, 1958).
The choice of control patients for this study may influence the 
incidence of recent infection in this group as they were selected from 
wards containing patients with predominantly pulmonary diagnoses. Although 
the Coxsackie B viruses have been frequently associated with upper 
respiratory tract infections they are conspicuously confined to younger age 
groups and their causal role in non-bac ter ial lower respiratory tract 
pneumonia is considered to be rare (Young, 1979). 11 is very unlikely that
a recent infection with one of the Coxsackie B viruses was responsible for 
any of the clinical signs exhibited by those control patients suffering 
terminal carcinoma of the bronchus; but it is possible that a proportion of 
those control patients with an idiopathic lower lobe, non-bac ter ial, 
pneumonia may have had a recent Coxsackie B infection. Of the four control 
patients with serological evidence of recent infection, three had clearly 
defined clinical presentations (carcinoma of the bronchus and chronic 
asthma) that have no known association with an acute or chronic Coxsackie B 
viral infection. However, an asthmatic may suffer exacerbation of symptoms 
when suffering from an acute viral infection of the respiratory tract. The 
acute bronchitis in the remaining control patient may have resulted from a 
r ec en t Coxsack ie B virus infection complicated by subsequent secondary 
pseudomonas and non-haemolytic streptococcus infections. Comparison of the 
number of patients in each test group, with strong clinical evidence of 
infection reveals a higher percentage in those groups with serological 
evidence of recent infection, with one of the Coxsackie B virus serotypes. 
This may account for the prodromal symptoms of respiratory tract infection 
and pyrexia experienced by a high proportion (34.2%) of infarct patients in 
the series examined by Nicholls and Thomas (1977).
However, cough, suggesting respiratory infection, is one of the most
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fr equen t card io-r espira tory symptoms (Braunwald, 1980). It is possible 
that in those patients with acute myocardial infarction, a concomitant 
cough may have resulted from associated cardiovascular complications such 
as pulmonary venous hypertension, interstitial and alveolar pulmonary edema 
or pulmonary infarction. Nonetheless, those patients suffering a cardiac 
infarction with associated cough produced sputum varying in colour and 
consistency from clear white mucoid sputum, indicative of viral infection, 
to thick yellow sputum, indicating an infectious cause other than a virus.
These results are in accord with a subsequent study conducted in 
Sussex, England which failed to show a significant difference between the 
incidence of serologically diagnosed recent infection in patients with 
acute myocardial infarction and age and sex matched control patients 
selected from a gastroenterology outpatient clinic (Griffiths et al, 
1980). The use of these patients as controls, as in the Midhurst study, 
may well account for a higher incidence of infection than in "normal" 
con trols as an inf ec tion w i th one of the Coxsackie B v iruses may cause a 
proportion of the enteric conditions that presented at this outpatient 
clinic. However, there is scant evidence incriminating Coxsackie B viruses 
in the etiology of severe gastroenteritis in the northern hemisphere 
(McLean, 1966).
An earlier Scottish study also failed to produce evidence in support 
of a viral etiology for acute myocardial infarction (Wood et al, 1978). 
These workers found a higher incidence of serologically diagnosed recent 
infection in their control group (52 patients with chest pain but no 
electrocardiographic abnormalities) than in their test group (52 patients 
with clinically diagnosed acute myocardial infarction). However, they do 
highlight the possibility that a proportion of the control patients from 
the "outpatient electrocardiographic clinic" may have been suffering from 
Bornholm disease. This would account for the high incidence of recent
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infection (19%) and hence may not be an accurate prediction of the 
background level of infection in the community from which the respective 
test groups were taken.
A common factor between the Midhurst study and the other comparable 
studies discussed was the lack of data available on the prevalence of 
recent infection within the local population, from which a large proportion 
of the study groups were selected. The incidence of 6.5% and 7.4%, with 
serologically diagnosed recent infection, in the total cardiac and control 
groups of the Midhurst study respectively may well reflect the degree of 
infection in the local populace. If this is so, then it is significantly 
lower than the 19% suggested by the Scottish study and; assuming this high 
level was not the result of a localised Coxsackie B "epidemic"; it could be 
accounted for by the variation in community incidence as a result of 
differing socio-economic class. This variation in "background" incidence 
may well reflect the difference in socio-economic class between the 
essentially "middle-class" Midhurst community and the Glaswegian population 
studied by Wood and his colleagues. Certainly this background incidence 
varies between 1% and 20% for different socio-economic populations (Bell, 
unpublished, Wood et al, 1978).
Seasonal fluctuation of Coxsackie B viral infections may well account 
for the disparity in the incidence of recent infection between the Midhurst 
and Scottish study groups. The Scottish study sampled patients between
i
November and the following May. As it has been shown that 97% of 
infections occured between May and November in temperate climates 
(Artenstein, 1965) this would generally be regarded as a time of minimal 
incidence. However, in the Br i tish Isl es, a high incidence of infection 
has been noted during the m i d - w i n t e r  months (Gamble, personal 
communication). To allow for seasonal variation Midhurst study samples
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comprised sera collected over more than twelve consecutive months. Results 
from both the Midhurst and Worthing study groups show a concentration of 
individuals with serologically diagnosed recent infection in the summer 
months with a marked increase during mid-winter. Although this variation 
is evident, meaningful conclusions may not be drawn because of the low 
number of individuals involved.
Attempts to correlate the monthly incidence of acute myocardial 
infarction in the Midhurst group with the seasonal variation in recent 
infection are not conclusive. Although there is an increase in the 
incidence of infarction for the summer and mid-winter periods, throughout 
the two year s a m p l e  period, this variation is m o r e  likely to be 
attributable to fluctuations in temperature associated with climatic 
conditions or increased human activity during the summer holiday period.
These results do not agree with certain uncontrolled studies which 
suggest an etiological relationship between acute myocardial infarction and 
recent Coxsackie B virus infection. Woods et al (1975) working in 
Freeman tie found an incidence of infection in their acute transmural 
myocardial infarction group (8.6%) very close to that of the total cardiac 
group studied over a three year period (9.3%). In view of the lack of data 
regarding the incidence of infection in the local community from which 
these patients were taken it would suggest these figures represent the 
background level of infection for that area of Western Australia. 
Similarly, th er e was no da ta r egard ing the incidence of infection in the 
local community for the study by Nicholls and Thomas (1977) but they stress 
that "positive serological evidence for C o x s a c k i e  infection w as 
conspicuously confined to the group of patients with acute myocardial 
infarction". Additionally, a large proportion (34.2%) of their infarct 
group gave an unsolicited history of an influenza-like illness during the 
seven days prior to admission. A Coxsackie B viraemia might have been
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responsible for these prodromal febrile symptoms.
The use of a significant increase or decrease in serum antibody titres 
as diagnostic of recent infection necessitates the demonstration that these 
changes will occur within the time of onset of infection, disease 
manifestation and recovery. A complication, in the serological diagnosis 
of human Coxsackie B virus induced heart disease, is the lack of knowledge 
regarding the time course between initial infection and the onset of the 
clinical manifestations of cardiac disease severe enough to precipitate 
admission to hospital, when the "acute" phase serum sample would normally 
be obtained. Inevitably, to infect cardiac tissues virus particles would 
have to pass haematogenously, during viraemia, from primary replication 
sites in the reticulo-endothelial system to the heart. This would result 
in a delay between the onset of infection and the production of overt 
clinical symptoms. This may account for the high proportion of clinically 
diagnosed cases of viral myocarditis that subsequently show static high 
titres, in both acute and convalescent serum samples, with virus isolation 
from throat swabs and faecal samples being rarely achieved. (Kawai, 1978). 
This inability successfully to isolate virus particles from faecal samples 
at this time in the disease process probably results from those virus 
particles being shed from the alimentary lymphatic tissues being bound by 
cell surface Immunoglobulin A (IgA). This may neutralise free virus 
particles. However, in contradistinction to this view, Lerner et al (1975) 
have isolated Coxsackie B viruses from the faeces of infected humans up to 
70 days after initial detection. These isolated cases may represent immune 
depressed individuals incapable of producing significant levels of 
alimentary IgA necessary for complete masking of viral particles shed from 
the gut lymphatic tissues. If this proposal is true, high, static humoral 
antibody titres may well be more suggestive of an etiological relationship
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between virus and clinical cardiac disease, while the fourfold or greater 
rise or fall in humoral antibody may simply indicate the early and late 
phases r espectively of an unrelated but coincidental infection. 
Prerequisite to accepting "high" concomitant titres as diagnostic of 
etiological infection would be details regarding the background Coxsackie B 
antibody titres in the local population without proven cardiac disease. 
Nicholls and Thomas (1977) regarded paired titres of 1/160 and 1/320 as 
diagnostic of recent infection. This was considered acceptable on the 
basis that routine requests for Coxsackie B virus serology passing through 
the laboratory during a nine month period (during which the sample group 
were selected) had failed to demonstrate titres greater than 1/80. This 
was considered to be the upper threshold of residual antibody in the local 
"normal" population for that particular period, (Nicholls, personal 
communication).
Results from these human studies ar e no t cons is ten t w i th previous 
observations that a proportion of cases of acute myocardial infarction in 
man correlates positively with serologically diagnosed recent Coxsackie B 
virus infection.
DELAYED ANTIBODY RESPONSE AND PREDOMINANCE OF INFECTION IN MALES
Data not in accord with the hypothesis of rapid antibody response 
arises from three patients admitted to hospital following acute myocardial 
infarction. All three patients showed a significant specific antibody rise 
following the acute infarction episode. These patients may represent 
individuals who produce relatively small quantities of antibody, 
predominantly Immunoglobulin M (IgM), during the acute phase viraemia. 
This would prevent high titres of antibody being detected by 
neutralisation. The subsequent gradual increase of neutralising titres may
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represent the increasing production of Coxsackie B virus specific 
Immunoglobulin G (IgG).
Alternatively, these patients may reflect cases of age-related 
immunodepression resulting in delayed or severely decreased production of 
neutralising antibody during the viraemia, or immune tolerance may apply in 
individuals previously expose! to a Coxsackie B virus serotype. Possible 
selective immunod epression of early neutralising IgM may be an important 
factor in influencing the degree of haema togenously disseminated virus to
secondary target organs, such as the heart.
In spite of the lack of correlation between recent Coxsackie B virus 
infection and cardiac infarction a comparison between the groups of the 
Midhurst and Worthing studies and the Midhurst population sample show that 
Coxsackie B4 virus antibody titres ^ 1/512, occur in male AMI group 
patients, at a higher incidence, than in female AMI group patients or the 
other test groups. Thes e r esul ts ar e cons is ten t w i th the observa tion by 
Sainani et al (1968) that overt clinical symptoms, of Coxsackie B viral 
etiology, are more common in males than in females. Certainly, there is a 
higher incidence of acute myocardial infarction in male patients. The 
ratio of male to female patients, with cardiac infarction, from the 
Midhurst and Worthing studies was approximately 2:1. Additionally, the 
incidence and severity of cardiac lesions occur ing after experimental 
Coxsackie B4 virus inoculation, in a CBA/Ca strain mouse model, is greater 
in males than females.
This apparent predominance of virus associated cardiac lesions in
males may result from variation in the concentration of C-21 and 19-nor-
steroids between males and females. Kilbourne (1957) has shown that final 
yields of influenza virus are increased in chick embryos by administration 
of cortisone. Further work has shown that the action of cortisone prevents
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synthesis of interferon in the cell membrane. (Kilbourne et al, 1961). 
Furthermore, it is possible that variation in hormonal levels associated 
with sex differences may influence, either directly or indirectly, affect 
the degree of viral replication in primary target tissues and subsequent 
dissemination to secondary target organs. (Berkovich and Ressel, 1967)
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P A R T  II 
HUMAN STUDIES 
(B)
I N T R O D U C T I O N
Part II comprises a summary of the post mortem reports of four 
patients and a discussion with relation to virology reports compiled from 
data obtained prior to death and post mortem.
A cardiac muscle biopsy was obtained from eleven patients included in 
the total cardiac series from the Midhurst study group. Virus isolation 
attempts were made on tissue from all eleven patients and all samples were 
e x a mined for the presence of Coxsackie B antigen by indirect 
immunofluorescence.
This data was later correlated with isolation and serological data 
from acute phase faecal samples and serum samples. Results for the four 
positive patients are as follows:
ISOLATION INDIRECT
PATIENT SEROLOGY FAECES CARDIAC TISSUE IMMUNOF LUORE S CENCE
D.K. +ve -ve -ve +ve
A.A. +ve -ve +ve +ve
P.B. +ve -ve +ve -ve
G.C. +ve -ve -ve +ve
The remaining seven patients showed negative results for serological, 
isolation and immunofluorescent criteria.
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CASE HISTORY I
Patient: D.K.; Age: 76 years; Sex: Male.
POST MORTEM REPORT
Pericardium: a little straw coloured fluid. Heart: some enlargement, 
weight 470 g. Coronary arteries: both branches of the left coronary artery 
were narrowed by partly calcified atheroma, the right coronary artery was 
of good size for its proximal 2.5 cms but was then narrowed by atheroma. 
Valves: normal. Chambers: the lower half of the endocardium of the left 
ventricle was white in appearance and fibrosed. On cutting the myocardium, 
the lower third of the left ventricle both posteriorly and more so 
anteriorly was replaced by dense scar tissue. A small localised area of 
scarring was present on the posterior surface of the left ventricle 
approximately in its mid portion. Aorta: a moderate degree of atheroma 
with some ulceration was present in both thoracic and abdominal aorta.
Histological examination of the left ventricle revealed extensive 
scarring associated with muscle fibre loss. Scattered macrophages were 
present containing brown pigment granules.
CAUSE OF DEATH
la. Carcinomatosis.
lb. ? Carcinoma right lung.
2. Myocardial infarction (healed) due to atherosclerosis.
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VIROLOGY REPORT
Serum antibody levels
This patient's sera showed an eight-fold decrease in specific 
neutralising antibody titres to Coxsackie B3 virus (1/128 - 1/16) over a 12 
day period.
Virus isolation
None of the Coxsackie virus B serotypes were isolated from either 
acute phase faecal samples or from cardiac muscle biopsy obtained within 
one hour of certified death.
Immunofluorescence
Using indirect immunofluorescent techniques Coxsackie B3 virus antigen 
was localised in the perivascular region of a cardiac biopsy from the 
anterior heart wall (Plate 3). Fluorescence was associated with an area of 
pathological change.
CASE HISTORY II 
Patient: A.A.; Age: 78; Sex: Female.
POST MORTEM REPORT
Pericardium: distended and contained approximately 200 ml of slighly 
bloodstained fluid and lumps of fibrin. On opening the pericardium a
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Photomicrograph of a section of 
cardiac biopsy material from the 
a n t e r i o r  heart wall (x640) showing 
Coxsackie viral antigen localised in 
the perivascular region and associated 
with an area of pathological change.
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fibrinous pericarditis was seen, with strands of fibrin attached to the 
epicardium and also to the inner surface of the pericardium. Heart: some
enlargement, weight 605g, appearing to involve all chambers. 
Coronary arteries: both branches of the left coronary artery showed a 
moderate degree of atheroma with some stenosis. The right coronary artery 
also showed moderate atheroma but the lumen was normal in size. Valves: 
The aortic ring and aortic cusps were partly calcified but the cusps moved 
freely and the valve apppeared competent. Other valves were normal. 
Chambers: The atria were both enlarged with an otherwise normal appearance. 
The myocardium of the left ventricle was a little thicker than normal and 
showed some yellowish discolouration involving the postero-inferior 
portion. The right ventricle was larger in size than normal but the wall 
was of normal thickness. Aorta: the root of the aorta was approximately 
three times its normal size. This change extended throughout the thoracic 
aorta and appeared to be atherosclerotic in origin.
Histological examination of the left ventricle revealed patchy 
fibrosis of the myocardium with a coronary artery, included on the surface, 
being partly occluded by atheroma. The epicardium was infiltrated by 
chronic i n f l a m m a t o r y  cells with thickening and fibrinous surface 
deposition.
CAUSE OF DEATH
la. Pleural effusion and pericarditis.
lb. Myocardial infarction.
lc. Ischaemic heart disease induced by atherosclerosis.
2. Hypertension.
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VIROLOGY REPORT
Serum antibody levels
Acute and convalsescent sera from this patient obtained over a 17 day 
period, showed concomitant high titres to Coxsackie virus B1 (1/512), B2 
(1/256), B3 (1/256) and B4 (1/512). Serum antibody titres from blood 
obtained at autopsy (15 days after convalescent serum sample) remained the 
same for Coxsackie Bl, B2 and B3 virus but Coxsackie B4 virus titres had 
decreased to 1/128.
Virus isolation
Coxsackie B4 virus was isolated in vero cells from a cardiac muscle 
biopsy, obtained within one hour of certified death, but no Coxsackie B 
serotypes were isolated from an acute phase faecal sample.
Immunofluorescence
Indirect immunofluorescent techniques confirmed the presence of 
Coxsackie B4 and B2 virus in the anterior heart wall (Plate 4). Moreover, 
examination of cardiac biopsy material by electron microscopy demonstrated 
the presence of intracytoplasmic inclusion bodies highly indicative of 
viral particles (Plate 5).
CASE HISTORY III 
Patient: P.B.; Age: 69 years; Sex: Male.
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Photomicrograph of a section (x640) of 
cardiac biopsy material from the anterior 
heart wall of patient A. A. Coxsackie B 2 
a n t i g e n  v i s u a l i s e d  b y  i n d i r e c t  
immunofluorescent microscopy and associated 
with an area of pathological change.
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E l e c t r o n  micr o g r a p h  (xl20,000) of biopsy 
material showing inclusion bodies (I.B.) within the 
cytoplasm (C).
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POST MORTEM REPORT
Pericardium: contained some brownish fluid. Heart: enlarged, weight 535g., 
and flabby. Coronary arteries: the anterior branch of the left coronary 
artery was partly occluded by atheroma approximately 1.5 cm from its 
origin, distal to this roughened area the artery was filled with recent 
thrombus. The c i r c u m f l e x  branch was also na r r o w e d  by a t h eroma 
approximately 2.5 cm from its origin. There was some atheroma with 
narrowing in the right coronary artery and 3.5 cm from its origin a small 
recent thrombus was present. Valves: normal. Chambers: recent thrombus 
was adherent to the apex of the left ventricle, a second area of thrombus 
was adherent to the lower portion of the interventricular septum and 
projecting into the left ventricle. The endocardium above these areas was 
white in appearance and fibrosed. The major portion of the anterior wall 
of the left ventricle was thinned and replaced by fibrous tissue. Recent 
infarction was present beneath the thrombus at the apex of the left 
ventricle and also in the lower portion of the interventricular septum. 
The myocardium of the septum above the thrombus was discoloured with small 
reddish and yellow areas. Aorta: a moderate degree of atheroma was present 
in the thoracic aorta with some surface ulceration. This change was more 
marked in the lower portion of the abdominal aorta.
Histological examination of the following revealed as follows; 
Apical infarct and thrombus: Antemortem thrombus, the endocardial portion 
of the thrombus was invaded by fibroblasts and small capillaries. The 
ventricle wall showed extensive muscle fibre loss and replacement by scar 
tissue. Posterior wall and septal thrombus: as for apical infarct and 
thrombus with additional areas of infarcted myocardial muscle fibre. 
Posterior wall left ventricle: Extensive scarring associated with muscle
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fibre loss. R e m a i n i n g  fibres were hypertrophic. A n t e rior- 
wall left ventricle: patches of scarring with muscle fibre loss.
CAUSE OF DEATH
la. Myocardial infarction, due to 
lb. Ischaemic heart disease, due to 
lc. Atherosclerosis.
2. Previous healed myocardial infarction.
VIROLOGY REPORT
Serum antibody levels
This patient exhibited a "delayed" diagnostic rise in neutralising 
antibody titres to Coxsackie B2 over a four month period (1/64 - 1/512). 
Serum from blood obtained at autopsy retained a neutralising titre of 1/512 
to Coxsackie B2 virus.
I
Virus isolation
No Coxsackie B virus serotypes were isolated from an acute phase 
faecal sample but Coxsackie B2 virus was isolated from cardiac biopsy 
material.
Immunofluorescence
Indirect immunofluorescent microscopy failed to demonstrate the 
presence of Coxsackie B viral antigen in cardiac biopsy material.
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CASE HISTORY IV
Patient: G.C.; Age 79 years; Sex: Male.
POST MORTEM REPORT
Pericardium: contained a moderate amount of fat. Heart: enlargement, 
w e i g h t  550g, m a i n l y  due to hypertrophy of the left ventricle. 
Coronary arteries: both branches of the left coronary artery were markedly 
stenosed by well calcified atheroma which was present almost immediately 
after their origins. The right coronary artery was also stenosed by 
calcified atheroma approximately 2 cm from its origin. Valves: the cusps
of the aortic valve were calcified and the left lateral commissure was 
partly fused, otherwise valves were normal. Chambers: the wall of the left 
ventricle was increased to approximately twice normal thickness. A little 
patchy subendocardial fibrosis was present but no recent infarct observed. 
Aorta: a moderate degree of atheroma was present in the thoracic aorta but 
was more marked in the abdominal aorta below the orifices of the renal 
arteries.
Histological examination of the left ventricle and interventricular 
septum revealed numerous small patches of muscle fibre replacement by scar 
tissue.
CAUSE OF DEATH
la. Ischaemic heart disease, due to 
lb. Atherosclerosis.
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VIROLOGY REPORT
Serum antibody levels
A diagnostic rise in Coxsackie B4 virus neutralising titres occured 
over the 14 days between this patients' acute and convalescent sera (1/256 
- 1/1024).
Virus isolation
No Coxsackie B virus serotypes were isolated from an acute phase 
faecal sample or from cardiac biopsy material obtained within one hour of 
certified death.
Immunofluorescence
The presence of Coxsackie B4 antigen in the anterior wall of the heart 
was confirmed by immunofluorescent microscopy (Plate 6). Furthermore, 
electron microscopic examination of heart biopsy material demonstrated 
inclusion bodies within the sarcomere suggestive of virus particles 
(Plate 7).
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localisation of Coxsackie antigen in 
biopsy material from the anterior heart 
indirect immunofluorescent microscopy.
cardiac 
wall by
Electron micrograph (x65,000) of cardiac biopsy material 
from the anterior heart wall showing inclusion bodies (I.B.) 
within the sarcomere (S).
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D I S C U S S I O N  A N D  C O N C L U S I O N S
In the case of three of the four patients good retrospective evidence 
has been produced for a "high-order association" (Lerner and Wilson, 1973) 
between Coxsackie B viruses and at least some of the cardiac symptoms and 
pathological tissue change seen in these cases.
Although the primary cause of death for patient D.K., was recorded as 
carcinomatosis an eight-fold decrease in specific serum neutralising 
antibody titre is suggestive of the drop in antibody levels consistent with 
recovery from viral infection. This is reinforced by the inability to 
recover infective virus from faeces, obtained soon after admission, and 
cardiac biopsy material, obtained after death. Immunoglobulin A (IgA) 
present on the surface of cells lining the gut and in the extra-vascular 
spaces would be expected to have neutralised any infective virus present in 
the lumen of the intestine. Moreover, in accord with evidence from mouse 
studies, where viral antigen is detectable after infective virus is no 
longer isolated, immunofluorescent microscopy has shown the presence of 
Coxsackie B3 antigen in the perivascular region of tissue from the anterior 
heart wall, associated with an area of pathological change. If this 
argument is correct then it is conceivable that the healed myocardial 
infarct scar, considered to result from ischaemia caused by atheromatous 
disease of the coronary vasculature, may have been precipitated during the 
acute phase of the infection. Furthermore, the presence of scattered 
macrophages may reflect residual cellular immune mechanisms employed to 
effect antigen clearance from infected tissues.
The evidence for the "high-order association" for patient A.A., is 
reinforced by isolation of Coxsackie B4 virus from cardiac biopsy material. 
The presence of high titres, in both acute and convalescent serum samples, 
to four Coxsackie B virus serotypes suggests that some may result from
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anamnestic responses as it is unlikely that an infection with all four 
serotypes Bl, B2, B3, and B4 would occur simultaneously (Brit. Med. J., 
1971). However, the presence of both Coxsackie B4 and B2 virus in the 
myocardium has been confirmed by immunofluorescence. Certainly, the four­
fold drop in Coxsackie B4 neutralising titre between the convalescent and 
post mortem serum samples is suggestive of recovery from recent infection. 
The inability to isolate infective virus from an acute phase faecal sample 
probably occurs for the same reasons discussed for patient D.K. It is 
possible, in this patient, that fatal arrhythmias arose as a result of 
pericarditis, with involvement of the underlying myocardium, probably 
aggravated by a circulation already compromised by atherosclerosis. There 
is good evidence to suggest that acute Coxsackie B myocarditis may 
precipitate life threatening arrhythmias. Woodward and McCrumb (1958) 
discuss a case report of a male child appearing normal at the time of birth 
as follows: "Two days prior to the advent of labour his mother had
experienced a brief episode of grippe but was asymptomatic at delivery. 
Three days following delivery, the mother developed an illness associated 
with fever, malaise and leukopaenia which persisted for 72 hours. On the 
4th post-natal day the baby developed fever, irritability and marked 
tachycardia. He remained febrile for about four days during which time a 
bacterial cause of the illness was not found. Tachycardia decreased during 
this period and the baby remained afebrile. There was gradual improvement 
until the 14th post-natal day when tachycardia suddenly recurred and the 
child expired". Coxsackie B2 virus was isolated from faecal material on 
the 4th day of illness and from the myocardium on the day of death. 
Specific Coxsackie B2 antibodies were not detectable in the childs serum 
during the illness but were present in the mothers serum by the 18th day.
An inability to isolate virus from either faecal or cardiac biopsy
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material and demonstrate Coxsackie B viral antigen in cardiac tissue from 
patient P.B.; in the presence of an eight-fold increase in neutralising 
antibody against Coxsackie B3 virus over a 50 day period; suggests complete 
clearance of antigen has occured at the time of obtaining clinical samples. 
Furthermore, all potentially infective cell surface and gut virus may have 
been effectively neutralised by IgA. This delayed antibody response 
possibly reflects a deficiency in antibody response for this patient. 
However, antigen release over the acute and convalescent phase of infection 
would provide a "continuous" stimulus to the immune system resulting in a 
gradual increase in titre. Although the evidence in this case is of a low- 
order association, it is possible that the extensive scarring of the left 
ventricle in this patient may have occured as a result of lesions induced 
following Coxsackie B3 virus infection.
The primary cause of death for patient G.C., was recorded as ischaemic 
heart disease resulting from atherosclerotic stenosis of both right and 
left coronary arteries. However, it is possible that small patches of 
muscle fibre necrosis in the left ventricle and interventricular septum 
resulted from an infection with Coxsackie B4 virus, reinforced by the 
presence of Coxsackie B4 viral antigen in heart biopsy material.
Although cardiac biopsy techniques provide a mechanism for producing 
retrospective evidence of an "association" between virus and cardiac 
syndromes at death, this technique is not commonly employed during life 
because of the risk of haemopericardium and subsequent cardiac tamponade. 
Indeed, the isolation of infective virus from cardiac tissue may only 
represent a coincidental but unrelated infection (Grist, 1977) playing no 
causal role in the development of cardiac symptoms.
It is important to note that failure to isolate infective virus from, 
or demonstrate viral antigen in, cardiac tissues obtained at biopsy is not 
conclusive proof that virus is not present. The amount of tissue obtained
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at biopsy is very small compared with the total volume of heart muscle and 
the biopsy needle may not sample an area of tissue supporting viral 
infection.
It is unlikely that a Coxsackie B virus infection, in any of the 
patients discussed, played a causal role in the pathogenesis of clearly 
evident acute heart disease. However, it is possible that focal lesions 
resulting from a Coxsackie B virus infection, in a patient with a 
circulation compromised by atheromatous disease, may precipitate life 
threatening arrythmias. Furthermore, the persistence of viral antigen in 
the heart tissue beyond the acute phase of infection may well cause 
continued cytotoxic reactions resulting in a chronic, potentially life 
threatening, cardiomyopathy (Cambridge et al, 1979).
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G E N E R A L  D I S C U S S I O N
In the mouse model studied there was little persistence of high 
antibody titres after either primary or secondary antigenic challenge with 
Coxsackie B4 virus. However, in several patients from the Midhurst study 
there was antibody persistence, in some cases for many months. Such a 
difference in response may be explained simply because there is maintenance 
of high levels of humoral antibody, resulting from primary or secondary 
Coxsackie B virus infection, in man but not in the particular mouse strain 
used. However, there may be other explanations. For instance the 
persistence of specific antibody in patients from the Midhurst Study may 
result from the release of viral antigen from an antigen "pool" retained 
within the host tissues which could cause repeated stimulation of the 
immune system. Indeed repeated antigenic challenge of the male MFl/Olac 
strain mouse with Coxsackie B4 virus resulted in sustained high levels of 
h u m o r a l  n e u t r alising antibody in all individuals. F urthermore, 
immunofluorescent studies on cardiac tissue of infected mice show 
persistence of antigen at a time when infective virus particles could not 
be isolated from the heart. This residual "pool" of viral antigen was 
present following primary virus inoculation but did not result in high 
titre antibody persistence. It is interesting that Burch et al. (1967) 
using immunofluorescent techniques demonstrated Coxsackie B viral antigen 
in the heart tissue of apparently uninfected people at routine autopsy but 
details regarding their specific Coxsackie B antibody status were not 
available.
A complicating factor may be that of anamnestic antibody responses. 
Heterotypic responses, of greater magnitude, occurred in the murine model 
used between Coxsackie B serotypes but not between encephalomyocarditis 
virus (EMC) and the Coxsackie B serotypes. Although high levels of
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antibody to one serotype may occur as a result of infection with another 
there is no evidence to suggest that heterotypic antibodies persisted for 
longer than homotypic antibodies.
It is possible that a number of virus types exist which share surface 
antigens with the Coxsackie B group and may therefore stimulate a 
heterotypic antibody response to the latter resulting in persistence of 
antibody in man.
It is also likely that differences in antibody persistence in mouse 
and man result from differences in the pathogenesis of the disease. Man is 
a natural host to the Coxsackie B virus group, the mouse is not. It has 
been shown that infective Coxsackie B virus may be shed from the alimentary 
tract of man up to 70 days following serological evidence of primary 
infection (Lerner et al, 1975) but drops to undetectable levels in the 
mouse strain used 18 days after primary infection. This prolonged presence 
of Infective virus in the alimentary tract of man could provide stimulation 
of the immune system resulting in prolonged antibody production.
It is possible that conventional methods of serological diagnosis of 
recent infection may not be applicable to the problem of Coxsackie B virus 
associated heart disease in man but failure to demonstrate diagnostic 
changes in specific antibody titres in conjunction with manifestations of 
cardiac disease does not prevent the diagnosis of recent infection by other 
means. Conventionally, isolation of viral specific Immunoglobulin M (Ig M) 
is considered reliable evidence of recent infection. Unfortunately, the 
ability of Coxsackie B viruses to initiate anamnestic antibody responses 
reduces any significance that might be drawn from a demonstration of 
Coxsackie B viral specific IgM antibody associated with proven cardiac 
disease, especially in view of the widespread incidence of Coxsackie B 
virus infections and the high probability of mild or sub-clinical infection
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prior to the onset of severe cardiac disease. However, the possibility 
remains that a proportion of cases of human heart disease, associated with 
Coxsackie B virus infections, occur in the months following Infection as a 
chronic degenerative process. The demonstration of persistence of 
Coxsackie B viral antigen in cardiac tissues following experimental 
inoculation in mice suggests the possibility of a continuous chronic 
reaction. Such a reaction in man might lead to a clinically distinct 
degenerative cardiomyopathy.
Studies using a murine model show that lesions, consistent with those 
seen in man suffering acute myocardial infarction, appear after Coxsackie B 
virus inoculation. Specific serum neutralising antibody titres to 
Coxsackie B virus have usually risen to high levels by the time lesions 
become histologically apparent. However, severe lesions have been shown to 
be caused by a cytotoxic T-lymphocyte reaction and should such virus/T-cell 
mediated focal necrosis occur in man it might lead to a differential 
diagnosis of acute myocardial infarction; a confusion compounded by the 
release, in mice, of significant levels of cardio-specific creatine kinase 
following T-cell mediated focal necrosis of heart tissues. Little or no 
specific cardiac enzyme is released following viral infection of the heart 
tissues in T-cell deprived mice.
Although it has been demonstrated that Coxsackie B viruses are capable 
of infecting peripheral blood leukocytes (Gomez et al, 1980), thereby 
exhibiting the potential for modifying cells of the cellular and humoral 
immune system, no evidence was produced during this study to suggest 
Coxsackie B virus infections mediated enhancement or depression of the 
immune response. Coxsackie B viruses have been shown to inhibit the 
phagocytic activity of horse and guinea pig leukocytes for bacteria 
(Kantock and Dubowska-Inglot, 1960). Furthermore, the degree of inhibition 
was closely associated with the concentration of virus present and the time
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course of action. It is not known how this inhibition of leukocyte 
phagocytic activity may influence the progression of disease but Harford 
and Hara (1950) have shown that mice infected with influenza viruses appear 
more susceptible to pneumonia, they noted a reduction in the migration 
capacity of phagocytic cells.
In spite of there being no evidence suggesting that antibody- mediated 
cytotoxicity plays a role in the production of cardiac lesions in vivo 
there is evidence suggesting that immune complexes, both circulating and 
tissue bound, may have the ability to initiate pathological change in 
certain tissues in both man (Gocke et al, 1970) and mouse (Oldstone and 
Dixon, 1971). Probably, of greatest significance is the association 
between the hepatitis virus and polyarteritis nodosa (Gocke et al, 1970). 
These workers showed an association between the lesions characteristic of 
this disease and tissue bound HBs Ag homologous immunoglobulin M and 
complement. It is possible that such a mechanism may occur to the cells 
lining the coronary arteries causing transient hypertrophy (Burch and 
Shewey, 1976). This may result in severe focal ischaemia of the myocardium 
precipitating the classical symptoms of acute myocardial infarction. Such 
a situation may account for certain cases of cardiac infarction in the 
absence of pathological evidence of thrombotic occlusion or atheroma. 
Focal damage by such a mechanism at an early age may well initiate or 
accelerate the production of atheromatous lesions in the coronary vessels.
In some virus infections, notably lymphocytic choriomeningitis of 
mice, the cell-mediated T-lymphocyte response is largely responsible for 
the pathological manifestations of the disease but in others it may be of 
considerably less importance. Certainly, the production of focal cardiac 
lesions in mice, resulting from Coxsackie B virus infections, is closely 
associated with the intact T-lymphocyte response (Woodruff and Woodruff,
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1974; Wong et al, 1977(c)) and consistent with the focal lesions produced 
in the human myocardium following an infarct. They would certainly be 
capable of invoking the a b n o r m a l i t i e s  of electrical transmission 
characteristic of the arrythmias associated with acute myocardial 
infarction in man.
When considering the problem of autoimmune reactions and their 
possible role in viral heart disease, it is important to distinguish 
between immune reactions directed against virus specified antigen and those 
directed against host antigens (true auto-antigens). Such distinctions 
would be difficult to make, especially when viruses have been transmitted 
to offspring from the mother and may be present thoughout life. Although 
the role of autoimmune processes in the pathogenesis of cardiac disease has 
been the subject of numerous studies in humans (Kaplan, 1969) and animals 
(Thompson and Halbert, 1971), Davies et al (1964) were unable to correlate
the extent of cardiac lesions with the titre of circulating anti-heart
antibodies. Grabar (1957) suggested the possibility that necrosis of heart 
muscle or commissurotomy may induce changes in the structure of proteins 
endowing them with an auto-antigenic quality. Subsequent interaction 
between homologous antibody and intra-cellular structures may markedly 
impair cellular function. The relationship of these findings to heart 
disease in humans is unclear. Circulating cardiac auto-antibodies have 
been shown to exist in humans (Shaper et al, 1968; Laufer et al 1970) but
their role, if any, in the causation of heart disease is not yet
established. It is not clear whether these auto-antibodies are formed 
after primary cardiac tissue damage or as a response to antigenic products 
with cross-reacting capabilities to heart tissue.
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CONCLUSIONS AND PROPOSALS FOR FURTHER STUDY
Until fairly recently cell mediated immunopathological processes had 
only been demonstrated for diseases caused by one group of viruses, the 
arenaviruses, of which the prototype is lymphocytic choriomeningitis virus. 
It has now been shown to play an important role in the development of 
experimental cardiac lesions in mice. Cardiac lesions are associated with 
varying degrees of mononuclear cell infiltration of necrotic cardiac 
fibres. Adult thymectomy in normal mice followed by bone marrow stem cell 
reconstitution reduced the severity of lesions showing that damage is 
associated with an intact T-lymphocyte response. Supportive in vitro 
evidence shows a significant decrease in spleen cell toxicity for "carrier" 
cells following a decrease in T-cell numbers after treatment with anti-Thy- 
1-2 antiserum. Thus activated T-lymphocytes have been incriminated in 
virus associated acute cardiac lesions in adult CBA/Ca male mice. A less 
marked T-cell cytotoxicity has been observed in female mice with increasing 
involvement of other cellular immune components.
Maximal in vitro and in vivo cytotoxicity is observed only when target 
cells and immune spleen cell donors are of the same strain suggesting the 
capacity for cytolytic interaction is dependent on genetic factors. 
Possibly relying on H-2 compatibility between lymphocytes and target cell 
donors.
It is proposed that histocompatibility antigens, modified by viral 
infection, are recognised by thymus derived lymphocytes (T-cells) which 
undergo clonal expansion with the subsequent immune elimination of cells 
bearing non-self antigenic determinants.
If a method of disease detection, employing serological techniques, is
/
to remain a viable form of diagnosis for virus associated heart disease in 
man, despite the uncertainties of individual immune response, a more
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specific test will have to be developed. A sensitive, quantitative 
technique for detecting Immunoglobulin M (IgM) should be designed. This 
would enable, in individuals with concomitant high titres, a prediction of 
the stage of infection at which samples were taken. Such a study would 
require the conclusive demonstration that IgM antibody production in man, 
in response to Coxsackie B virus infections, followed conventional patterns 
for acute infection and was not produced during the chronic phase of 
infection.
Although there is evidence that Coxsackie B viruses are capable of 
infecting lymphoid tissue in man a detailed evaluation should be carried 
out on the effects of these viruses on the different cells of the reticulo­
endothelial system, particularly T and B lymphocytes and phagocytic 
macrophages. In this way it would be possible to ascertain whether 
effects, either depressive or enhancing, were directed at the cellular or 
humoral response. Furthermore, whether any effects directed at the humoral 
response were selective for different immunoglobulin types. If such a 
depressive effect took place with Coxsackie B virus infections it might 
well prolong the exposure of susceptible tissue to this virus thereby 
increasing the severity of pathological changes.
The possibility that immune complexes may damage coronary vessels 
resulting in transient i s c haemia or precipitating the onset of 
atherosclerosis should be studied further. Immunofluorescent studies would 
confirm the presence of Coxsackie B viral antigen in the coronary 
vasculature of human heart material obtained by biopsy or early post 
mortem.
Although it has been shown clearly that Coxsackie B viral antibody has 
a cytolytic effect on virus infected "carrier" cells in vitro detailed 
studies should be implemented to ascertain whether cytotoxic antibody plays
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any significant role in the production of heart disease in vivo. The 
effect of administration of cytolytic Coxsackie B virus antibody on certain 
infected models, with various levels of blood complement present, should be 
investigated. Additionally the presence of antibody and complement on 
infected target cells could be demonstrated by immunofluorescence. This 
would be particularly applicable at the sites of tissue injury.
Attempts should be made to determine the role, if any, of cell- 
mediated tissue damage in certain virus associated cardiac syndromes in 
man. Preliminary investigations should be made on patients with variable 
cardiac diagnoses to determine the cytotoxic potential, if any, for 
peripheral blood lymphocytes against Coxsackie B virus infected "carrier" 
cells. Because of the reduced cytotoxic action when lymphocyte donors 
differ in strain or species from "carrier" cell hosts it may prove 
necessary to use a continuous line of human heart cells as infected target 
cells. Even primary cell lines from muscle biopsy tissue would be 
feasible providing a "carrier" cell condition could be established.
Despite the lack of evidence to suggest acute heart disease results 
from an auto-immune reaction it is possible that progressive degenerative 
cardiomyopathy following recent Coxsackie B virus infection, may result 
from auto-immune processes. In these instances a clear distinction should 
be made between responses to cell bound viral antigen and reactions against 
host antigens or host antigen possibly altered by virus infection.
Finally, in view of the correlation in mice between H-2 type and 
susceptibility to certain virus induced diseases, and the analogy between 
H-2 and HL-A antigens, studies should be implemented to look further at the 
association between HL-A phenotype and susceptibility to certain diseases. 
Especially cardiac diseases of possible viral etiology.
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STATISTICAL METHODS
STATISTICAL METHODS
All statistical evaluation of results was performed using non- 
parametric statistical methods.
Standard deviation of mean values was calculated according to the 
following formula:
i/Ex2 - <Ex)2 t n
S.D. = W  -------------------
n-1
The probability of differences between two independent groups being 
due to chance was calculated by means of the chi-square test (Snedecor and 
Cochran, 1967) using the following formula:
.2 V (^°-E>2
The probability of differences between geometric mean titres being due 
to chance was calculated by means of Wilcoxon's signed rank test (Siegel, 
1956).
Significant differences between groups in the in vitro cytotoxicity 
testing were tested for using the Mann-Whitney "u" test (Siegel, 1956).
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